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Abstract 
 
The proper workings of an organism rely on the accurate expression of genes 
throughout its lifetime. An important determinant for protein production is the availability 
of template mRNA molecules, the net effect of which is governed by their rates of 
synthesis vs. their rates of degradation. Normal mRNAs are proposed to be relatively 
stable in the cytoplasm while present in a protective, circularized conformation – the 
closed loop – through eIF4G-bridged interactions with 3’-bound poly(A) binding protein 
(Pab1p) and 5’-bound eIF4E. Introduction of a premature nonsense codon into an 
otherwise normal mRNA results in its rapid destabilization in cells, suggesting that not 
all stop codons behave the same, and events at premature termination events that lead 
to accelerated degradation of nonsense-containing mRNAs likely differ from those at 
normal termination, in which normal decay rates are maintained. The enhanced 
degradation observed for nonsense-containing mRNAs occurs through an evolutionarily 
conserved pathway involving the products of the UPF1, UPF2/NMD2, and UPF3 genes, 
the precise biochemical roles of which have remained elusive. We have developed a 
yeast cell-free translation system that allows us to assay biochemical events occurring 
at premature termination codons, compare them to those occurring at normal 
terminators, and study the role of Upf1p in these events. We find that premature 
termination is an inefficient process compared to normal termination and that one 
outcome of termination at a premature termination codon (PTC) is reinitiation at a 
nearby start codon. This in vitro post-termination reinitiation phenotype is dependent on 
the presence of Upf1p, a finding we have recapitulated in vivo. We also developed 
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biochemical assays to define a role for Upf1p in translation following premature 
termination in vitro and find that Upf1p is involved in post-termination ribosome 
dissociation and reutilization. Supporting this idea are our findings that Upf1p 
predominantly cosediments with purified 40S ribosomal subunits. Finally, using our in 
vitro translation/toeprinting system, we have further characterized events leading to the 
formation of the mRNA closed loop structure and find that two states of the closed loop 
exist. The first requires the preinitiation 48S complex and includes Pab1p, eIF4G, 
eIF4E, and eIF3, whereas the second is formed after 60S joining and additionally 
requires the translation termination factors eRF1 and eRF3. 
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Chapter I - Introduction 
 
Overview 
The respective levels of individual cellular mRNAs are an important determinant 
of gene expression. The advent of accurate multiplexed quantitative methodologies, 
such as microarray analyses, have allowed genome-wide views of changes in mRNA 
levels under different conditions (He et al. 2003; Mata et al. 2005), leading to the use of 
transcript abundance as a hallmark with which to predict changes in pathway activities 
(Johansson et al. 2007). Although transcriptional activation has been a predominant 
focus of studies seeking to elucidate the mechanisms by which steady-state levels of all 
RNAs are controlled, it is critical to recognize that these levels are reflective of the sum 
of both transcript synthesis as well as degradation. In addition, many RNA degradation 
pathways are affected by translation (Doma and Parker 2007). There is growing 
appreciation of the interplay between translation and RNA decay factors and the work 
described in this thesis provides biochemical evidence for a translational role for factors 
involved in nonsense-mediated mRNA decay, a pathway in cells that eliminates mRNA 
transcripts that prematurely terminate translation. This chapter will introduce our current 
understanding of mRNA stability and its relationship to translation, the pathways 
involved in cytoplasmic mRNA degradation, and mechanisms that mediate RNA quality 
control, including a detailed description of the nonsense-mediated mRNA decay 
pathway. I will conclude by providing the rationale for the work described in the 
remaining chapters of the thesis.    
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Translation, mRNA stability determinants, and the closed loop model 
The generation of most mRNAs involves nuclear processing events that result in 
the modification of the 5’ end with a 7-methyl guanosine cap structure and, with the 
exception of histone mRNAs, a 3’ poly(A) tail. Work conducted in a variety of model 
systems has shown that these features are important for the translatability of an mRNA, 
in terms of both translational efficiency as well as mRNA stability. Both have been found 
to be required for the translation and stabilities of mRNAs in different systems (Peltz et 
al. 1987; Munroe and Jacobson 1990; Gallie 1991). Introduction of synthetic RNAs 
differing in cap and/or poly(A) status have demonstrated that these structures act 
synergistically to stimulate translation in vivo (Gallie 1991). Experiments conducted in 
reticulocyte cell-free extracts using mRNAs that differ only in the length of their poly(A) 
tails demonstrated that both modifications were necessary for optimal translation of  the 
in vitro-synthesized VSV.N and rabbit β-globin transcripts. Poly(A)- or uncapped RNAs 
were translated two-fold less and uncapped,poly(A)- transcripts were translated four-fold 
less than the capped, polyadenylated mRNAs, suggesting that each modification was 
important for the translatability of the message (Munroe and Jacobson 1990). 
Cytoplasmic poly(A)-binding protein [PABP; Pab1p in yeast; (Sachs et al. 1986)] has 
been shown to play a role in determining translational efficiency and that suppressors of 
pab1 mutants (spb mutants) in yeast include those affecting 60S ribosomal subunits 
(Sachs and Davis 1990).  
3
A relationship between poly(A) metabolism and mRNA stability has also been 
noted. It has been observed that decay of individual mRNAs is preceded by shortening 
of the poly(A) tail (Muhlrad and Parker 1992; Hsu and Stevens 1993) and mRNAs 
lacking poly(A) tails are preferentially degraded in Xenopus oocytes or crude extracts 
(Huez et al. 1978; Peltz and Ross 1987). Decay intermediates that accumulate when 
the 5’ to 3’ Xrn1p exoribonuclease is inhibited show shortened poly(A) tails (Shyu et al. 
1991; Hsu and Stevens 1993; Muhlrad et al. 1994). The relationship between 
deadenylation and decay has been demonstrated to be present for mRNAs with a range 
of decay rates and has been found to be dependent on specific sequence elements 
(see below). Unstable mRNAs harboring such sequence elements promote rapid 
deadenylation and decay of the message, such that a block in one process usually 
leads to a block in the other (Shyu et al. 1991; Muhlrad and Parker 1992).   
The “closed loop” model has been proposed to account for the requirement of 
structures found at either end of the mRNA (the 5’ cap and 3’ poly(A) tail and associated 
PABP) to stimulate translation and prevent degradation of an mRNA. This model 
postulates that the poly(A) tail and its associated PABP acts as a translational 
enhancer, a function achieved by the interaction of factors located at the 5’ and 3’ ends 
of an mRNA to form a closed loop structure thereby allowing the Pab1p located at the 3’ 
end of the message to stimulate the formation of 80S ribosomal complexes (Munroe 
and Jacobson 1990). Such a model is supported by electron micrographs of circular 
polysomes (Bloemendal et al. 1967; Hsu and Coca-Prados 1979) and structural maps 
of rabbit α-globin and murine β-globin mRNAs which suggested that the 5’ and 3’ ends 
of the mRNAs were in close proximity (Heindell et al. 1978; Lockard et al. 1986). The 
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closed loop model further predicts that as a consequence of the ability of Pab1p to 
stimulate 80S formation, the 5’ cap remains protected from decapping enzymes and the 
RNA is protected from degradation (Jacobson 1996). Further support for this model 
comes from experiments showing that yeast Pab1p can physically interact with the 
eIF4G component of the eIF4F complex (Tarun and Sachs 1996). Moreover, atomic 
force microscopy has shown that purified eIF4e, eIF4G, and Pab1p can circularize a 
capped, polyadenylated RNA (Wells et al. 1998). Electron microscopy studies in various 
systems have visualized polyribosomes as circular structures (Yazaki et al. 2000; Madin 
et al. 2004) and polyribsomes formed by a wheat-germ continuous cell-free translation 
system have been found to form a double-row structure in which small subunits of non-
adjacent ribosomes are in close proximity (Kopeina et al. 2008). 
In addition to mRNA 5’ and 3’-associated factors, other studies looking at 
determinants of mRNA stability in various systems have also suggested that the 
processes of translation and mRNA turnover are linked [reviewed in (Peltz et al. 1991; 
Jacobson and Peltz 1996; Jacobson and Peltz 2000)]. It has been observed using 
chimeric constructs in yeast that the MATα1 coding region contains an instability 
element and that translation of this region is required for rapid decay of the transcript 
(Parker and Jacobson 1990). Similar observations have been made for the unstable 
HIS3 and STE3 mRNAs (Heaton et al. 1992; Herrick and Jacobson 1992). The 
presence of an early stop codon in an ORF has also been found to destabilize an 
mRNA implying that impaired translation of an mRNA can hasten its degradation in a 
process termed nonsense-mediated mRNA decay [NMD; (Losson and Lacroute 1979)]. 
This inverse correlation is strengthened by the observation that coexpression of a 
5
nonsense-suppressing tRNA leads to restoration of a normal decay rate for the PTC-
containing mRNA (Losson and Lacroute 1979; Gozalbo and Hohmann 1990) or that 
altered translation termination factors that suppress termination can antagonize NMD 
(Keeling et al. 2004). 
 
General cytoplasmic mRNA turnover 
 RNA decay mechanisms have been most extensively studied to understand the 
fate of mRNAs in the cytoplasm. Proper mRNP packaging allows the export of the 
mRNA to the cytoplasm where it likely is maintained in a “circularized” state, interacts 
with the protein synthesis machinery, and undergoes translation. During the life of an 
mRNA molecule in the cytoplasm, progressive deadenylation of the 3’-poly(A) tail [by 
the Ccr4-NOT deadenylase complex in yeast (Tucker et al. 2001); or PARN in human 
cells (Korner and Wahle 1997)] can lead to the gradual loss of bound Pab1p and 
presumably disruption of the closed-loop structure of the mRNP. This leads to the 
association of additional factors with the mRNA, accessibility of the 5’ cap to the 
Dcp1p/Dcp2p decapping complex and subsequent 5’?3’ exonucleolytic digestion of the 
decapped mRNA by the Xrn1p exoribonuclease (Garneau et al. 2007). Alternatively, 
3’?5’ decay of the mRNA can occur via the the multisubunit exosome complex 
(Beelman and Parker 1995). Thus, one mechanism for turnover of many cytoplasmic 
mRNAs is a deadenylation-dependent, 5’?3’ process that is regulated by the rate of 
decapping. Given its importance to the decay pathway, it is not surprising that efficient 
decapping requires the activity of several accessory factors [reviewed in (Coller and 
Parker 2004)]. Following deadenylation, the activities of the heptameric Lsm1p-7p 
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complex, the Dhh1p RNA helicase (also known as RCK/p54 or Me31B in higher 
eukaryotes), and Pat1p are proposed to enable recruitment of the decapping complex 
(Fischer and Weis 2002), since loss of any of these factors leads to the accumulation of 
capped, deadenylated mRNAs. In addition to their roles as stimulators of Dcp1p/Dcp2p 
activity, Dhh1p and Pat1p also behave as translational repressors (Coller and Parker 
2005). Other factors that act as enhancers of mRNA decapping (EDC) activity are the 
Edc1, Edc2, and Edc3 (Lsm16) proteins. Edc1p and Edc2p have been shown to be 
RNA-binding proteins that interact with the Dcp1p/Dcp2p complex (Dunckley et al. 
2001; Schwartz et al. 2003). Edc3p is unique in seemingly being rate-limiting for the 
regulated degradation of only two transcripts in yeast – the YRA1 pre-mRNA (Dong et 
al. 2007) and RPS28B mRNA (Badis et al. 2004).  
Following deadenylation, an alternative pathway can degrade mRNA. The 
exosome, a large multisubunit complex that acts in the nucleus and the cytoplasm can 
mediate 3’?5’ mRNA decay (Mitchell et al. 1997; Allmang et al. 1999). A nine subunit 
exosome core comprised of catalytically inactive 3’?5’ prokaryotic exonuclease 
homologues is present in both the nucleus and the cytoplasm, with the complex in each 
compartment possessing at least one additional defining catalytic factor (Allmang et al. 
1999). Structural and functional studies [reviewed in (Schmid and Jensen 2008)] have 
determined that the yeast exosome is composed of 11 subunits, nine of which (Rrp4p, 
Rrp40p, Csl4p, Ski6p/Rrp41p, Rrp42p, Rrp43p, Rrp45p, Rrp46p, Mtr3p) comprise a 
nuclease-free scaffold. The tenth subunit, Dis3p/Rrp44p, is a nuclease component, and 
the eleventh subunit is either the 3’?5’ exonuclease Rrp6p (found in the nuclear 
exosome) or Ski7p (in the cytoplasmic exosome). The exosome structure appears to be 
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conserved in humans, except that: i) the association of Dis3p/Rrp44p is not as stable 
with the 9-subunit scaffold as in yeast (Chen et al. 2001); ii) Rrp6p in humans may be 
present in both the nucleus and cytoplasm (van Dijk et al. 2007); and iii) humans may 
have an additional nuclear subunit, MPP6, not present in yeast (Schilders et al. 2005). 
Modeling of the exosome suggests a channel-containing ring-like structure formed by 
the 9-subunit scaffold, with the location of Dis3p/Rrp44p remaining ill-defined (Liu et al. 
2006). Until recently, it was thought that the exosome possessed only 3’?5’ 
exonuclease activity. However, recent work has demonstrated that Dis3p/Rrp44p has 
an endoribonuclease activity mediated through a highly conserved PIN domain at its N-
terminus (Lebreton et al. 2008). Exosome activity in the cytoplasm requires the 
Ski2p/Ski3p/Ski8p complex which is thought to be recruited to the exosome via 
interaction with Ski7p (Wang et al. 2005).   
 In the yeast Schizosaccharomyces pombe, an additional pathway has been 
identified in which some mRNAs do not undergo deadenylation prior to decapping. 
Instead, Lsm1p-dependent decapping is preceded by the addition of one to two uridyl 
residues to the 3’ end of the polyadenylated mRNA by Cid1p, a putative poly(U) 
polymerase (PUP) and/or terminal uridyl transferase (TUTase) (Rissland and Norbury 
2009). Additional transcripts that undergo poly(U)-dependent degradation are the 
metazoan histone RNAs, which are unique in not possessing a poly(A) tail (Marzluff et 
al. 2008). Instead, the 3’-end of the transcript ends in a conserved stem-loop that is the 
binding site for a stem-loop binding protein, SLBP1. Bridging of histone mRNA 5’ and 3’ 
ends is effected by SLBP-interacting protein 1 (SLIP1), which interacts with both SLBP 
and eIF4G. Accelerated degradation of histone mRNAs occurs upon termination of DNA 
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synthesis at the end of S-phase in cells. SLBP, in the presence of the ATR kinase and 
the NMD factor Upf1p (see below), acts to recruit factors involved in poly(U) addition, 
followed by binding of the heptameric Lsm1p-7p complex, and the triggering of 
exosome-mediated 3’?5’ decay. This pathway is not the exclusive mode of histone 
mRNA decay since these RNAs can also serve as substrates for decapping by the 
Dcp1p/2p complex and 5’?3’ decay by Xrn1p (Mullen and Marzluff 2008).  
It has been proposed that degradation of mRNAs in the cytoplasm may take 
place in P bodies, discrete foci highly enriched in components of the decay machinery 
(Dcp1p/Dcp2p, Pat1p, Dhh1p, Lsm1-7p, and Xrn1p, among others) into which 
translationally repressed mRNAs are thought to localize to undergo degradation (Parker 
and Sheth 2007). However, the significance of P bodies remains unclear since recent 
evidence suggests that assembly of these structures is not essential for mRNA decay 
(Hu et al. 2009; Stalder and Muhlemann 2009). P bodies have been detected in all 
eukaryotes in which they have been sought, although their composition varies 
depending on the organism (Parker and Sheth 2007). P body assembly and size appear 
to depend on the pool of nontranslating, ribosome-free mRNAs (Teixeira et al. 2005). 
Overexpression of a nontranslating mRNA fragment leads to larger P bodies, as does 
inhibition of translation initiation under conditions of stress, or through the use of 
conditional alleles of initiation factors (Kedersha et al. 2005; Teixeira et al. 2005). 
However, inhibition of translation elongation by treatment of cells with cycloheximide, 
which traps mRNAs associated with ribosomes, leads to a loss of P bodies suggesting 
an inverse relationship between ribosome-associated mRNAs and P bodies (Sheth and 
Parker 2003; Teixeira et al. 2005). Translational repression is thought to be an 
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upstream step in the compartmentalization of mRNPs to P bodies, since loss of Pat1p 
and/or Dhh1p, which can act as translational repressors, leads to a loss in observable P 
bodies and increased accumulation of the mRNAs in polysomes (Sheth and Parker 
2003). Conversely, overexpression of Dhh1p or Pat1p leads to increased translation 
repression and increased P body formation (Coller and Parker 2005). 
 
Conditional mRNA decay through protein binding   
 The presence of a cap and poly(A) tail at either end of an mRNA and the factors 
that associate with them to confer stability from cellular nucleases highlight the 
importance of both cis-acting sequence elements and sequence-specific trans-acting 
factors in regulating mRNA decay. mRNA stability determinants are usually present in 
the 3’-untranslated regions (UTRs) of the mRNAs they regulate, although coding region 
and 5’-UTR elements have also been described (Tucker and Parker 2000).  
One of the most well-characterized 3’-UTR sequence determinants is the 
mammalian adenylate-uridylate rich element (ARE) present in many metazoan 
transcripts that exhibit rapid response to cellular cues such as those encoding 
cytokines, proto-oncogenes, and interferons [reviewed in (Khabar 2005)]. AREs were 
originally defined as having the pentameric sequence AUUUA, but have since been 
further subclassified according to the number and context of the AUUUA pentamers 
(Chen and Shyu 1995). These sequences can be bound by ARE-binding proteins (ARE-
BPs) to stabilize or destabilize ARE-containing transcripts (Khabar 2005). The Hu family 
of ARE-BPs is comprised of four members - HuR (HuA), HuB (Hel-N1), HuC, and HuD 
– and these proteins are mammalian homologs of Drosophila ELAV proteins that 
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possess mRNA stabilizing effects. HuR, the best studied member, is ubiquitous, 
contains three RNA recognition motifs (RRMs), and targets transcripts such as those 
derived from the TNF, IL-3, and VEGF genes. Other classes of ARE-BPs target mRNAs 
for degradation. These include the RRM-containing AU-rich binding factor 1 (AUF1) and 
the KH splicing regulatory protein, KSRP. Originally identified as a promoter of c-myc 
degradation in vitro, AUF1 has four functionally distinct isoforms (p37, p40, p42, and 
p45). A different structural class of destabilizing ARE-BPs, typified by CCCH-type zinc 
fingers, includes tristetraprolin (TTP), BRF1, and BRF2. TTP has been found to bind 
and destabilize the TNF-α, IL-3, GM-CSF, and COX-2 transcripts. T-cell internal antigen 
1 (TIA-1) and TIA-related protein (TIAR) constitute a set of ARE-BPs that do not lead to 
mRNA decay upon binding, but instead induce translational silencing and aggregation 
of TNF-α mRNA into stress granules. RHAU is an RNA helicase that was isolated as an 
ARE-BP of the urokinase plasminogen activator mRNA (Meister and Tuschl 2004). 
Destabilizing AREs appear to function by enhancing the recruitment of decay factors to 
target mRNAs. The ARE itself has been seen to interact directly with the exosome 
(Gitlin and Andino 2003) and ARE-BPs can directly/indirectly interact with mRNA decay 
factors [reviewed in (Garneau et al. 2007)]. AUF1(p37), KSRP, RHAU, and TTP have 
also all been found to interact with the exosome. KSRP and RHAU also bind to the 
PARN deadenylase, while TTP has been shown to interact with the decapping enzyme 
and the CCR4 deadenylase to modulate PARN activity in vitro. The mechanism by 
which the Hu proteins stabilize their targets is not fully understood. It is thought that they 
might either compete with destabilizing factors for binding to AREs or somehow 
enhance PABP:poly(A) interaction to prevent deadenylation. This is thought to be the 
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mechanism for other mRNA stabilizing elements such as the U-rich ARE sequence 
recognized by Pub1p in yeast or poly(C)-rich elements recognized by KH-domain RNA 
binding proteins. 
Another 3’-UTR sequence-specific modulator of mRNA stability is the 
evolutionarily conserved PUF family of proteins that have been proposed to support the 
mitotic proliferation of stem cells [reviewed in (Wickens et al. 2002)]. PUF proteins 
usually have eight consecutive Puf repeats, each about 40 amino acids long, that form a 
three-helix domain that stacks into a crescent-shaped structure thought to bind RNA 
targets on one surface and interacting proteins on the other. PUF target sequences are 
sometimes referred to as Nanos Response Elements (NREs), and have a “UGUR” core 
recognition sequence (Wickens et al. 2002). Individual PUFs can target multiple 
mRNAs, and PUF target specificity is mediated in part by interactions with other 3’-UTR-
binding proteins such as Nanos and cytoplasmic polyadenylation element-binding 
proteins [CPEBs; (Wickens et al. 2002)]. PUFs function to enhance degradation of 
target mRNAs by accelerating deadenylation (Olivas and Parker 2000). Puf3p in yeast 
can also promote decapping after deadenylation (Olivas and Parker 2000), while 
Pumilio may effect deadenylation-independent repression of hunchback mRNAs in 
Drosophila (Chagnovich and Lehmann 2001).   
The iron-response element (IRE), a cis-acting stem-loop sequence that is 
present in the 5’ or 3’ UTRs of certain mammalian mRNAs involved in iron metabolism, 
is modulated through the binding of the iron response proteins, IRP1 and IRP2. 
Whereas 5’-UTR localized IREs act to repress translation of mRNA [e.g., ferritin mRNA; 
(Aziz and Munro 1987; Hentze et al. 1987)], those in the 3’-UTR appear to modulate 
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mRNA stability (Leipuviene and Theil 2007). Transferrin receptor 1 (TfR1) mRNA 
contains five IRE stem-loops that constitute a 3’-UTR instability element (Casey et al. 
1988). The TfR1 mRNA also contains an ARE, which confers a short half-life to the 
mRNA through a deadenylation-independent endonucleolytic cleavage event in the 
absence of IRPs (Mullner et al. 1989). IRP binding to the IREs in iron-deficient cells 
blocks this cleavage event and increases the half-life of the TfR1 mRNA, leading to 
production of the receptor and to increased iron uptake into cells (Mullner et al. 1989). 
As previously mentioned, metazoan histone RNA decay is regulated through the 
binding of SLBP to the stem-loop at the 3’ end of the histone RNAs (Marzluff et al. 
2008). This degradation pathway also requires Upf1p, a putative RNA helicase involved 
in the elimination of mRNAs containing premature translation termination codons (see 
below), which is thought to bind SLBP and stimulate poly(U) addition (Mullen and 
Marzluff 2008). Another mammalian pathway that utilizes Upf1p in the absence of an 
abnormally positioned stop codon is the Staufen 1-mediated decay (SMD) pathway, in 
which Staufen 1 (STAU1) recruits Upf1p to the 3’-UTR of the ARF1 mRNA to stimulate 
its degradation (Kim et al. 2005). 
 
Conditional mRNA decay through RNA interference 
 Small non-coding RNAs (ncRNAs) – which include antisense transcripts, small 
interfering RNAs (siRNAs), and microRNAs (miRNAs) – play critical roles in maintaining 
gene expression in eukaryotes by binding to complementary/near-complementary sites 
on target RNAs and affecting their degradation or translation. Although originally 
thought to be restricted to multicellular organisms, recent evidence suggests that similar 
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mechanisms may operate in some yeasts (Drinnenberg et al. 2009). RNA interference 
(RNAi) has mainly been characterized through the effects of siRNAs and miRNAs, each 
of which follows a distinct pathway for biogenesis (Meister and Tuschl 2004). siRNAs 
are 21-23 nucleotide RNA molecules that are usually perfectly complementary to their 
target sequences. They constitute a part of the Argonaute (AGO) RNA-induced 
silencing complex (RISC), a multiprotein complex that uses the siRNA strand to 
recognize the complementary target sites on mRNAs and induce their degradation. 
miRNAs are 20-25 nucleotides long, may have mismatches to their target sequences 
and are also present in multiprotein miRNP/RISC complexes containing an AGO family 
member. mRNA degradation by RISCs/miRNPs is thought to occur by inducing 
cleavages at sites of the RNA duplexes, although recent evidence suggests that 
miRNAs can trigger deadenylation by the CAF1-CCR4 deadenylase (Chen et al. 2009; 
Fabian et al. 2009). These mechanisms are thought to function in innate immune 
responses against viruses and transposable elements (Gitlin et al. 2002). Many 
endogenous genes also contain miRNA binding sites in their 3’ UTRs, which serve to 
regulate target mRNA expression during different cellular processes (Taft et al. 2009).  
 Antisense transcripts to specific mRNAs can also act to stabilize their target 
transcripts (Faghihi and Wahlestedt 2009), e.g., an antisense transcript to the induced 
nitric oxide synthase (iNOS) mRNA stabilizes the mRNA by binding to the HuR ARE-
binding protein and the target, presumably inhibiting deadenylation and decay (Matsui 
et al. 2008).   
 
 
14
Cytoplasmic RNA quality control 
Quality control checkpoints at different stages of gene expression maximize the 
fidelity of gene output, and the fidelity of protein synthesis is dependent not only on a 
functional translational apparatus, but on the integrity of mRNA coding sequences as 
well.  
Studies from yeast have shown that rRNAs in mature ribosomes with deleterious 
point mutations in the peptidyl transferase center (25S rRNA) or the decoding site (18S 
rRNA) undergo more rapid decay than their wild-type counterparts (LaRiviere et al. 
2006; Cole et al. 2009). This process, termed nonfunctional rRNA decay (NRD), is a 
late stage ribosome quality control pathway that takes place in the cytoplasm. 
Degradation of the mutant 18S rRNA, but not 25S rRNA, is dependent on translation 
elongation, since addition of elongation inhibitors such as cycloheximide or hygromycin 
B stabilized these transcripts. Whereas both mutant transcripts are partly subject to 
exosome-mediated decay, only the aberrant 18S transcript is sensitive to Ski7p and 
Xrn1p and appears to localize in P bodies. Further analysis has provided evidence that 
18S NRD is also dependent on Dom34p and Hbs1p, factors that participate in the “no-
go decay” (NGD) pathway (discussed below) used to eliminate transcripts containing 
stalled ribosomes (Cole et al. 2009). 
 mRNAs that exhibit translational defects are also subject to accelerated 
degradation. Transcripts lacking in-frame stop codons undergo non-stop decay (NSD), 
which serves to not only downregulate the production of extended polypeptides, but 
also to release ribosomes that are stalled at the 3’ end of an mRNA with no codon at the 
A-site (Frischmeyer et al. 2002; van Hoof et al. 2002). NSD requires eRF3 (Sup35p in 
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yeast) and the exosome co-factor, Ski7p (van Hoof et al. 2002). The latter protein 
shows similarity to translation elongation factor eEF1A and may serve to recruit the 
exosome to the mRNA. In addition, translation through the poly(A) tail likely displaces 
Pab1p, leading to the promotion of decapping and Xrn1p-mediated decay (Ito-
Harashima et al. 2007).  
 Transcripts in yeast on which translation elongation is blocked, e.g. by the 
introduction of a stem-loop structure, are recognized and degraded by the “no-go” 
mRNA decay (NGD) pathway (Doma and Parker 2006). Unlike NMD (see below) or 
NSD which initiate exonucleolytic digestion of their transcripts, NGD initiates an 
endonucleolytic cleavage event close to the stalled ribosome by an as yet unidentified 
factor. The cleaved fragments are further degraded by the combined actions of the 
3’?5’ exosome and the 5’?3’ Xrn1 proteins. NGD involves the activity of the eRF1-
related factor, Dom34p, and Hbs1p, a GTPase family member related to eEF1A, and 
may mimic the roles of eRF1 (Sup45p in yeast) and eRF3 (also a GTPase) in ribosome 
dissociation from the mRNA (Doma and Parker 2006).   
The most well studied pathway in this category is the evolutionarily conserved 
nonsense-mediated mRNA decay (NMD) (Jacobson and Izaurralde 2007; Brogna and 
Wen 2009) pathway that targets mRNAs containing premature translation termination 
codons (PTCs), thus minimizing the accumulation of potentially toxic truncated 
polypeptides (Pulak and Anderson 1993). Observations in yeast made in the late 1970’s 
suggested that transcripts bearing PTCs were rendered unstable  through the NMD 
pathway (Losson and Lacroute 1979), a finding later extended to mammalian cells 
(Kinniburgh et al. 1982; Daar and Maquat 1988), flies (Schneuwly et al. 1989), worms 
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(Pulak and Anderson 1993), and zebrafish (Wittkopp et al. 2009). It has also been 
observed that there is a polarizing effect to this instability, such that nonsense mutations 
positioned 5’-proximal to the beginning of the ORF are more destabilizing than more 
distally located PTCs (Losson and Lacroute 1979; Peltz et al. 1993) and detailed 
studies of the PGK1 transcript have shown that only PTCs located in the first two-thirds 
of the PGK1 protein coding sequence render the mRNA unstable (Peltz et al. 1993). 
However, the presence of a premature nonsense codon alone in the mRNA is 
insufficient to lead to NMD. A series of observations have suggested that ribosome 
recognition of the early stop is necessary to invoke NMD. Mutations or drugs that impair 
translation initiation (Ruiz-Echevarria et al. 1998; Zuk and Jacobson 1998; Welch and 
Jacobson 1999) or elongation (Herrick et al. 1990; Zhang et al. 1997; Zuk et al. 1999) 
have been found to stabilize nonsense-containing mRNAs. Nonsense mRNAs that have 
been stabilized in cells treated with cycloheximide (CHX) can be rendered unstable 
again upon the removal of CHX (Cui et al. 1995). Both nonsense mRNAs and NMD 
factors have been found to be polysome associated (He et al. 1993; Peltz et al. 1993; 
Mangus and Jacobson 1999); and NMD factors have been biochemically shown to be 
capable of interacting with the translation termination release factors eRF1 and eRF3 
(Czaplinski et al. 1998). 
All eukaryotes have a conserved set of core NMD factors encoded by the UPF1, 
UPF2/NMD2, and UPF3 genes and higher eukaryotes additionally require the products 
encoded by the SMG1 and SMG5-9 genes (Jacobson and Izaurralde 2007; Yamashita 
et al. 2009). The central component of the NMD pathway is the ATPase/helicase Upf1p, 
with the other factors serving to regulate its function. 
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UPF1 - A major breakthrough in the understanding of the nonsense-mediated decay 
pathway came from the discovery that UPF1 encodes a trans-acting factor that 
regulates this process in yeast (Leeds et al. 1991). Loss of function alleles of UPF1 
were isolated in a screen aimed at selecting high temperature up frameshift 
suppressors of his4-38, a +1 frameshift mutation near the 5’ end of the HIS4 gene that 
causes translation termination at a nearby downstream stop codon (Culbertson et al. 
1980). upf1 mutants were found to stabilize the his4-38 mRNA by reducing its decay 
rate. Moreover, loss of UPF1 function was found to increase stabilities and steady state 
levels of transcripts from nonsense-containing alleles of HIS4 and LEU2, but had no 
effect on their WT counterparts. Further characterization of UPF1 has revealed that it is 
nonessential for vegetative growth and produces a 3.1kb transcript with an ORF that 
encodes a 109-KDa polypeptide (Leeds et al. 1992). Analysis of the protein sequence 
has revealed that the N-terminus contains a cysteine/histidine-rich (CH) zinc-finger-like 
domain, whereas the C-terminus possesses a nucleotide (ATP) binding site and RNA 
helicase (superfamily I) motifs (Leeds et al. 1991; Altamura et al. 1992). Western blot 
analyses have shown that Upf1p in yeast is present at very low levels, approximately 
1600 molecules/cell (Jacobson and Peltz 1996). The subcellular localization of Upf1p 
has been investigated using either an N-terminal FLAG epitope tag (Peltz et al. 1993) or 
a C-terminal triple HA epitope tag (Atkin et al. 1995), neither of which affect activity of 
the protein. Sucrose gradient fractionation studies have revealed that most Upf1p co-
sediments with polysomes, although some is seen with monosomes and mRNP 
fractions (Peltz et al. 1993; Atkin et al. 1995). Confocal microscopy has also indicated a 
predominantly cytoplasmic localization for Upf1p (Peltz et al. 1994; Atkin et al. 1995). 
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The FLAG-tagged allele of Upf1p has been purified from yeast and further characterized 
for biochemical activity (Czaplinski et al. 1995). The UPF1 sequence had predicted an 
NTP-binding and possible NTPase domain for Upf1p, a prediction confirmed using the 
purified protein. It has been shown that FLAG-Upf1p possesses nucleic acid-dependent 
ATPase activity in vitro and that purified variants containing a mutation in a conserved 
lysine in the NTP binding and hydrolysis motif (K436Q) lose this function, which 
correlates with the observation that introduction of this allele in vivo inactivates NMD 
(Czaplinski et al. 1995). Furthermore, it has been found that in the absence of ATP, 
FLAG-Upf1p is able to bind to single-stranded DNA or RNA, and that hydrolysis of ATP 
results in its release from the single-stranded nucleic acid (Czaplinski et al. 1995). 
Characterization of Upf1p’s helicase activity has revealed that it possesses ATP-
dependent 5’ to 3’ DNA and RNA helicase activity (Czaplinski et al. 1995). Comparisons 
of structural analyses of the Upf1p helicase core in three states (phosphate-, AMPPNP-, 
and ADP-bound forms) in combination with mutational analyses suggest the presence 
of a single-stranded RNA binding channel able to undergo conformational changes 
upon ATP binding and hydrolysis (Cheng et al. 2007). It has been demonstrated that 
Upf1p can interact biochemically with the translation termination factors eRF1 and eRF3 
(Sup45p and Sup35p, resp., in yeast) in yeast and human cells (Czaplinski et al. 1998; 
Wang et al. 2001) and further analysis has shown that the Upf1p N-terminal CH domain 
interacts with eRF3 (Ivanov et al. 2008) and Upf2p/Nmd2p (He et al. 1997; Kadlec et al. 
2006). Moreover, studies using purified factors and synthetic poly(U) RNA have shown 
that eRF3 and RNA compete for binding to Upf1p and that eRF1 and eRF3 can inhibit 
Upf1p ATPase activity (Czaplinski et al. 1998). Genetic data also suggests Upf1p can 
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affect nonsense codon readthrough (Maderazo et al. 2000; Keeling et al. 2004). It has 
recently been proposed that the CH domain may play a RING-related role for Upf1p to 
mediate E3 ubiquitin ligase activity in yeast (Takahashi et al. 2008).  
NMD has been found in all eukaryotes studied to date and homology searches 
have identified UPF1 (as well as UPF2 and UPF3) orthologs in all eukaryotic model 
organisms: SMG2 in C.elegans (Page et al. 1999); hUPF1/Rent1 in humans and mice 
(Perlick et al. 1996; Applequist et al. 1997); Drosophila DmUPF1 (Gatfield et al. 2003); 
and Upf1 in zebrafish (Wittkopp et al. 2009). Whereas UPF1 is not essential for viability 
in yeast or worms (Leeds et al. 1991; Page et al. 1999), loss of Upf1 function in higher 
organisms leads to developmental arrest (Medghalchi et al. 2001; Metzstein and 
Krasnow 2006; Wittkopp et al. 2009). It is now well established that Upf1p is a 
phosphoprotein in non-yeast eukaryotes (Page et al. 1999; Yamashita et al. 2001) and 
that cycles of Upf1p phosphorylation and dephosphorylation are critical for NMD 
function (Ohnishi et al. 2003; Grimson et al. 2004), with factors (SMGs1,3-7; discussed 
below) regulating the phosphorylation status being conserved in all metazoans. There is 
some evidence to suggest that Upf1p may be phosphorylated in yeast as well (Wang et 
al. 2006), although what role this may play in NMD is not known since no yeast 
homologs of the SMG factors have been found.  
  
UPF2/NMD2 - The second core NMD factor (so-called because it is required for NMD in 
all organisms tested) was identified in yeast by two strategies (Cui et al. 1995; He and 
Jacobson 1995) and has orthologs in mammals (Mendell et al. 2000; Serin et al. 2001), 
flies (Gatfield et al. 2003), worms (Pulak and Anderson 1993), and zebrafish (Wittkopp 
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et al. 2009). The Peltz lab utilized a genetic screen (Cui et al. 1995) to complement a 
upf2 allele that had been previously isolated as an allosuppressor of the his4-38 allele 
(Culbertson et al. 1980), whereas the Jacobson lab utilized the yeast two-hybrid system 
to detect Upf1p-interacting proteins in vivo (He and Jacobson 1995). Among the six 
genes identified by two-hybrid analysis (NMD1-4, DBP2, and SNP1), NMD2 was found 
to be allelic to UPF2. Cloning and characterization of yeast UPF2/NMD2 has indicated 
an ORF 3267 nt in length consisting of 2 exons and a 5’-proximal intron, with a protein 
product predicted to have a mass of 126-kDa that is not essential for viability. Structural 
determination from sequence analysis has inferred a highly acidic region near the C-
terminus, a putative bipartite nuclear localization sequence near the N-terminus, and a 
putative helical transmembrane domain in the middle of the protein all of which have 
been found to be essential for function (He and Jacobson 1995). Further analysis of the 
sequence has revealed that NMD2 possesses 3 MIF4G (middle portion of eIF4G) or 
4GH (eIF4G homology) domains (Aravind and Koonin 2000; Ponting 2000). In eIF4G, 
this domain has been found to bind eIF4A and eIF3 (Lamphear et al. 1995; Imataka and 
Sonenberg 1997), as well as to RNA (Pestova et al. 1996). Mutations in S.pombe Upf2p 
4GH domains are sufficient to abrogate its function (Mendell et al. 2000). Two-hybrid 
analysis has shown that the hUpf2 can interact with eIF4AI and Sui1 (Mendell et al. 
2000) and recent structural studies have shown that the third MIF4G domain of hUpf2 is 
capable of binding RNA (Kadlec et al. 2004). The C-terminal 157 amino acids of 
Upf2p/Nmd2p constitutes the Upf1p-interacting domain with the last 56 amino acids 
being critical for decay function in vivo (He et al. 1996) and biophysical studies have 
demonstrated that two distinct structural elements in this region bind in a bipartite 
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fashion on opposite surfaces of Upf1p (Clerici et al. 2009). Coimmunoprecipitation 
studies have confirmed that hUpf1p and hUpf2p interact with each other as well. 
Genetic and biochemical data have also shown that Upf2p/Nmd2p can interact with 
Upf3p and eRF3 (He et al. 1997; Wang et al. 2001; Chamieh et al. 2008) and that hUpf2 
is capable of binding to RNA (Kadlec et al. 2004). Upf2p/Nmd2p has been shown to act 
as a bridge between Upf1p and Upf3p to form a trimeric complex (He et al. 1997; 
Chamieh et al. 2008). Upf2p/Nmd2p is polysome-associated in yeast (Atkin et al. 1995) 
and present at very low levels (Jacobson and Peltz 1996). Yeast and human Upf2p 
have been proposed to be phosphorylated (Chiu et al. 2003; Wang et al. 2006), 
although the precise role of this phosphorylation remains to be elucidated.  
 
UPF3 – The least abundant of the Upf factors (Jacobson and Peltz 1996) and initially 
isolated as an allosuppressor of his4-38 (Culbertson et al. 1980), the third core NMD 
factor, encoded by UPF3, was subsequently shown to be specifically involved in the 
degradation of PTC-containing mRNAs (Leeds et al. 1992). Cloning and 
characterization of the yeast gene have revealed that UPF3 is not essential for cell 
viability and consists of an 1161 nt ORF with a 44.9-KDa predicted protein product that 
is cytoplasmic and polysome-associated (Lee and Culbertson 1995; Shirley et al. 1998). 
The protein contains three putative nuclear localization sequences (NLSs), each of 
which is functional on a heterologous reporter; and two putative nuclear export 
sequences (NESs), only one of which appears to be functional (Lee and Culbertson 
1995; Shirley et al. 1998; Shirley et al. 2002). Early studies in yeast showed that 
disruption of UPF3, UPF1, or both yielded the same degree of his4-38 mRNA 
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stabilization, suggesting that both genes function in the same pathway (Lee and 
Culbertson 1995). Yeast two-hybrid studies have demonstrated that a fragment of 
Upf3p spanning residues 78-278 interacts with a domain of Upf2p/Nmd2p 
encompassing residues 564-771 (He et al. 1997). This region of Upf2p/Nmd2p is 
distinct from its Upf1p-binding domain (He et al. 1996). Two-hybrid analysis has also 
shown that Upf1p can interact with Upf3p when bridged by Upf2p/Nmd2p, suggesting 
that all three Upf proteins form a complex and function in the same pathway. In support 
of this conclusion, deletion of all three genes in a single strain give a similar decay 
phenotype to the single or double deletion strains (He et al. 1997) and genetic studies 
have shown that Upf1p is the central effector of this pathway, and is regulated by 
Upf2p/Nmd2p and Upf3p (Maderazo et al. 2000). Upf3p has also been shown to interact 
with eRF3 (Wang et al. 2001) and can affect readthrough of nonsense codons 
(Maderazo et al. 2000).  
Human orthologs to yeast Upf3p derive from 2 genes, one of which is X-linked, 
and are known as hUPF3 and hUPF3-X or hUPF3a and hUPF3b (Serin et al. 2001). 
Whereas hUpf1p and hUpf2p are found in the cytoplasm, hUpf3p-X is detected primarily 
in the nuclei of HeLa cells. Coimmunoprecipitation studies using tagged alleles have 
also shown that hUpf3p and hUpf2p interact (Serin et al. 2001) and structural studies 
have elucidated the interaction domains involved (Kadlec et al. 2004). In mammalian 
cells, it has been shown that hUpf3p can bind to the exon-junction complex (EJC) factor 
Magoh-Y14 to act as a bridge between the EJC and hUpf2p (Chamieh et al. 2008). 
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Additional regulators of Upf1p function - In yeast, only UPF1, UPF2/NMD2, and 
UPF3 are specifically required for NMD, whereas additional genes are required for NMD 
function in higher eukaryotes. Upf1p has been demonstrated to be the key effector, 
whereas Upf2p and Upf3p regulate Upf1p function (Page et al. 1999; Maderazo et al. 
2000). Initially identified in a genetic screen in worms (Pulak and Anderson 1993), 
SMG1 and SMGs5-7  have been found to be regulators of Upf1p phosphorylation in all 
metazoan cells, except flies which lack SMG7 (Muhlemann et al. 2008). SMG1 encodes 
a serine/threonine kinase that functions to phosphorylate Upf1p (Page et al. 1999; 
Denning et al. 2001; Yamashita et al. 2001).  SMG3 (UPF2) and SMG4 (UPF3) 
enhance phosphorylation of Upf1p, whereas SMG5, SMG6, and SMG7 function to 
promote dephosphorylation of Upf1p (Page et al. 1999; Wilkinson 2003), though not 
directly. None of these proteins are phosphatases themselves, but are thought to recruit 
protein phosphatase 2A (PP2A) (Anders et al. 2003; Chiu et al. 2003; Ohnishi et al. 
2003). It has recently been shown that SMG6 encodes an endonuclease that functions 
in NMD (Huntzinger et al. 2008; Eberle et al. 2009). Recently, two novel NMD factors, 
SMG-8 and SMG-9, were isolated in metazoan cells (Yamashita et al. 2009). They have 
been proposed to regulate the kinase activity of SMG-1 in addition to bridging the SURF 
(SMG-1, UPF1, eRF1, eRF3) complex on ribosomes to the EJC on PTC-containing 
mRNAs. 
 
Nonsense Substrate Spectrum - mRNAs containing premature stop codons can arise 
at the DNA level through mutations, frameshifting events, or programmed DNA gene 
rearrangements in the genome of an organism or at the RNA level through errors in 
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transcription, RNA processing, or alternative RNA splicing events that generate in-frame 
nonsense codons. Identification and characterization of the Upf factors required for 
NMD have enabled the screening in various organisms for NMD substrates (He et al. 
1993; Pulak and Anderson 1993; Muhlrad and Parker 1999; Johns et al. 2007).  The 
use of DNA microarray technology has led to the realization that a significant portion of 
the yeast transcriptome is subject to NMD regulation, approximately 750 genes (He et 
al. 2003). In addition to the predicted classes of NMD substrates in yeast – mRNAs from 
genes containing PTCs, inefficiently spliced pre-mRNAs, mRNAs undergoing leaky 
scanning, and mRNAs containing upstream ORFs (u-ORFs) – a number of other 
classes of substrates have been recognized. These include pseudogene mRNAs, 
mRNAs derived from transposable elements or their LTRs, bicistronic mRNAs, and 
mRNAs that use +1 frameshifting in their translation (He et al. 2003). This study also 
confirmed, at the genome-wide level, prior observations that Upf1p, Upf2p/Nmd2p, and 
Upf3p function in the same pathway since inactivation of either of these genes resulted 
in similar expression profiles. Although these early studies could not distinguish direct 
from indirect effects of loss of NMD function in cells (Rehwinkel et al. 2006), later 
studies directed towards RNAs that were specifically associated with Nmd factors have 
shown good correlation with the previous data (Johansson et al. 2007).  
  
Nonsense Recognition - Translation termination involves the translating ribosome 
encountering a nonsense codon in its A-site, subsequent binding of release factors, 
polypeptide hydrolysis, and ribosome subunit dissociation. In normal termination, the 
terminating ribosome dissociates efficiently from the mRNA without accelerating the 
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mRNA’s decay rate. Termination is carried out by two classes of release factors: class I 
factors (eRF1 in eukaryotes; Sup45p in yeast) recognize stop codons and trigger 
hydrolysis of the ester bond connecting the polypeptide chain and the tRNAs in the 
ribosomal P site while class II release factors (eRF3 in eukaryotes; Sup35p in yeast) are 
GTPases that stimulate class I factor activity (Zhouravleva et al. 1995). The essential 
eRF1 and eRF3 proteins interact and are thought to function as a complex. It has been 
found that eRF3’s GTPase activity is dependent on ribosome-bound eRF1 and is 
necessary for eRF1 recognition of the stop codon and subsequent polypeptide chain 
release (Alkalaeva et al. 2006). Normal termination is also stimulated by PABP (Pab1p 
in yeast) (Cosson et al. 2002). This is thought to occur through PABP’s interaction with 
eRF3, leading to termination, ribosome dissociation, and possibly in cis recycling of 
ribosomal subunits (Cosson et al. 2002; Hosoda et al. 2003). 
When a stop codon occurs sufficiently upstream of its normal position, however, 
accelerated degradation of the mRNA (NMD) ensues. Recognition of the PTC in most 
eukaryotes, which occurs in a UPF-dependent manner, triggers decapping of the 
substrate mRNA, usually without prior deadenylation, and the decapped transcript is 
then degraded primarily by the 5’?3’ Xrn1p exonuclease, with some degradation 
occurring 3’?5’ by the cytoplasmic exosome [reviewed in (Jacobson and Izaurralde 
2007)]. Decay activity in Drosophila NMD is instituted by endonucleolytic cleavage of 
the nonsense mRNA by the PIN-containing SMG6 protein followed by exosome-
mediated digestion of the 5’ cleavage fragment and Xrn1-mediated degradation of the 
unprotected 3’ cleavage fragment (Gatfield and Izaurralde 2004).  
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Despite conservation of the NMD pathway, the detailed mechanism by which 
PTCs are recognized has yet to be resolved. Based on the complexity of the organism, 
there are two predominant models for NMD induction:  
Pioneer Round Model – hypothesized to function in mammalian cells, this 
model is predicated on the recognition of splicing-dependent “marks”- the exon junction 
complex (EJC) - present on the mRNAs post-termination by the surveillance machinery. 
In mammalian cells, NMD is activated when a PTC is 50-55 nucleotides upstream of an 
exon-exon junction (Zhang et al. 1998), the site of deposition of the exon junction 
complex (EJC). The latter contains the Upf2 and Upf3X proteins in addition to factors 
involved in pre-mRNA splicing (RNPS1, UAP56, and SRm160), factors involved in 
mRNA export (REF/Aly, Y14, and Magoh), and factors with incompletely characterized 
functions (eIF4AIII and Barentz/MLN51)(Le Hir et al. 2001). The “pioneer round model” 
proposes that translation by the first, or pioneer, ribosome is able to displace EJCs from 
each spliced junction (Ishigaki et al. 2001). Hence, the presence of a PTC upstream of 
an EJC allows Upf1 that is part of the SURF (Smg1, Upf1, eRF1, and eRF3) complex 
on the terminating ribosome to interact with the EJC through Upf2, leading to Upf1 
phosphorylation by the Smg1 kinase, recruitment of Smgs5-7 (which serve to 
dephosphorylate phospho-Upf1) to form the decay-inducing complex (DECID), and 
subsequent decapping and decay (Behm-Ansmant and Izaurralde 2006; Kashima et al. 
2006). Cycles of phosphorylation/dephosphorylation of Upf1 are required for Upf1 to 
mediate its function, although the significance of this cycle remains to be elucidated. 
Amongst other observations, tethering EJC factors downstream of a normal termination 
codon leads to mRNA destabilization, providing support for this model (Ivanov et al. 
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2008). Other observations suggest that excessive distance between the premature 
termination codon and the poly(A) tail of metazoan mRNAs may also trigger NMD 
(Eberle et al. 2008). 
NMD of some transcripts in mammalian cells has been observed to be nucleus-
associated and cytoplasmic nonsense-containing mRNAs appear to be immune to the 
NMD pathway. This has prompted the idea that only newly synthesized mRNAs that are 
bound by the nuclear cap binding complex CBP80/CBP20, and not the cytoplasmic cap 
binding factor eIF4E, are subject to decay (Ishigaki et al. 2001; Lejeune et al. 2002), 
and recent studies have provided evidence to show that Upf1 is associated with CBP80-
containing mRNAs (Yamashita et al. 2009). This is in contrast to findings in yeast that 
show that NMD is not limited to newly synthesized transcripts (Maderazo et al. 2003; 
Gaba et al. 2005). The discovery of Smg-8 and Smg-9 has provided additional 
mechanistic insight into the events following recognition of the PTC (Yamashita et al. 
2009). It is hypothesized that Smgs-1, 8, and 9 (the SMG1 complex – SMG1C) binds to 
Upf1p prior to its incorporation into the SURF complex. This SMG1C:SURF complex 
assembles onto the terminating ribosome of a CBP80/20-bound nonsense substrate 
mRNA. Smg-8 is thought to maintain Upf1 hypophosphorylated by suppressing Smg-1 
kinase activity in the SURF complex. Association of the EJC with the ribosome:SURF 
complex through Upf1:Upf2 interaction leads to Smg-1-mediated phosphorylation of 
Upf1, recruitment of Smgs 5-7, followed by decapping and decay of the mRNA.     
Faux 3’-UTR Model - in lower eukaryotes, NMD is predicated on the idea that 
PTC recognition occurs due to an absence of factors 3’ to the nonsense codon that are 
associated with a normal 3’-UTR. According to this “faux 3’-UTR” model (Jacobson 
28
1996), normal termination codons are located in the vicinity of bound Pab1p. Interaction 
between 3’-bound Pab1p, or a factor whose UTR-association is enhanced by Pab1p, 
and the terminating ribosome precludes the stable interaction of the Upf complex to the 
ribosome and mediates efficient peptide hydrolysis and ribosome release. At a PTC, the 
absence of proximal Pab1p leads to stable binding of the Upf proteins, a prerequisite for 
decapping and subsequent Xrn1p-mediated degradation. The polarity effect observed 
by nonsense codon position supports this model (Losson and Lacroute 1979; Peltz et 
al. 1993) as do mutations that lead to extended 3’-UTRs resulting in mRNAs with 
shortened half-lives (Muhlrad and Parker 1999). Moreover, this model also accounts for 
observed interactions between the eRFs and the Upf proteins (Czaplinski et al. 1998) as 
well as Pab1p (Cosson et al. 2002; Hosoda et al. 2003). Although initially thought to be 
limited to lower eukaryotes, this model may be operational in higher eukaryotic cells, 
since localizing Pab1p downstream of a PTC suppresses the NMD of those reporter 
mRNAs (Behm-Ansmant et al. 2007; Eberle et al. 2008; Ivanov et al. 2008; Silva et al. 
2008; Singh et al. 2008).  
Deletion of UPF1, NMD2/UPF2, and/or UPF3 in yeast leads to similar decay 
phenotypes (He et al. 1997), Nmd2p can bridge Upf1p and Upf3p (He et al. 1997), and 
Upf1p activity is regulated by Nmd2p and Upf3p (Maderazo et al. 2000). These 
observations suggest that all three factors may be recruited and function as a complex. 
However, polysome distribution analyses indicate that ribosome association of these 
factors is not necessarily codependent (Atkin et al. 1997) and recent evidence from 
studies on P bodies suggests that these three factors may not be recruited as a 
complex to a PTC-containing mRNA (Sheth and Parker 2006). Upf1p may be recruited 
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to the termination complex at the PTC, where it is proposed to induce translational 
repression (Muhlrad and Parker 1999) and targets the mRNA to P bodies (Sheth and 
Parker 2006). Nmd2p/Upf2p and Upf3p are present in P bodies and interact with the 
Upf1p-bound mRNA to induce decapping by the Dcp1p/Dcp2p complex and subsequent 
Xrn1p-mediated decay (Sheth and Parker 2006).    
 
Work done in this thesis 
The mechanistic details regarding NMD in yeast still remain a mystery. Why does 
the presence of a premature nonsense codon cause an mRNA to become unstable? 
Shouldn’t a stop codon be just that…a signal to terminate translation? Why does the 
presence of a PTC lead to such aggressive destruction of the mRNA? Moreover, why 
should the position of the PTC in the ORF affect NMD-sensitivity? What is the role of 
the NMD factors? Despite a wealth of data, satisfactory answers to these fundamental 
questions remain inadequate. The “faux 3’-UTR” model offers a comprehensive 
blueprint for the mechanistic aspects determining recognition of a premature nonsense 
codon  This model predicts that recognition of nonsense codon as being premature 
stems from the lack of interaction between the terminating ribosome and poly(A) tail-
associated Pab1p, but this hypothesis has never been tested directly. In Chapter II of 
this thesis, we have sought to address this question by artificially tethering Pab1p in the 
vicinity of an otherwise NMD-sensitive PTC. We show that NMD of a PTC can be 
suppressed in the presence of proximal Pab1p. Furthermore, implicit in the “faux 3’-
UTR” model is the notion that there exist mechanistic differences in translation 
termination at normal vs. premature stop codons and that the NMD factors facilitate 
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events at premature termination. In this chapter, I also elaborate the development and 
use of an in vitro assay system that allows us to take advantage of the translation of 
synthetic mRNAs by yeast cell-free extracts from different genetic backgrounds to 
address these issues. We demonstrate that premature termination is an inefficient 
process and biochemically distinct from normal termination.  
In yeast, Upf1p, Nmd2p/Upf2p, and Upf3p are required for NMD to occur. 
However, we have yet to understand what functions these factors perform. Despite 
extensive characterization of its biochemical properties, Upf1p’s function at premature 
termination and mode of action are relatively unknown. Prior observations and some 
results from our work presented in Chapter II indicate a role for Upf1p in translation 
initiation. However, there is very little understanding of what Upf1p is doing. In Chapter 
III of this dissertation, I detail our investigations dissecting a role for Upf1p in translation 
initiation and provide evidence as to its function at premature termination. Using a 
series of constructs in vivo, we show that the Upf proteins mediate translation 
reinitiation subsequent to a premature termination event in cis. To further understand 
this phenotype and reconcile them with previous observations, we developed a series of 
novel in vitro translation assays and used our cell-free translation system to show that 
Upf1p-dependent initiation/reinitiation phenotypes are a consequence of its role at 
premature termination. 
mRNA translatability and stability have been shown to require the 5’ cap 
structure and 3’ poly(A) tail. The “faux 3’-UTR” model also suggests that the structure of 
an mRNP is important in determining whether an mRNA is viewed as normal or 
aberrant by the cell. The “closed loop” model for mRNP structure was proposed over 20 
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years ago (Jacobson and Favreau 1983). Except for electron micrographic evidence 
which allows us to directly visualize these structures, an assay system to readily monitor 
this structure and understand the requirements for its maintenance have been lacking. 
We have once again taken advantage of our cell-free translation/toeprinting system to 
biochemically assay, monitor the strength of, and factors required to maintain a 
circularized mRNA structure. In Chapter IV of this dissertation, I detail our findings 
showing that, consistent with previous observations, factors that interact with both ends 
of the mRNA and those that are involved in translation initiation are required to form and 
maintain a stable closed loop. Surprisingly, we find that translation termination factors 
also play a role in this process. Using drugs that allow us to detect early vs. late steps in 
translation initiation, we show that we are able to detect two distinct forms of the closed 
loop structure. In Chapter V, I discuss the implications of our findings.  
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Chapter II  
 
 A faux 3’-UTR promotes aberrant termination and triggers 
 nonsense-mediated mRNA decay 
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Chapter II - A faux 3’-UTR promotes aberrant termination and triggers 
nonsense-mediated mRNA decay   
 
Summary 
Nonsense-mediated mRNA decay (NMD) is triggered by premature translation 
termination (Pulak and Anderson 1993; Maquat 1995; Jacobson and Peltz 1996), but 
the features distinguishing that event from normal termination are unknown. One model 
for NMD suggests that decay-inducing factors bound to mRNA during early processing 
events are routinely removed by elongating ribosomes, but maintain an mRNA 
association when termination is premature, thereby triggering rapid turnover (Gonzalez 
et al. 2001). Recent experiments (Gatfield et al. 2003; Maderazo et al. 2003; LeBlanc 
and Beemon 2004) challenge this notion and point to a model which posits that mRNA 
decay is activated by the intrinsically aberrant nature of premature termination (Hilleren 
and Parker 1999; Jacobson and Peltz 2000). Here we use a primer extension inhibition 
(toeprinting) assay (Sachs et al. 2002) to delineate ribosome positioning and find that 
premature translation termination in yeast extracts is indeed aberrant. Ribosomes 
encountering premature UAA or UGA codons in the CAN1 mRNA fail to release and, 
instead, migrate to upstream AUGs. This anomaly depends on prior nonsense codon 
recognition and is eliminated in extracts derived from cells lacking the principal NMD 
factor, Upf1p, or by flanking the nonsense codon with a normal 3'-UTR. Tethered 
poly(A)-binding protein (Pab1p), used as a mimic of a normal 3'-UTR, recruits the 
termination factor Sup35p (eRF3) and stabilizes nonsense-containing mRNAs. These 
findings indicate that efficient termination and mRNA stability are dependent on a 
properly configured 3'-UTR. 
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Results 
 
Toeprint analyses of initiation and premature termination in cell extracts  
The results presented in this chapter are largely based on data obtained by the 
studying ribosomal positioning on various synthetic mRNAs using the toeprinting 
technique (see Appendix D). The yeast can1-100 allele contains a premature UAA 
codon at position 47 of the CAN1 coding region that effectively terminates translation 
and destabilizes the CAN1 mRNA (Maderazo et al. 2000). We constructed a gene 
fusion encompassing the UAA-containing segment of this allele and the firefly LUC 
coding region, and used this construct to generate synthetic mRNA (UAA RNA). 
Mutagenesis techniques were used to create a variant with a weak terminator (Bonetti 
et al. 1995) (CAA UGA CAA) at codon 47 (UGA RNA) and two control RNAs with no 
early stop codon (Fusion and AAA RNAs; Fig. 2.1). In vivo expression experiments 
demonstrated that the UAA and UGA RNAs were substrates for NMD, but the Fusion 
RNA was not (data not shown). Translation reactions in wild-type extracts were 
incubated with these mRNAs and subjected to toeprinting analyses (see Appendix D), 
using sensitivity to the cap analog 7mGpppG, an inhibitor of translation initiation, as a 
means to distinguish bona fide toeprints from background bands (Sachs et al. 2002). 
Toeprints corresponding to ribosomes stalled with a stop codon in their A sites were 
obtained with the UAA and UGA RNAs at the expected position, 12-14 nucleotides (nt) 
downstream of the premature nonsense codons (Sachs et al. 2002) (Fig. 2.2(a), lanes 1 
and 3). The toeprints were dependent on mRNA translation, because they were 
sensitive to cap analog (lanes 2 and 4) and dependent on the presence of the stop 
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codon, because they were absent in the Fusion RNA (lanes 5 and 6). Whereas toeprints 
were readily detectable from premature termination codons in the absence of CHX in 
wild-type extracts [e.g., Fig. 2.2(a)], no toeprints were obtained under the same 
conditions when the normal termination codons of the Fusion and ADE2 RNAs were 
analyzed even after long periods of translation [Fig. 2.2(b)] or upon incubation in 
extracts with temperature-sensitive eRF1 (data not shown). These results suggest that 
ribosomes terminating prematurely are released much less efficiently than those 
encountering normal terminators.  
 Addition of the elongation inhibitor cycloheximide (CHX) to the translation 
reactions also failed to reveal toeprints from normal terminators (data not shown), but 
did allow detection of additional toeprints (Kozak 1998; Dmitriev et al. 2003). CHX-
dependent initiator AUG toeprints on the UAA, UGA, Fusion, and AAA RNAs were 
sensitive to cap analog (Fig. 2.3(a), +16 arrow, lanes 1-6 and Fig. 2.3(b), top panel) and 
reflect 80S ribosomes, centered on AUG codons, protecting 16-18 nt 3’ of those 
codons. Other CHX-dependent toeprints were present in close proximity to the locations 
of the early stop codons. These unanticipated bands mapped to a position 6-7 nt 
downstream of the U of the terminator in both the UAA and UGA RNAs (Fig. 2.3(a), 
lanes 1 and 3, +6 arrow), as well as to a position 17 nt downstream of the terminator U 
in the UGA RNA (lane 3, +17 arrow). The appearance of these toeprints was dependent 
on concurrent mRNA translation (lanes 2 and 4), the presence of yeast extract (lanes 7-
9), and termination codon recognition (lanes 5 and 6 and Fig. 2.3(b), bottom panel). The 
dependence of these toeprints on prior termination codon recognition was underscored 
by experiments showing that, after CHX addition, the +6 toeprint of the UAA RNA 
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accumulated subsequent to the disappearance of the +12 toeprint [Fig. 2.3(c)], and by 
the observation that extracts of sup45-2 cells with defective eRF1 (Stansfield et al. 
1997) only yielded the +12 toeprint, regardless of the presence or absence of CHX (Fig. 
2.2(a), lanes 7-12 and Fig. 2.8, lanes 7, 8, 17, and 18).  
 
Aberrant toeprints are dependent on the presence of NMD factors  
Most importantly, the aberrant toeprints of the UAA and UGA RNAs were linked 
to NMD because they failed to accumulate in extracts lacking Upf1p or Upf2p/Nmd2p 
(Fig. 2.3(d) and data not shown). The lack of aberrant toeprints in upf1Δ or 
upf2Δ/nmd2Δ extracts cannot be due to inefficient translation since these extracts 
display premature terminator +12 toeprints in the absence of CHX (Fig. 2.2(a), lanes 13-
18 and data not shown) and normal initiator AUG toeprints in the presence of CHX (data 
not shown).  
 
Aberrant toeprints derived from PTCs in wild-type extracts in the presence of 
CHX are dependent on upstream AUGs  
The UAA and UGA RNAs both contained AUG codons just upstream of their 
premature terminators [Fig. 2.1]. To determine whether these AUGs were relevant to 
the toeprints of Figs. 2.3(a) and (b), we analyzed two RNAs in which the upstream 
AUGs were mutated. Toeprint analyses of the UAA-M and UGA-M RNAs in wild-type 
extracts supplemented with CHX, in the presence or absence of cap analog, showed 
that: a) mutation of the –11 AUG of the UAA RNA eliminated the +6 band (Fig. 2.4, 
compare lanes 1 and 3) and b) mutation of the –11 and –1 AUGs in the UGA RNA led 
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to the disappearance of the +6 and +17 bands (compare lanes 7 and 9) and to the 
appearance of a +12 toeprint characteristic of weak terminators (Bonetti et al. 1995) 
(lane 9 and data not shown). These results indicate that the +6 toeprints obtained with 
the UAA and UGA RNAs correspond to the P site of the ribosome stalled at the –11 
AUG and that the +17 toeprint derived from the UGA RNA corresponds to ribosomes 
stalled at the –1 AUG (Kozak 1998). One explanation for these results is that post-
termination ribosomes fail to be released at premature terminators and are able to scan 
backwards and reinitiate at the –11 AUG in the UAA RNA or at the –11 or –1 AUG in 
the UGA RNA. Such retroreinitiation has been previously suggested by studies in 
mammalian cells (Peabody and Berg 1986; Thomas and Capecchi 1986).  The 
propensity for backwards scanning was independently confirmed by analyses of 
luciferase activity obtained in vitro from RNAs harboring in-frame LUC fusions to 
upstream or downstream AUGs (Fig. 2.5). Six constructs were made in which the LUC 
ORF was in frame with AUGs at either -11 in the Fusion, UAA, UAA-W, and UAA-DS 
RNAs or at +5 in the UAA-M-DS and UAA-DS constructs (designated Inf-Fusion, Inf-
UAA, Inf-UAA-W, Inf-UAA-DS, Inf-UAA-M+5D and Inf-UAA+5DS, respectively). A 
seventh construct, used as a control, contained the UAA stop codon, but lacked the –11 
and +5 AUGs (Inf-UAA-M). Constructs containing the -11 AUG in frame with the LUC 
ORF were made by insertion of an A at position 4 downstream of the stop codon, or its 
equivalent position in the case of the control Inf-Fusion RNA. Constructs containing the 
+5 AUG in frame with the LUC ORF were made by insertion of an A at position 10 
downstream of the stop codon, plus a deletion of the G at position 4 in the case of the 
Inf-UAA+5DS. Translation of these RNAs in vitro showed that ribosomes effectively 
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reinitiate at the upstream -11 AUG, or at the downstream +5 AUG, and are able to 
produce luciferase activity that is dependent on the presence of both the termination 
codon and flanking AUG codons (Fig. 2.5). Consistent with the toeprint data of Fig. 2.7 
(see below), ribosomes exiting the premature stop codon prefer retroreinitiation to 
downstream reinitiation (compare Inf-UAA-DS to Inf-UAA+5DS). Moreover, as expected 
from the toeprinting results of Fig. 2.3(d), the in vitro translational yield of all RNAs is 
markedly reduced in upf1Δ extracts (Fig. 2.5). These data showing that the luciferase 
activity obtained from an in-frame fusion of the –11 AUG to the LUC ORF was 4-5-fold 
greater in the presence of the codon 47 UAA and the –11 AUG than in their absence 
(Fig. 2.5) support the notion that ribosomes can reinitiate translation at AUG codons 
upstream or downstream of the stop codon in an NMD-dependent manner. While 
retroreinitiation is alternatively explainable as leaky scanning (Kozak 1998), the 
absence of a toeprint signal at the –11 AUG in the Fusion or AAA RNAs or in upf1Δ 
extracts [Fig.2.3(d)], as well as the chase experiments of Fig. 2.3(c), reduce the 
likelihood of that explanation. Collectively, these experiments indicate that access to 
internal AUG codons of the UAA and UGA mRNAs depends on prior recognition of a 
downstream premature stop codon.  
The distance limits of retroreinitiation were assessed by constructing nonsense-
containing RNAs that harbor AUG codons 21 or 32 nt upstream of the premature 
terminator (Fig. 2.6). Control RNAs (Fusion-21 and Fusion-32), containing the -21 and -
32 AUGs, respectively, but not the premature stop codon, were also constructed. 
Toeprint analyses revealed strong bands, sensitive to cap analog, in the UAA-M-21 and 
UGA-M-21 RNAs at positions 16-18 nt downstream of the –21 AUG (lanes 3-6, see 
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asterisks) and other bands at comparable positions in the UAA-M-32 and UGA-M-32 
RNAs (lanes 9-12, see asterisks). Additional bands ~19 nt downstream of the –32 
AUGs (lanes 9 and 11), bands upstream of the -21 toeprints (lanes 3 and 5, arrow a), 
and bands downstream (lanes 3, 5, 9, and 11, arrow b) may arise from translocating 
ribosomes, ribosomes scanning backwards that collide with those already engaged at 
the initiation codon, or the binding of non-ribosomal factors to the RNA. The nonspecific 
band indicated by arrow c in the UGA-M-21 and UGA-M-32 samples may reflect the 
binding of factors specific to AUGs at least 21 nt upstream of the UGA since this band is 
absent in the UGA, UGA-M, UGA-DS and UGA-M-DS RNAs (data not shown). It is 
important to note that none of the aforementioned toeprint bands are detected with the 
Fusion-21 and Fusion-32 control RNA (lanes 1, 2, 7, and 8). These experiments thus 
demonstrate that yeast ribosomes can reinitiate in vitro at least 32 nt 5' to a premature 
terminator.  
 
Reinitiation at upstream AUGs is favored over downstream reinitiation 
To test the relative efficiencies of upstream and downstream reinitiation, we 
constructed mRNAs that presented both options (Fig. 2.7). Analysis of the UAA-DS 
RNA (containing the –11 AUG and another AUG 5 nt downstream of the stop codon) 
showed only the cap analog-sensitive +6 toeprint (lanes 3 and 4). A derivative of this 
RNA lacking the –11 AUG (UAA-M-DS RNA) exhibited a new translation-dependent 
toeprint signal 24-25 nt downstream of the stop codon (lanes 1 and 2) that corresponds 
to ribosomes stalled with their P site on the +5 AUG. Similar results were obtained with 
derivatives of the UGA RNA. Mutation of only the –11 AUG in the No-11-UGA RNA led 
40
to elimination of the +6 toeprint and maintenance of the +17 toeprint (lanes 5 and 6). 
Analysis of an RNA containing the +5 AUG as well as the upstream -11 and -1 AUGs 
(UGA-DS RNA) showed only the +6 and +17 toeprints (lanes 7 and 8). However, 
mutation of both upstream AUGs accompanied by inclusion of a +5 AUG (UGA-M-DS 
RNA) eliminated the retroreinitiation toeprints but generated a translation-dependent 
signal 24-25 nt downstream of the UGA stop codon (lanes 9 and 10). Since toeprints 
are only detected at downstream AUGs when proximal upstream AUGs are eliminated, 
post-termination ribosomes exiting premature termination codons must have a 
propensity for backwards scanning.  
 
eRF1 activity is required prior to any reinitiation event  
Regardless of the site of post-termination reinitiation, all nonsense-containing 
RNAs yielded toeprints corresponding to ribosomes stalled with the stop codon in their 
A sites when translated in sup45-2 extracts (Fig. 2.8).  RNAs having weak terminators 
yield strong translation-dependent toeprints 12-14 nt downstream of the premature stop 
codon (lanes 5, 6, 13-22, and 25-28) and RNAs with strong terminators yield faint bands 
at the same position (lanes 3, 4, 7-12). No comparable toeprints are obtained with the 
Fusion RNAs (lanes 1, 2 and 23, 24). Unlike wild-type extracts, those from sup45-2 cells 
show no differences with RNAs that do or do not contain upstream or downstream 
AUGs (Figs. 2.4, 2.6, and 2.7 vs. Fig. 2.8) and are thus incapable of scanning either 
backward or forward after premature termination. The epistasis of the toeprints obtained 
in sup45-2 extracts to those obtained in wild-type extracts provides additional evidence 
that the aberrant toeprints do not arise from leaky scanning and suggests that, prior to 
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any reinitiation event, a premature stop codon in the ribosomal A site must be 
recognized by eRF1 and trigger peptide hydrolysis in the adjoining P site (Stansfield et 
al. 1997; Song et al. 2000).  Interestingly, translation of the WT-like mini RNAs (Fig. 2.9 
and see below) in sup45-2 extracts in the presence of CHX did not yield detectable cap 
analog-sensitive toeprints, reinforcing the notion that normal termination is different from 
premature termination [Fig. 2.10(c)].  
  
An extended 3’-UTR leads to aberrant termination events 
To determine whether aberrant termination and its consequences resulted from 
the relative positioning of a nonsense codon within an mRNA, four constructs were 
made in which the PGK1 3’-UTR (Peltz et al. 1993; Muhlrad and Parker 1999) was 
inserted immediately downstream of early stop codons in can1 alleles. These "mini" 
wild-type mRNA mimics included the miniUAA, miniUAA-M, and miniUGA RNAs, as 
well the miniUAA-M-W RNA (which has the UAA in weak context (Bonetti et al. 1995) 
but lacks the upstream AUG) (Fig. 2.9). All mini RNAs yielded normal levels of initiator 
AUG toeprints in CHX-supplemented wild-type extracts (data not shown), but lacked the 
aberrant +6 toeprint [Fig. 2.10(a)]. Unlike the normal terminators of the Fusion and 
ADE2 RNAs, translation programmed by the mini RNAs in sup45-2 extracts yielded cap 
analog-sensitive +14 toeprint signals in the absence of CHX [Fig. 2.10(b)], but not in its 
presence [Fig. 2.10(c)]. The lack of aberrant toeprints at +6 and/or +17 with these 
mimics of wild-type mRNA indicates that backwards scanning, or at least its apparent 
end-product, is eliminated when termination codons are flanked by normal 3'-UTR 
sequences. These results indicate that aberrant termination promotes the novel 
42
initiation events and raise the question of why a 3'-UTR created by a premature 
termination codon should differ from that of a wild-type mRNA.   
Tethered Pab1p stabilizes nonsense-containing mRNAs 
The “faux UTR” model suggests that the downstream element (DSE) thought to 
be a key cis-acting regulator of NMD (Peltz et al. 1993) promotes mRNA decay because 
it lacks a termination regulatory factor (or factors) normally present on a legitimate 3'-
UTR, a hypothesis that may also explain why deletions that eliminate most coding 
sequences downstream of premature terminators stabilize mRNAs that would otherwise 
be substrates for NMD (Peltz et al. 1993; Muhlrad and Parker 1999). This inadequacy 
could occur because translation to the normal end of a coding region remodels an 
mRNP (Hilleren and Parker 1999) or because proximity to the poly(A) tail (and bound 
Pab1p) has a qualitative and/or quantitative influence on the nature of proteins bound to 
the UTR (Jacobson and Peltz 2000). To test whether proximity of a termination codon to 
Pab1p is germane to NMD, the in vivo stability of mRNAs bearing an MS2 coat protein 
binding-site 3' to premature terminators in the CAN1 and PGK1 mRNAs was assessed 
in cells expressing an MS2-Pab1p fusion. Pab1p tethered 37-73 nt 3' to premature UAA, 
UGA, or UAG codons promoted 5- to 11-fold increases in mRNA stability and 
abundance [Fig. 2.11(a) and (b)].  MS2 dimer or MS2-Sxl tethered at the same position, 
or MS2-Pab1p tethered 164 nt downstream (3' to the DSE) had no effect on mRNA 
stability or abundance [Fig. 2.11(a)]. MS2-Pab1p-mediated stabilization was: a) specific 
for mRNA containing the MS2-binding site since the CYH2 pre-mRNA, an NMD 
substrate, was not detectable on these blots [Fig. 2.11(a)] , b) not attributable to non-
specific effects on translation since the average number of ribosomes associated with 
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the PGK1-MS2 mRNA does not change in the presence or absence of tethered Pab1p 
[Fig. 2.11(c)], and c) partially manifested by tethered fragments of Pab1p [Fig. 2.11(d)]. 
The ability of the latter fusion proteins, including those containing only RRMs1-4 or just 
the C-terminus of Pab1p, to partially stabilize the PGK1-MS2 mRNA suggests that 
Pab1p-mediated mRNA stabilization might be attributable to protein:protein interactions 
characteristic of its respective domains (Mangus et al. 2003). To test this possibility, we 
utilized anti-MS2 coat protein antibodies to immunoprecipitate mRNPs and assayed for 
the presence of co-immunoprecipitated regulatory factors. Fig. 2.12(a) shows that, in 
the presence of MS2-Pab1p or MS2-Sxl, this method selectively precipitates PGK1 
nonsense mRNAs containing the MS2 binding site (lanes 4 and 7). Western blotting 
demonstrated that immunoprecipitation of these mRNPs from extracts containing MS2-
Pab1p led to the recovery of MS2-Pab1p and Sup35p (Fig. 2.12(b), left panel), but did 
not lead to the recovery of eIF4G or eIF4E (data not shown). We attribute co-
immunoprecipitation (co-IP) of Sup35p to a specific interaction with MS2-Pab1p 
because the reciprocal co-IP was also productive (Fig. 2.12(b), right panel) and 
because no comparable recovery of Sup35p was obtained from immunoprecipitates of 
MS2-Pab1p lacking the Sup35p-interaction domain [Fig. 2.12(c)]. As an additional test 
for the specificity of Sup35p recruitment, inactivation of Upf1p was utilized to provide an 
independent means of stabilizing the nonsense-containing mRNA. Western blotting of 
extracts from upf1Δ cells demonstrated that this alternative mode of stabilizing the 
PGK1-MS2 mRNA did not enhance recovery of endogenous Sup35p in an MS2-Sxl IP 
[Fig. 2.12(d)], thereby implicating a specific MS2-Pab1p:Sup35p interaction. 
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 Recovery of Sup35p, a termination factor known to interact with Pab1p and 
thought to play a role in the stability of conventional mRNAs (Uchida et al. 2002; 
Hosoda et al. 2003), suggested a role for this protein in the tethered-Pab1p-mediated 
reversal of NMD. This appears to be the case since tethered Sup35p also stabilized 
PGK1 nonsense transcripts, albeit to a lesser extent than tethered Pab1p (Fig. 2.13). 
Similar experiments, in which Sup45p was the tethered component (Fig. 2.13), failed to 
stabilize the same mRNA significantly, indicating that regulatory aspects of termination 
played a key role in antagonizing NMD and that Pab1p's role in this process most likely 
reflected its function as a scaffold for post-transcriptional regulators (Mangus et al. 
2003). 
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Fusion ......GCAAUG ACA  ......AAA GAU GAG AAA AGU GUC GAC GCC AAA AAC AUA AAG AAA GGC......UUG UAACUG......
-11
UAA AAUACCA......GCAAUG ACA  ...... AAA GAU GAG AAA AGU UAA GUCGACGCCAAAAACAUAAAG AAAGGC......UUGUAACUG......CCUGCAAAAAA......
Transcription 
start
Translation 
start -11 PTC
AAA ......GCAAUG ACA  ......AAA GAU GAG AAA AGU AAA GUC GAC GCC AAA AAC AUA AAG AAA GGC......UUG UAACUG......
-11
UGA ......GCAAUG ACA  ...... AAA GAU GAG AAA CAA UGA CAAGACGCCAAAAACAUAAAG AAAGGC......UUGUAACUG.....
-11 PTC-1
LUC PGK1
~65
can1-100
123nt (5’-UTR) 141nt 1647nt 151nt (3’-UTR)
poly(A)
/ /
Fig. 2.1 : General schematic and sequences of selected regions of the UAA, UGA, 
Fusion, and AAA CAN1/LUC RNAs. PTC, denotes premature termination codon. Each 
RNA contains a the 5’-UTR and first 47 codons of the yeast can-100 gene fused in frame 
with firefly Luciferase and the PGK1 3’-UTR followed by ~65 adenylate residues. -11, 
denotes position of the upstream AUG codon. 
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Fig. 2.2 : Toeprint analyses of termination in cell extracts in the absence of CHX. (a) 
PTC toeprints are detected during translation of CAN1/LUC RNAs in wild-type, sup45-2, 
and upf1∆ extracts in the absence of CHX. (b) No toeprints are detectable at normal 
terminators of the Fusion or ADE2 RNAs in wild-type extracts in the absence of CHX. 
Sequence ladders on the left side of each panel correspond to the normal terminator 
region of each mRNA.
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Fig. 2.3 : Toeprint analyses of initiation and termination in cell extracts in the 
presence of CHX. (a) CHX addition to wild-type extracts promotes the appearance of 
normal toeprints at initiator AUGs and aberrant toeprints in the vicinity of PTCs. Lanes 7-9 
show products from reactions lacking added extract. (b) The +6 toeprint of the UAA RNA 
incubated in the presence of CHX is eliminated by a single nucleotide substitution. (c) 
The +6 toeprint in the UAA RNA appears subsequent to CHX-chasing of the PTC toeprint. 
CHX was added after 4 min of translation and samples were taken for toeprinting at the 
designated times. (d) upf1∆ extracts do not reveal the +6 toeprint of the UAA RNA when 
incubated for 1 to 5 min and terminated by the addition of CHX for 3 min. Positions of the 
toeprints are indicated with arrows. The left portions of panels (a) and (b) show 
dideoxynucleotide sequencing reactions for the UAA or AAA templates, respectively (with 
5' to 3' sequence reading from the top to the bottom). 
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Fig. 2.4 : Aberrant toeprints derived from PTCs in wild-type extracts in the 
presence of CHX are dependent on upstream AUGs. Toeprint analyses of the UAA, 
UAA-M (left panel), or Fusion, UGA, and UGA-M (right panel) RNAs. CHX addition to 
wild-type extracts promotes the appearance of  aberrant toeprints in the vicinity of PTCs. 
Pertinent sequences of mutated CAN1/LUC constructs are shown below each panel. 
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-11
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Fig. 2.5 : Ribosomes can reinitiate translation at AUG codons upstream or 
downstream of the stop codon. Translation reactions in wild-type (n=4) or upf1∆ (n=3) 
extracts were programmed with the respective in-frame LUC fusion (Inf) mRNAs and 
analyzed for luciferase activity. Sequences of pertinent segments of the Inf constructs are 
shown. 
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Fig. 2.6 : Ribosomes can migrate to AUG codons 21 or 32 nt upstream of premature 
stop codons. The Fusion-21 and Fusion-32 constructs, used as controls, lack PTCs, but 
contain the -21 or -32 AUGs, respectively. Sequences indicate mutational changes to the 
Fusion, UAA-M, or UGA-M RNAs (see Figs. 2.1 and 2.4 for original sequences). Asterisks 
(*) show toeprint bands 16-18 nt downstream of the -21 (left panel) or -32 (right panel) 
AUGs. Arrows a, b, and c are explained in the main text.
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Fig. 2.7 : Reinitiation at upstream AUGs is favored over downstream reinitiation. 
Top panel: toeprint analyses of UAA RNA derivatives containing an additional 
downstream AUG 5 nt from the PTC with (UAA-DS) or without (UAA-M-DS) the -11 AUG. 
Bottom panel: UGA RNA derivatives lacking the –11 AUG (No-11-UGA), containing an 
additional AUG 5 nt 3’ to the stop codon (UGA-DS), or containing the +5 AUG, but lacking 
the –11 and –1 AUGs (UGA-M-DS). Numbers under the AUGs denote position relative to 
the PTCs and numbers on the right of each panel indicate the positions of toeprints 
relative to PTCs.
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Fig. 2.8 : RNAs translated in sup45-2 extracts in the presence of CHX yield only +12 
toeprints.  UAA and UGA RNAs and their derivatives with or without AUG codons 5’ or 
3’ to the respective terminators (see Figs. 2.1, 2.4, 2.6, and 2.7) were subjected to 
toeprint analysis. UAA-M-W RNA is a construct containing the UAA codon in a weak 
termination context (CAA UAA CAA)12. The sequence ladder depicted are derived from 
the UAA template.
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AAUACCACGG......GCAAUG ACA AAU ...... AAA GAU GAG AAA AGU UAAGUCGACGCCCUGCA......AGAGUCGACCUGCAAAAAA......
NTC
miniUGA ......GCAAUG ACA AAU ...... AAA GAU GAG AAA CAA UGACAAGACGCCCUGCA......AGAGUCGACCUGCAAAAAA......
-11 NTC-1
miniUAA-M ......GCAAUG ACA AAU ...... AAA GAC GAG AAA AGU UAAGUCGACGCCCUGCA......AGAGUCGACCUGCAAAAAA......
NTC
miniUAA-M-W ......GCAAUG ACA AAU ...... AAA GAC GAG AAA CAA UAACAAGACGCCCUGCA......AGAGUCGACCUGCAAAAAA......
NTC
PGK1
~65
can1-100
123nt (5’-UTR) 141nt 151nt (3‘-UTR)
poly(A)
Fig. 2.9 :  General schematic and sequences of the mini RNAs. NTC, denotes PTCs that have 
been converted to normal termination codons by virtue of coding region deletions. 
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were toeprinted using oligoprimer #3029. (b) Translation of mini RNAs in the absence of 
CHX, in sup45-2 extracts, but not in wild-type extracts yields +14 toeprints. The left portion 
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Fig. 2.11 : Stabilization of nonsense-containing mRNAs by tethered Pab1p. (a) Stabilization 
of the PGK1-MS2 mRNA is dependent on the presence and proximity of tethered Pab1p. Half-lives 
of the PGK1-MS2, PGK1-3’-MS2, and CYH2 mRNAs were assessed by northern blotting at 
different times (min) subsequent to transcription inhibition19. Cells expressed the mini-PGK1 
allele19 containing an insertion of MS2 coat protein binding sites 37 nt (PGK1-MS2) or 164 nt 
(PGK1-3’-MS2) 3’ of the premature UAG.  (b) Cellular steady-state levels of PTC-containing CAN1 
(lanes 1-4) and PGK1 (lanes 5 and 6) mRNAs with or without tethered Pab1p. Cells expressed 
UAA or UGA alleles of CAN1/LUC (see Fig. 2.1) or the mini-PGK1 UAG allele, all of which 
contained insertions of MS2 coat protein binding sites.  Levels of all transcripts were determined 
by northern blotting. The * denotes decay intermediates generated by 5’ to 3' degradation up to the 
site of bound MS2-Pab1p. Simultaneous expression of MS2 fusion proteins in (a) and (b) are 
indicated. (c) Tethered Pab1p does not affect translation of the PGK1-MS2 mRNA. Extracts from 
cells expressing the PGK1-MS2 mRNA with (right) or without (left) co-expressed MS2-Pab1p were 
fractionated on sucrose gradients and subsequently analyzed by northern blotting. Top: OD
254
 
profiles, with sedimentation proceeding from right to left. Bottom: northern analysis of the gradient 
fractions for PGK1-MS2 mRNA and control CYH2 mRNA. (d) Tethered fragments of Pab1p 
partially stabilize the PGK1-MS2 mRNA. MS2 fusion proteins encompassing Pab1p full-length, 
RRM1-4 (residues 1-405); C-terminus only (residues 406-577); and RRM2 through the C-terminus 
(residues 119-577) were expressed and assessed as in part (b) for their effects on the 
steady-state level of PGK1-MS2 mRNA.
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Fig. 2.12 : Tethered Pab1p interacts with Sup35p. (a) PGK1-MS2 mRNA is selectively 
recovered in α-MS2 immunoprecipitates. RNA extracted from IP reactions using α-MS2 coat 
protein antibodies (IP anti-MS2), no antibodies (IP no Ab), or non-specific antibodies (IP NS-Ab) 
was analyzed by northern blotting for the presence of PGK1-MS2 or control TCM1 mRNA. 
PGK1-MS2 mRNA is not stabilized in cells expressing MS2-Sxl fusion protein (lanes 7-12), thus 
rendering its signal weaker than in MS2-Pab1p-expressing cells (lanes 1-6). The loading for the 
input, the unbound fraction (sup), and the wash represent half of the loading of the different IP 
fractions. (b) Sup35p co-IPs with tethered MS2-Pab1p and vice versa. Left; western blot analysis 
of IP reactions described in (a) using antibodies that detect Pab1p (left upper panel) or Sup35p 
(left lower panel). Right: lysates from cells expressing PGK1-MS2 and MS2-Sup35p were IP’d 
with α-MS2 antibodies and analyzed by western blotting for the presence of Sup35p (upper 
panel) or Pab1p (lower panel). The positions of Pab1p, MS2-Pab1p, Sup35p, MS2-Sup35p, and 
marker proteins are indicated. (c) Sup35p does not co-IP with MS2-Pab1p lacking the 
Sup35p-interacting domain. MS2-Pab1p harboring only PAB1 RRM1-4  was co-expressed with 
PGK1-MS2 mRNA and analyzed for co-IP of Sup35p as in (b). (d) Sup35p does not co-IP with 
mRNPs stabilized by deletion of UPF1. Extracts of upf1Δ cells expressing PGK1-MS2 mRNA 
and MS2-Sxl fusion protein were immunoprecipitated with anti-MS2 antibodies and 
characterized as in (b).  
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Fig. 2.13 : PTC-containing mRNA is stabilized by tethered Sup35p, but not by 
tethered Sup45p. RNA extracted from wild-type or upf1Δ cells expressing PGK1-MS2 
mRNA was analyzed by northern blotting. Cells used for the wild-type (WT) and upf1∆ 
samples contained no fusion protein whereas those of the remaining lanes contained the 
indicated MS2 fusion proteins. Fold stabilization, relative to the WT sample, was 
determined by phosphorimaging.  
58
 
 
 
Chapter III 
 
Translational competence of ribosomes released from a premature 
termination codon is modulated by NMD factors 
 
 
 
 
 
The work presented in this chapter is currently under revision for publication in RNA as: 
 
Ghosh S., Ganesan R., Amrani N., and Jacobson A. Translational competence of 
ribosomes released from a premature termination codon is modulated by NMD factors. 
RNA (submitted 2009; under revision). 
 
SG performed all in vitro experiments. 
In vivo assays were performed by R. Ganesan.  
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Chapter III – Translational competence of ribosomes released from a 
premature termination codon is modulated by NMD factors 
 
Summary 
In addition to their well-documented roles in the promotion of nonsense-mediated 
mRNA decay (NMD), the yeast Upf proteins (Upf1p, Upf2p/Nmd2p, and Upf3p) have 
also manifested translational regulatory functions, at least in vitro, including roles in 
premature translation termination (but not normal termination) and subsequent 
translational reinitiation. Using a PGK1/LUC reinitiation reporter, we have found that all 
upfΔ strains fail to reinitiate translation after encountering a PTC in vivo, a result that led 
us to seek a possible unifying mechanism for these collected translation phenomena. 
Comparing the in vitro translational activities of wild-type (WT) and upf1Δ extracts, we 
find that Upf1p appears to play a role in regulating the efficiency of post-termination 
ribosome reutilization. Relative to WT extracts, non-nucleased extracts lacking Upf1p 
manifest an almost 2-fold decrease in the translation of synthetic CAN1/LUC mRNA, a 
defect paralleled by fewer ribosomes per mRNA and reduced efficiency of the 60S 
joining step at initiation. We hypothesized that these deficiencies, which could be 
complemented by purified FLAG-Upf1p or 60S subunits, reflected diminished cycling of 
ribosomes from endogenous PTC-containing mRNAs to the exogenously added 
synthetic mRNA in the same extracts. This hypothesis was tested, and supported, by 
experiments in which nucleased WT or upf1Δ extracts were first challenged with high 
concentrations of synthetic mRNAs that were templates for either normal or premature 
translation termination and then assayed for their capacity to translate a normal mRNA. 
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Collectively, our results strongly suggest that Upf1p is required in vitro for efficient 
termination and release of ribosomes at a PTC and their subsequent reutilization for 
their next round of translation initiation. 
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Results 
 
Mutations in a PGK1/LUC reporter attenuate its reinitiation activity 
We have shown that, in vitro, yeast ribosomes will reinitiate translation 
subsequent to premature termination, provided that Upf1p is present in the translation 
reaction (Chapter II). This observation indicated that premature termination was 
inefficient and suggested that Upf1p might influence the extent to which prematurely 
terminating ribosomes remain associated with an mRNA (Chapter II). To determine 
whether Upf1p, and other NMD factors, play a similar role in vivo, we constructed a 
reinitiation reporter and evaluated its expression in wild-type yeast strains and in strains 
devoid of NMD function. The reporter, a chimeric PGK1/LUC gene (Fig. 3.1(a), 
construct 1) that encodes an mRNA subject to NMD [Fig. 3.1(b)], consists of the 
following: i) the PGK1 5’-untranslated region (UTR); ii) the first 5% of the PGK1 open 
reading frame (ORF) followed by a UAG stop codon; iii) an 82 nt PGK1 coding region 
sequence element whose first AUG codon, designated +19 AUG (relative to the U of the 
UAG), is out of frame with the upstream PGK1 ORF; iv) the LUC ORF lacking its normal 
start codon, fused in frame with the +19 AUG; and v) the 3’-UTR of PGK1. Luciferase 
assays, performed on extracts of wild-type yeast strains bearing this construct, yielded 
activity that was assigned a value of 100% for purposes of comparison with subsequent 
experiments [Fig. 3.1(c)]. In this, and all other assays, luciferase activity was normalized 
to both total protein content of the sample, as well as to the level of the construct-
specific mRNA. The derived values were thus expressed as relative light units 
(RLUs)/μg protein/unit mRNA. 
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 Our analyses indicated that the luciferase activity derived from the reporter 
represented reinitiation from the +19 AUG codon downstream of the partial PGK1 ORF 
or from one additional in-frame AUG located five codons downstream of the +19 AUG. 
First, we measured luciferase activity from cells containing construct 2 [Fig. 3.1(a)], in 
which the +19 AUG and the additional downstream AUG codon were deleted, and 
observed a 5-fold decrease in luciferase expression relative to construct 1 [Fig. 3.1(c)] . 
(The residual luciferase activity appears to derive from an in-frame AUG codon 82 nt 
into the LUC sequence (Fig. 3.2, construct 6). Second, in a separate construct, the LUC 
ORF was placed out of frame with respect to the +19 AUG, as well as out frame with the 
PGK1 ORF (Fig. 3.1(a), construct 3). This construct yielded almost no luciferase activity 
[Fig. 3.1(c)], indicating that the LUC ORF has to be in-frame with the +19 AUG to 
produce functional luciferase protein. Finally, deletion of the PGK1 stop codon (Fig. 
3.1(a), construct 4), which allows translation until a termination codon 75 nt into the LUC 
coding region, also resulted in a substantial decrease in luciferase activity [Fig. 3.1(c)]. 
These results strongly implicate the +19 AUG codon in the expression of luciferase from 
a translational reinitiation event in the PGK1/LUC mRNA derived from construct 1.  
 
Reinitiation on nonsense-containing PGK1/LUC mRNA is sensitive to mutations 
in the NMD pathway 
To assess whether NMD factors influence reinitiation events in vivo, PGK1/LUC 
construct 1, on a YCp plasmid, was transformed into isogenic yeast strains bearing 
deletions of UPF1, UPF2/NMD2, or UPF3, and combinations thereof. Although the 
mRNA derived from this construct is sensitive to NMD, as indicated by the observation 
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that it is stabilized in yeast strains defective in this pathway [Fig. 3.1(b)], the expression 
of low-copy PGK1/LUC construct 1 in upf/nmd strains yielded a dramatic decrease in 
luciferase activity when compared to that in wild-type cells [Fig. 3.1(d)]. It was important 
to determine whether this apparent decrease in luciferase activity was simply due to the 
increased stability of the PGK1/LUC mRNA and consequent increase in its steady-state 
level in these strains without a parallel increase in luciferase protein. To clarify this 
question, PGK1/LUC construct 1 was inserted into a high-copy YEp vector and 
transformed into the wild-type and upf/nmd mutant strains. Normalized values for 
luciferase activity in strains harboring the YEp construct were very similar to those in 
cells harboring the construct on a YCp plasmid [Fig. 3.1(d)]. Notably, the increased 
levels of PGK1/LUC mRNA in wild-type cells [Fig. 3.1(b)] did not lead to any apparent 
decrease in normalized values of reinitiation activity, showing that mRNA levels do not 
affect overall reinitiation in this reporter. Additionally, the upf/nmd mutant strains showed 
a similar reduction in luciferase activity regardless of whether there was an increase in 
steady-state levels of the mRNA [Fig. 3.1(b)]. As an additional control, we utilized 
sucrose gradient analysis to evaluate the polysomal distribution of the PGK1/LUC 
mRNA in wild-type and upf1Δ cells. These experiments manifested indistinguishable 
polysomal profiles for the PGK1/LUC mRNA in wild-type and upf1Δ cells, with >90% of 
the mRNA on polysomes in both cases (data not shown). Collectively, these results 
indicate that the mutation-dependent variations in reinitiation activity evident in Fig. 
3.1(d) are not simply a function of increases in the abundance of PGK1/LUC mRNA, or 
of decreases in its overall translatability, and that, as was seen previously in cell-free 
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translation reactions (Chapter II), reinitiation in vivo is decreased in the absence of the 
key NMD factors. 
 
A small percentage of ribosomes reinitiate downstream of the premature stop 
codon 
To determine the proportion of ribosomes that initiate at the normal PGK1 AUG 
and are subsequently able to reinitiate, post-termination, on the PGK1/LUC mRNA, it 
was necessary to first assess the efficiency with which ribosomes initiated at the PGK1 
AUG. We made a construct in which the premature PGK1 stop codon plus one 
nucleotide were deleted, resulting in a fusion ORF which begins at the PGK1 start 
codon and ends at the normal LUC terminator (Fig. 3.2(a), construct 5). The luciferase 
activity of construct 1 was found to be approximately 2.5% that of construct 5 [Fig. 
3.2(b)], a comparison indicating that approximately one in forty ribosomes reinitiated 
translation after encountering the premature PGK1 nonsense codon.  
 
NMD is independent of translation reinitiation 
Since our data indicated that reinitiation efficiency is directly affected by the NMD 
factors, and other experiments have shown that reinitiation can affect NMD (Zhang and 
Maquat 1997), it was of interest to determine whether rapid mRNA decay still occurred 
in the absence of reinitiation. To address this question, we introduced a strong stem-
loop structure (ΔG = 58.3 kcal/mol) between the PGK1 stop codon and the PGK1 
downstream +19 AUG (Fig. 3.3(a), construct 7). This stem-loop structure bears a 25-nt-
pair stem and 4 nt loop and is preceded by a 30 nt spacer between the stop codon and 
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the stem-loop to ensure that the structure does not interfere with termination. mRNA 
derived from construct 7 displayed almost no luciferase activity [Fig. 3.3(b)], but 
continued to undergo NMD since it could be stabilized in an nmd2Δ strain [Fig. 3.3(c)]. 
Further insight into the potency of the stem-loop structure used in these experiments 
was obtained from an additional construct that contains the stem-loop, but lacks the 
premature PGK1 stop codon, generating an ORF that extends from the PGK1 initiator 
AUG, through the stem loop and PGK1 downstream sequence, to the LUC terminator 
(Fig. 3.3(a) construct 8). Luciferase activity derived from construct 8 was only 25% that 
of construct 5, which is identical but lacks the stem-loop [Fig. 3.3(b)]. Collectively, the 
results of Fig. 3.3 suggest that the strong stem-loop disrupts reinitiation (and 
presumably ribosome scanning), and substantially inhibits elongation, but is not 
sufficient to prevent NMD. Thus, we conclude that neither reinitiation, nor any form of 
ribosome scanning beyond the termination codon, is required for the promotion of NMD.   
 
NMD-deficient extracts manifest a translation defect in vitro 
The in vivo results of Figs. 3.1 - 3.3 are consistent with our earlier in vitro data 
(Chapter II) and suggest that factors regulating NMD have an as yet undefined function 
that affects translation reinitiation. To characterize this role further, we returned to the 
analysis of yeast cell-free translation and evaluated the ability of non-nucleased extracts 
prepared from WT or upf/nmd mutant strains to translate a synthetic CAN1/LUC fusion 
mRNA [Fig. 3.4(a)] that harbors a full-length open reading frame and which remains 
stable during the course of in vitro translation (Chapter II). Fig. 3.4(b) shows that, 
relative to WT extracts, extracts from strains lacking Upf1p activity manifested reduced 
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luciferase expression from the CAN1/LUC mRNA. Similar results were observed with 
extracts lacking Upf2p/Nmd2p or Upf3p (data not shown). Northern analyses of WT and 
upf1Δ translation reactions fractionated on sucrose gradients demonstrated that the WT 
extract had higher relative amounts of CAN1/LUC mRNA in the heavier polysome 
fractions, thus confirming the relatively poor translation activity of the mutant extracts 
and suggesting that they initiated translation inefficiently [Fig. 3.4(c)]. 
Further evidence for a translational deficiency in extracts from upf/nmd mutant 
strains followed from experiments that we dubbed ribosome reutilization assays. Here, 
translation of an extract’s endogenous mRNA was allowed to proceed and, at regular 
intervals, the translation reaction was supplemented with CAN1/LUC mRNA and 
incubated for 25 additional minutes to allow for synthesis of the luciferase fusion protein. 
Thus, luciferase activity at each time point should reflect the relative ability of ribosomes 
and factors to initiate and translate the exogenously added reporter mRNA. As shown in 
Fig. 3.4(d), WT extracts exhibit enhanced translatability of the reporter mRNA over time, 
whereas upf1Δ extracts (as well as nmd2Δ, and upfΔ3 extracts; data not shown) fail to 
do so. These results suggest that, upon preincubation, WT extracts increase the 
availability or activity of a limiting component of the translation system whereas the 
mutant extracts maintain over time a smaller and relatively unchanged pool of the 
functionally available component. One possible explanation for this observation, 
considered below, is that the increase in translation activity in WT extracts arises from 
translation termination and dissociation of ribosomal subunits from endogenous 
mRNAs. Thus, ribosomes in WT extracts might readily enter the pool of functional 
ribosomes over time, leading to an overall increase in CAN1/LUC expression, whereas 
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the reutilization of ribosomes that were previously engaged in translation is somehow 
compromised in the mutant extracts.  
 
Upf1p affects translation in vitro 
To test whether the decrease in translation of the CAN1/LUC reporter mRNA 
observed in upf1Δ extracts was due to the absence of Upf1p, or resulted from an 
indirect effect of the lack of a functional NMD pathway, we assessed translation of the 
CAN1/LUC mRNA in upf1Δ extracts supplemented with either purified FLAG-Upf1p or 
BSA (as a control). As shown in Fig. 3.5(a), purified FLAG-Upf1p was sufficient to 
restore the translation activity of a upf1Δ extract to that approaching the activity of a WT 
extract. In addition, purified FLAG-Upf1p was also able to stimulate the translational 
capacity of a upf1Δ extract at different time points in a ribosome reutilization assay (Fig. 
3.5(b), compare white boxes to gray boxes at each time point). These results suggest 
that Upf1p may play a direct role in enabling or enhancing the availability of functional 
ribosomes in vitro.  
 
Translation initiation is compromised in upf1Δ extracts 
To evaluate the relative efficiency of translation initiation on the CAN1/LUC 
mRNA in different extracts, we used a primer extension inhibition (toeprinting) assay 
(Dmitriev et al. 2003; Amrani et al. 2004). WT and upf1Δ extracts were preincubated for 
different lengths of time and then supplemented with CAN1/LUC mRNA, as in Fig. 
3.4(d). After incubating the extracts with the mRNA for 25 min, cycloheximide (CHX) 
was added to terminate the reactions and stall elongating 80S ribosomes. Toeprinting 
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reactions were then performed using a radiolabeled oligonucleotide that allowed 
visualization of a gel band corresponding to a ribosome positioned at the initiator AUG 
codon (Fig. 3.6(a), upper panel). Accumulation of this “toeprint” was sensitive to cap 
analog (Fig.3.6(a), upper panel), indicating that it arose from initiation activity, and WT 
extracts routinely showed a more intense toeprint than the upf1Δ extracts (Fig. 3.6(a), 
upper and lower panels), reflecting better translation initiation.  
Since the AUG toeprints could arise as a consequence of both de novo initiation, 
as well as recycling of ribosomes post-termination, we modified the assay such that 
CHX was added at the same time as the CAN1/LUC mRNA. Thus, only ribosomes 
undergoing de novo initiation would contribute to the AUG toeprints. Fig. 3.6(b) shows 
that, using this approach, only WT extracts exhibit a significant increase in the AUG 
toeprint within the first twenty minutes, whereas upf1Δ extracts fail to show any 
appreciable increase in the AUG toeprint band even at late timepoints, suggesting an 
absence of 80S ribosomes at the initiator AUG. This result indicates further that the 
availability of functional ribosomes may be diminished in the absence of Upf1p. To 
determine whether Upf1p affects an early or late step in initiation, we repeated the same 
assay, replacing CHX with the nonhydrolyzable GTP analog, GMP-PNP, which allows 
48S formation, but inhibits joining of the 60S ribosomal subunit [Fig. 3.6(c)] (Dmitriev et 
al. 2003). In this experiment we observed that both WT and upf1Δ extracts exhibited 
strong AUG toeprint bands in the presence of GMP-PNP, indicative of the presence of 
40S ribosomal subunits on the RNA, with the upf1Δ extracts showing a slightly 
diminished signal. Taken together, these results suggest that, although 40S loading is 
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slightly impaired in upf1Δ extracts, Upf1p is likely to influence a late stage of translation 
initiation, namely the joining of the 60S subunit to the 48S complex. 
 
Initiation efficiency depends on prior termination events 
The results depicted in Figs. 3.4-3.6 implicate Upf1p in the determination of 
translational initiation efficiency in vitro, but the mechanism underlying this activity, and 
its relationship to the reinitiation defects seen in vivo (Figs. 3.1-3.3) and in vitro (Amrani 
et al. 2004), were unclear. Our translation reactions are carried out in the absence of 
any prior nuclease treatment and the ongoing translation of endogenous mRNAs 
includes that of a substantial number of mRNAs that are NMD substrates (He et al. 
2003; Johansson et al. 2007). Since premature termination on the latter transcripts is 
altered in the absence of UPF1 (Chapter II) we considered the possibility that these 
events might influence subsequent translation initiation activity in the extracts. 
Accordingly, we devised an assay to monitor translation of the CAN1/LUC reporter 
mRNA by ribosomes that had undergone a prior termination event at either a normal or 
a premature termination codon. To achieve this, we first treated WT and upf1Δ extracts 
with micrococcal nuclease to eliminate endogenous mRNAs. With this treatment, the 
ability of upf1Δ extracts to translate the CAN1/LUC mRNA in vitro resembled  that of 
WT extracts [3.7(a)], confirming our earlier observation that MN-treated extracts showed 
similar AUG toeprints of the CAN1/LUC transcript (Amrani et al. 2004). We then primed 
these extracts with different amounts of synthetic WT CAN1 mRNA, or its nonsense-
containing counterpart (can1-100 mRNA), in order to generate extracts in which 
ribosomes were preferentially undergoing either normal or premature translation 
70
termination events. We rationalized that ribosomes undergoing one termination event or 
the other might be differentially predisposed for further rounds of translation in these 
extracts, a difference that we could test by measuring the luciferase activity generated 
by the subsequent addition of the CAN1/LUC reporter mRNA. Fig. 3.7(b) depicts the 
ratios of luciferase activity obtained in WT and upf1Δ extracts from reactions that were 
first primed with can1-100 or CAN1 mRNAs. The results of this experiment indicate that 
WT extracts manifest as much as twofold more translation of the CAN1/LUC reporter 
mRNA when primed with high levels of the can1-100 mRNA vs. the CAN1 mRNA, but 
that translation of the reporter mRNA in upf1Δ extracts is unaffected by the nature of the 
priming mRNA. This result suggests that in WT extracts, but not in upf1Δ extracts, the 
termination and release of ribosomes from premature stop codons generates a pool of 
ribosomes with greater “recycling” ability than ribosomes released from the normal 
terminator.  
In principle, the size of the ORF, rather than the nature of the termination event, 
could be responsible for the increased luciferase activity in translation reactions primed 
with the can1-100 mRNA in WT extracts. Hence, we repeated the assay in WT extracts 
using either the can1-100 mRNA or the miniUAA mRNA (Fig. 2.9 and Chapter II). The 
latter is a transcript that contains the same ORF as the can1-100 mRNA, but which has 
a normal termination event because the short ORF is followed by a normal 3’-UTR 
(Chapter II). A comparison of the ratios of luciferase activities obtained with the two 
RNAs showed that priming with the can1-100 mRNA yielded enhanced translation of 
the CAN1/LUC mRNA relative to priming with the miniUAA mRNA (Fig. 3.7(c), middle 
box). The experiments in Fig. 3.7(c) [right box] also demonstrate that the luciferase 
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output obtained when reactions were primed with the miniUAA mRNA were comparable 
to those primed with the CAN1 mRNA. Taken together, these results  indicate that 
premature termination events, not the length of the ORF, are responsible for the 
increased luciferase activity, and reflect the possibility that more ribosomes, or more 
active ribosomes, were released from the nonsense-containing transcript than from the 
WT or pseudo-WT mRNA.   
To test whether Upf1p is involved in the increase of translation activity 
subsequent to premature termination, we primed upf1Δ extracts with the CAN1 or can1-
100 mRNAs in the presence of purified FLAG-Upf1p or BSA and measured the 
responses of the respective extracts to CAN1/LUC mRNA that was added 
subsequently. We found that addition of purified FLAG-Upf1p was sufficient to  enhance 
luciferase activity in upf1Δ extracts primed with can1-100 mRNA, similar to that 
observed with WT extracts (Fig. 3.8(a), compare gray boxes in WT+BSA and 
upf1Δ+FLAG-Upf1p). To further analyze the translation status of the CAN1/LUC mRNA 
in reactions primed with the can1-100 mRNA in the presence of FLAG-Upf1p or BSA, 
we fractionated the translation reactions on sucrose gradients and analyzed the 
fractions by northern blotting for their levels of specific transcripts. These experiments 
showed that, in WT extracts (supplemented with BSA), the CAN1/LUC mRNA was 
distributed throughout the sucrose gradient, including the polysomes and lighter 
fractions (Fig. 3.8(b), left panel). In upf1Δ extracts (supplemented with BSA) there was 
significantly less CAN1/LUC mRNA in the polysome fractions, with most of the mRNA 
being confined to the sub-80S fractions. However, addition of FLAG-Upf1p to the upf1Δ 
extracts restored the polysome distribution of the CAN1/LUC mRNA to that seen in the 
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WT control. To determine whether the decreased translation of the secondary 
CAN1/LUC mRNA was due to overall decreased translational capacity of the nuclease-
treated upf1Δ extracts, we also analyzed the distribution of the can1-100 mRNA (Fig. 
3.8(b), right panel) used to prime the reactions. We observed a similar distribution 
pattern for the primary can1-100 mRNA in extracts containing or lacking Upf1p, further 
indicating that decreased CAN1/LUC translation in upf1Δ extracts is most likely a 
consequence of translational termination at a PTC in the absence of Upf1p. 
 
Addition of WT ribosomal subunits enhances translation in upf1Δ extracts 
Although Upf1p has been shown to cosediment with polyribosomes (Peltz et al. 
1993; Atkin et al. 1995; Yamashita et al. 2009), little is known about the nature of this 
association. Since the results of Figs. 3.7 and 3.8 suggested that Upf1p might enhance 
the ability of ribosomes to recycle to another round of translation, we evaluated the 
effect of adding purified WT ribosomal subunits to upf1Δ extracts. We reasoned that the 
absence of Upf1p in these extracts might lead to the accumulation of defective 40S 
and/or 60S subunits and that the possible amelioration of the translation defects upon 
addition of the WT subunits would shed light on which subunit was affected in the 
absence of Upf1p. Fig. 3.9(a) [right panel] shows that addition of purified 40S or 60S 
subunits to non-nucleased upf1Δ extracts was sufficient to increase the translation of 
the CAN1/LUC mRNA. WT extracts (Fig. 3.9(a), left panel), on the other hand, did not 
show any increases in translation upon addition of either ribosomal subunit. The 
stimulatory activity of 40S and 60S subunits in upf1Δ extracts suggested that either both 
subunits were affected by the absence of Upf1p, or that only one subunit was affected 
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but that the other contained bound Upf1p. Indeed, Fig. 3.9(b) shows that Upf1p 
preferentially copurified with 40S subunits, although the amount of Upf1p associated 
with the ribosomal subunits is much lower than the total WT Upf1p present in a 
translation reaction (Fig. 3.9(b), compare 40S lanes vs. WT extract lane) or the purified 
FLAG-Upf1p required for complementation in vitro (the 11 ng lane represents 4% of the 
purified FLAG-Upf1p used per translation reaction). Since the subunit purification 
protocol (Algire et al. 2002) involves high salt washes, this result indicates that Upf1p 
can form a stable association with 40S subunits, and may account in part for the 
increase in luciferase activity observed upon their addition to upf1Δ extracts. 
Comparison of the amount of Upf1p present in association with ribosomal subunits to 
the amount of purified FLAG-Upf1p [Fig. 3.9(b)] used in the complementation assays in 
Figs. 3.5, 3.8, and 3.9 suggests that 40S-associated Upf1p may retain more activity 
than the purified FLAG-Upf1p or that 40S subunits themselves may have a slight defect. 
In turn, this suggests that the stimulatory activity of the purified 60S subunits may reflect 
a relative inactivity of such subunits in upf1Δ extracts. It should be noted that the 60S 
subunit sample also contains a polypeptide band in the approximate position of Upf1p, 
but this band is significantly less abundant than that associated with the 40S sample 
and does not show a linear increase with overall protein loaded on the gel.  
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Fig. 3.1 : Reinitiation activity is reduced in strains bearing mutations in the NMD 
pathway. (a) Schematic representation of PGK1/LUC chimeric constructs 1-4. Start and 
stop codons are indicated, as are their reading frames and that of the LUC coding region, 
relative to the PGK1 start codon. “X” indicates deletion or mutation of a particular feature. 
“+19 AUG” denotes the first of two in-frame PGK1 AUGs downstream of the PTC. Details 
of the constructs are given in Table 2. (b) Northern analysis of the PGK1/LUC mRNA 
expressed from either a low-copy (YCp) or high-copy (YEp) vector in WT cells or in 
isogenic cells harboring deletions of UPF1, UPF2/NMD2, or UPF3. Blots were stripped 
and reprobed for CYH2 transcripts as an internal control for NMD function (CYH2 
pre-mRNA) and loading (CYH2 mRNA). (c) Relative luciferase activities of constructs 1-4 
normalized for protein content and mRNA levels in the WT strain HFY114. The luciferase 
activity of construct 1 was assigned a value of 100%. (d) Reinitiation activity. Construct 1 
was inserted into either a low-copy (YCp) or high-copy (YEp) vector and transformed into 
the indicated strains. Relative luciferase activities, normalized for protein content and 
mRNA levels, are shown for YCp-bearing strains in black boxes and for YEp-bearing 
strains in white boxes. The luciferase activity of construct 1 on a YCp plasmid in a WT 
strain was assigned a value of 100%. The symbol ∆1 represents upf1∆; ∆2, nmd2∆; ∆3, 
upf3∆; and combinations thereof. Vertical bars represent standard error of the mean.
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Fig. 3.2 : Determination of ribosomal initiation efficiency and proportion of 
ribosomes that reinitiate downstream of the PGK1 stop codon. (a) Schematic 
representations of chimeric PGK1/LUC constructs 5 and 6. Labeling of start and stop 
codons and reading frame is as depicted in Fig. 3.1, with “X” indicating deletion or 
mutation of a particular feature. (b) Luciferase activities of constructs 5 and 6 in the wild 
type strain HFY114. Activity is expressed as RLU/µg protein/unit mRNA. The activity of 
construct 1 (Fig. 1) is shown for purposes of comparison. Vertical bars represent standard 
error of the mean.
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Fig. 3.3 :  A strong stem loop structure does not eliminate nonsense-mediated 
mRNA decay. (a) Schematic representations of chimeric PGK1/LUC constructs 7 and 8. 
Labeling of start and stop codons and reading frame is as depicted in Fig. 1, with “X” 
indicating deletion or mutation of a particular feature. (b) Luciferase activities of 
constructs 7 and 8 in the WT strain HFY114. Activity is expressed as RLU/µg protein/unit 
mRNA. Activities of constructs 1 and 5 are shown for purposes of comparison. Vertical 
bars represent standard error of the mean. (c) Northern analysis of PGK1/LUC construct 
7 mRNA expressed from a low-copy (YCp) vector in WT cells or in isogenic cells 
harboring a deletion of UPF2/NMD2. Blots were stripped and reprobed for CYH2 
transcripts as an internal control for NMD function (CYH2 pre-mRNA) and loading (CYH2 
mRNA). 
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Fig. 3.4 : Translation of CAN1/LUC mRNA is decreased in upf1∆, nmd2∆, and upf3∆ extracts. 
(a) Schematic representation of the CAN1/LUC fusion mRNA. (b) Luciferase activities of WT 
(diamonds) and upf1∆ (squares) extracts prepared without micrococcal nuclease (MN) treatment 
and incubated with 100ng CAN1/LUC mRNA at 18oC for the indicated times. Relative luciferase 
activity was calculated using the WT 60 min values as 100%. (c) Upper panel - northern analysis 
of polysomal distribution of CAN1/LUC mRNA translated in vitro in WT or upf1∆ extracts. Lower 
panel - ratio of the polysomal distributions of the CAN1/LUC mRNA during in vitro translation. WT 
and upf1∆ extracts, prepared without MN treatment, were incubated with synthetic CAN1/LUC 
mRNA at 18oC for 30 min and then analyzed by fractionation on 7-47% sucrose gradients and 
subsequent northern blotting using a probe specific for the CAN1/LUC mRNA. The amount of 
CAN1/LUC mRNA (in arbitrary units) in each gradient fraction was determined by 
phosphorimaging and the Y-axis depicts the ratios of those amounts in WT vs. upf1∆ extracts.  
Sedimentation of the gradients was from right to left; the bars at the top of the panel indicate the 
polysomal and non-polysomal fractions. (d) Relative luciferase activities of WT (black boxes) and 
upf1Δ (white boxes) extracts treated as in (b) and incubated for 25 min after addition of CAN1/LUC 
mRNA at the indicated times. Relative luciferase activities were measured using WT 20 min values 
as 100%. Vertical bars in (b) and (d) depict standard deviation.79
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Fig. 3.5 : Purified FLAG-Upf1p can complement translation defects in vitro. 
Cell-free translation extracts were prepared from WT or upf1∆ cells without MN 
treatment and preincubated on ice for 10 min with 270-360ng BSA or purified 
FLAG-Upf1p, followed by incubation at 18oC in either of two modes: (a) addition of 
100ng CAN1/LUC mRNA at t=0 min and sampling for luciferase activity at the 
indicated time points or (b) addition of 100ng CAN1/LUC mRNA at the indicated time 
points and translation at 18oC for 25 min prior to measurement of luciferase activity. 
(a) Relative luciferase values were calculated as in Fig.3.4b for WT extracts 
supplemented with BSA (diamonds), upf1Δ extracts supplemented with BSA 
(squares) or upf1Δ extracts supplemented with FLAG-Upf1p (triangles). (b) Relative 
luciferase activites of upf1Δ extracts supplemented with BSA (gray boxes) or 
FLAG-Upf1p (white boxes) normalized to the corresponding WT+BSA values at each 
given time point. Vertical bars in (a) and (b) depict standard deviation.  
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Fig. 3.6 : Formation of 80S toeprints is diminished in upf1∆ extracts. (a) Cell-free 
translation extracts, prepared from WT and upf1∆ cells without MN treatment, were 
incubated at 18oC. CAN1/LUC mRNA (100ng) was added at the indicated time points 
and reactions were further incubated for 25 min, followed by addition of 2 mM 
cycloheximide (CHX) for 3 min. Reactions were frozen and subsequently analyzed by 
toeprinting. The upper panel shows the autoradiograph, and the lower panel depicts 
the densitometry of the AUG band in WT (diamonds) and upf1Δ (squares) reactions 
normalized to the WT 0 min value. (b) Translation conditions were as in (a), except 
that 2 mM CHX was added with 100ng CAN1/LUC mRNA at each time point, followed 
by incubation for 25 min. Lanes in (a) and (b) in which control reactions contained 
2.7mM cap analog are indicated. (c) Translation and incubation conditions were as in 
(b), except that CHX was replaced with 2 mM GMP-PNP. 
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Fig. 3.7 : Initiation efficiency depends on prior termination events. Translation 
extracts prepared from WT or upf1∆ cells were treated with MN for 5 min at 25oC. (a) 
Luciferase activities of WT (diamonds) and upf1∆ (squares) extracts incubated with 
100ng CAN1/LUC mRNA at 18oC for the indicated times. (b) Treated extracts were 
incubated with the designated concentrations of the priming CAN1 or can1-100  
mRNA for 7 min at 18oC, followed by addition of 300ng of CAN1/LUC mRNA and 
incubation for an additional 25 min. Ratios of luciferase activities calculated from 
reactions programmed with can1-100 and CAN1 mRNAs are shown for WT (black 
boxes) and upf1∆ (white boxes) extracts. (c) CAN1 or can1-100 mRNA (500ng of 
either), or 50ng of miniUAA mRNA, was incubated with WT extracts for 7 min, followed 
by addition of 300ng CAN1/LUC mRNA and further incubation for 25 min at 18oC. 
Ratios of luciferase activity were calculated as designated on the X-axis. Vertical bars 
all panels depict standard deviation.
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Fig. 3.8 : Purified FLAG-Upf1 restores efficient translational activity to upf1∆ 
extracts. Cell-free translation extracts were prepared from WT or upf1∆ cells and 
treated with MN for 5 min at 25oC. Extracts were incubated with 270ng of BSA or 
FLAG-Upf1p on ice for 10 min and added to translation mixes containing 500ng of 
CAN1 (a) or can1-100 (a and b) mRNA and incubated for 7 min at 18oC. CAN1/LUC 
mRNA (300ng) was then added and reactions were further incubated for 25 min at 
18oC. (a) Relative luciferase activities in the respective reactions as detailed on the 
X-axis. Black and gray boxes indicate reactions primed with the CAN1 or can1-100 
mRNAs, respectively. (b) can1-100-primed translation reactions were set up as in (a), 
terminated by the addition of CHX (2 mM), and subsequently fractionated on sucrose 
gradients. The fractions were then analyzed by northern blotting using a DNA probe 
specific for the CAN1/LUC (left panel) or the can1-100 (right panel) mRNA.
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Fig. 3.9 : 40S and 60S ribosomal subunits enhance translation in upf1∆ extracts. 
Cell-free translation extracts were prepared from WT or upf1∆ cells. In (a) extracts 
were supplemented with 100ng CAN1/LUC mRNA and then incubated with BSA 
(white boxes), purified 40S subunits (black boxes), or purified 60S subunits (gray 
boxes) at 18oC for 60 min. Luciferase activity is depicted relative to the value obtained 
with the BSA control for each extract. The graph depicts the average of two 
experiments. (b) Western blot of increasing amounts of purified 40S subunits (5 and 
10 µg), 60S subunits (10 and 20 µg), and FLAG-Upf1p (11, 22, 45 and 90 ng) probed 
with polyclonal anti-Upf1p antibody. WT and upf1∆ extracts (5 µg each) were run as 
controls. The bottom panel is a lighter exposure of the top panel to allow visualization 
of the Upf1p band in the WT extract lane.  
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Chapter IV 
 
Translation factors promote formation of two states of 
the closed loop mRNP 
 
 
 
 
 
 
The work presented in this chapter has been published as: 
 
Amrani N., Ghosh S., Mangus D.A., Jacobson A. (2008). Translation factors promote 
formation of two states of the closed loop mRNP. Nature 453(7199):1276-80. 
 
SG’s contributions to this work include extract preparation, handling and processing of 
toeprint gels, all sucrose density gradient experiments, and northern blotting.  
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Chapter IV - Translation factors promote formation of two states of 
the closed loop mRNP 
 
Summary 
Efficient translation initiation and optimal stability of most eukaryotic mRNAs depends 
on the formation of a closed loop structure and the resulting synergistic interplay 
between the 5’ m7G cap and the 3’ poly(A) tail (Gallie 1991; Jacobson 1996). Evidence 
of eIF4G and Pab1p interaction supports the notion of a closed loop mRNP (Wells et al. 
1998), but the mechanistic events that lead to its formation and maintenance are still 
unknown. Here we have used toeprinting and polysome profiling assays to delineate 
ribosome positioning at initiator AUG codons and ribosome:mRNA association, 
respectively, and find that two distinct stable (cap analog resistant) closed loop 
structures are formed during initiation in yeast cell-free extracts. The integrity of both 
forms requires the mRNA cap and poly(A) tail, as well as eIF4E, eIF4G, Pab1p, and 
eIF3, and is dependent on the length of both the mRNA and the poly(A) tail. Formation 
of the first structure requires the 48S ribosomal complex whereas the second requires 
an 80S ribosome and the termination factors eRF3/Sup35p and eRF1/Sup45p. 
Surprisingly, the involvement of the termination factors is independent of a termination 
event.  
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Results 
 
Responsiveness of the yeast cell-free translation system to the presence or 
absence of a 5’ cap and/or a 3’ poly(A) tail on LUC mRNA  
The mRNA 5’ cap and 3’ poly(A) tail have previously been shown to enhance 
mRNA translational efficiency synergistically (Gallie 1991). Fig. 4.1 shows that the yeast 
cell-free translation system utilized for this study recapitulates this phenomenon. In the 
absence of both the 5’ cap and the 3’ poly(A) tail, the LUC mRNA is barely translated, 
but the addition of either a cap or a poly(A) tail enhances its translation several fold. The 
simultaneous presence of both a cap and a poly(A) tail stimulate luciferase production 
to a much larger extent than the sum of the two effects, i.e., the two mRNA appendages 
provide a synergisitic effect.  
 
AUG toeprints and cap analog resistance are specific and independent of the 
polynucleotide concentration  
Our in vitro translation reactions utilizing synthetic mRNAs derived from yeast 
transcripts were also able to recapitulate competitive inhibition of translation initiation by 
m7GpppG (cap analog), and analyses of ribosome positioning or mRNA association by 
toeprinting and sucrose gradient sedimentation. Addition of the elongation inhibitor, 
cycloheximide (CHX), to translation reactions programmed by the 2135nt AAA and UAA 
mRNAs containing long or short ORFs, respectively, (Fig. 4.2) allowed detection of 
CHX-dependent initiator AUG toeprints that reflect 80S ribosomes protecting 16-18 nt 3’ 
of the AUG (Dmitriev et al. 2003; Amrani et al. 2004; Wu et al. 2007) (Fig. 4.3(a), left 
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and right panels, lanes 1 and 3). A shorter mRNA (miniUAA1, 488nt, Fig. 4.2) also 
yielded the AUG toeprint (Fig. 4.3(b) upper panel, lane 1), but this band was resistant to 
2.7mM cap analog (lane 2) and only manifested sensitivity at higher concentrations (Fig. 
4.3(c) lower panel). These toeprints were dependent on initiation codon recognition, the 
presence of yeast extract, and concurrent mRNA translation (Fig.4.4). Translation 
reactions in wild-type extracts were incubated with either capped and polyadenylated 
miniUAA1 or AAA mRNAs, or with both the capped and polyadenylated miniUAA1 
mixed with the non-capped, non-polyadenylated AAA mRNA for 4 min, followed 
incubation with CHX for 3 min. Toeprints corresponding to ribosomes stalled with the 
AUG codon in their P sites were obtained with the miniUAA1 and AAA RNAs at the 
expected position, 16-18 nt downstream of the start codons (Fig. 4.4(a), lanes 1-4). The 
toeprint bands were dependent on the presence of the start codon, because they were 
absent in the No-iATG mRNA [a derivative of miniUAA1 mRNA with a deletion of the 
initiator AUG codon; Fig. 4.4(c)], and dependent on mRNA translation, because they 
were not detected in the absence of the mRNAs (Fig. 4.4(a), lane 5) or in the absence 
of the extract (Fig.4.4(a), lanes 6 [contains miniUAA1 mRNA] and 7 [contains AAA 
mRNA]). Supporting the latter conclusion, toeprints were almost completely eliminated 
by 2.7mM cap analog, a concentration that distinguished bona fide toeprints from 
background bands (Fig. 4.3(a), lanes 2 and 4). Lower cap analog concentrations also 
inhibited AUG toeprint accumulation, with 70% and 96% sensitivity obtained at 0.05mM 
and 0.5mM, respectively (Fig. 4.3(c), left panel).  
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Resistance to cap analog is mRNA size dependent but is not mRNA sequence 
dependent   
In wild-type extracts, the short capped and polyadenylated miniUAA1 mRNA is 
~160-fold more resistant to cap analog than the longer AAA mRNA [Fig.4.3(c)]. 
Translation and toeprinting analyses of miniADE2 mRNA (485nt) and full-length ADE2 
mRNA (2070nt), which have the same 5’-UTR and 3’-UTR, show the expected AUG 
toeprint bands (Fig. 4.5(a), lanes 1 and 3). However, addition of 2.7mM of cap analog 
had no effect on the miniADE2 AUG toeprints (lane 2) whereas the ADE2 AUG toeprints 
were eliminated in the presence of the same concentration of the drug (lane 4). These 
data are consistent with the results obtained with the miniUAA1 and AAA mRNAs (Fig. 
4.3), which are, respectively, similar in size to the miniADE2 and ADE2 mRNAs, and 
demonstrate that resistance to cap analog is mRNA size dependent in vitro, not mRNA 
sequence dependent. Consistent with the apparent mRNA size dependence of cap 
analog resistance in vitro, mRNAs with intermediate sizes (from 488nt to 2135nt), but 
with the same stability [Fig. 4.5(c)], showed intermediate phenotypes, with 
approximately 40% sensitivity to 2.7mM cap analog obtained with an 882nt mRNA, 60% 
sensitivity with an 1105nt mRNA, and near maximal sensitivity reached with a 1336nt 
mRNA [Fig. 4.5(b)].  
 
Cap analog resistance is not due to cap-independent translation  
To rule out cap-independent translation as the basis for cap analog resistance, 
we translated and toeprinted a polyadenylated miniUAA1 mRNA with no 5’ cap. This 
mRNA, which is stable during translation [Fig 4.6(c)], initiates inefficiently in wild-type 
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extracts (Fig. 4.6(a), lane 1), strongly suggesting that translation of our reporter mRNAs 
is cap-dependent. As reported previously (Tarun and Sachs 1995; De Gregorio et al. 
1998) the addition of cap analog stimulates translation of uncapped mRNA (Fig. 4.6(a), 
lane 2), possibly because it titrates other inhibitors. Collectively, these data suggest that 
interactions between the eIF4F cap-binding complex and the 5’ m7G cap of the mini 
mRNAs are much stronger than those occurring with the long mRNAs.  
 
Translation of poly(A)-deficient mRNA is sensitive to cap analog  
Short mRNAs may be preferentially resistant to cap analog because they form a 
more stable closed loop mRNP than long mRNAs, possibly by promoting increased 
affinity of mRNP factors for each other or for mRNA structures such as the 5’ cap 
(Christensen et al. 1987; Wells et al. 1998; Sachs 2000; Karim et al. 2006). To test the 
relationship of the closed loop state to m7GpppG resistance, we analyzed the 
toeprinting of capped, poly(A)- miniUAA1 mRNA. This transcript showed strong 
sensitivity to cap analog (Fig. 4.6(b), lane 2). Further analyses of miniUAA1 mRNAs 
having different poly(A) tail lengths [but identical stabilities; Fig 4.6(e)] showed that 
miniUAA1 mRNA with a poly(A) tail of 14 or 18As (Fig. 4.6(d), lanes 1-4) displayed a 
phenotype similar to poly(A)-deficient mRNA (>95% sensitivity to 2.7mM cap analog). 
Increasing the poly(A) tail length to 22, 25, or 33 residues yielded an intermediate 
phenotype (~80% sensitivity to cap analog; lanes 5-10), whereas a miniUAA1 mRNA 
with 57 As showed no sensitivity to 2.7mM cap analog (lanes 11 and 12). These results 
correlate cap analog resistance with poly(A) length, a result consistent with closed loop 
formation. Since Pab1p:poly(A) association requires a minimum of 12 adenosines, and 
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multiple Pab1p molecules can bind the same poly(A) tract in a 27nt repeating unit (Baer 
and Kornberg 1983; Sachs et al. 1986; Sachs et al. 1987), it appears that at least two 
Pab1p molecules are required for a stable closed loop structure. Consistent with this 
conclusion, previous studies showed that an A15 tail did not suffice to stimulate 
translation in Drosophila (Gebauer et al. 1999) and mammalian (Munroe and Jacobson 
1990) extracts, but that longer poly(A) tails promoted strong translational enhancement.  
 
Pab1p is required for cap analog resistance of the miniUAA1 mRNA  
Toeprinting of the miniUAA1 mRNA after translation in Pab1p-deficient 
(pab1∆/pbp1∆) extracts reinforced the notion of a critical role for Pab1p in cap analog 
resistance. Translation initiation in these extracts was highly sensitive to cap analog 
(Fig. 4.7(a), lanes 3 and 4; compare to extracts from wild-type [lanes 1 and 2] or pbp1Δ 
[a pab1∆ suppressor] cells [lanes 5 and 6]). Toeprinting of miniUAA1 mRNA after 
translation in Pab1p-deficient (pab1∆/pbp1∆) extracts indicated an 80-fold increase in 
cap analog sensitivity [Fig. 4.3(c) and Fig.4.7(c)] that was directly attributable to the 
absence of Pab1p because supplementation with 15pmole of recombinant Pab1p, but 
not the same amount of BSA, restored cap analog resistance to wild-type levels [Fig. 
4.7(b)]. While Pab1p is essential for cap analog resistance, its level must be well 
balanced since excess Pab1p, i.e., the addition of 15pmole Pab1p to wild-type extracts 
(lanes 3 and 4) or 38pmole Pab1p to pab1∆/pbp1∆ extracts (data not shown), reduces 
the extent of cap analog resistance.  
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Cell-free extracts derived from mutants defective in Pab1p activity, or the activity 
of Pab1p-interacting proteins, are markedly sensitive to cap analog  
To further evaluate the relationship between cap analog resistance and closed 
loop formation, we determined whether the same regions of Pab1p were required for 
both phenomena. Extracts derived from pab1-134 cells, where Pab1p has wild-type 
affinity for eIF4G1 but reduced affinity for eIF4G2 [yeast has two eIF4G isoforms 
encoded by the functionally redundant TIF4631 and TIF4632 genes, respectively 
(Goyer et al. 1993; Otero et al. 1999)], showed a wild-type phenotype (Fig. 4.7(a), lanes 
7 and 8). However, toeprinting analyses in pab1-184 extracts, in which Pab1p does not 
bind to eIF4G1 or eIF4G2 (Otero et al. 1999), revealed a strong sensitivity to cap analog 
(Fig. 4.7(a), lanes 9 and 10). Similarly, extracts of pab1-ΔRRM1 cells, in which Pab1p 
has lost the ability to interact with the poly(A) tail, and probably with either isoform of 
eIF4G as well (Kessler and Sachs 1998), also exhibit strong sensitivity to cap analog 
(Fig. 4.7(a), lanes 11 and 12), but not to the same concentration of GTP [Fig. 4.7(d)]. 
Both pab1-184 and pab1-ΔRRM1 extracts show about 10-fold more sensitivity to cap 
analog than those obtained from cells lacking the PAB1 gene [Fig. 4.7(c)]), possibly 
indicating dominant-negative effects of the mutant proteins. To determine whether 
Pab1p interaction with the termination factor eRF3/Sup35p (Cosson et al. 2002) is also 
required for cap analog resistance, we analyzed extracts of pab1-ΔC-term cells. Fig. 
4.7(a) [lanes 13 and 14] shows that this mutation also confers cap analog sensitivity, 
albeit 2.5-fold less sensitivity than that observed in pab1Δpbp1Δ extracts [Figs. 4.7(c) 
and 4.9(b)]. In addition, the pattern of toeprint inhibition with the pab1-ΔC-term extract 
appears different from that seen with other pab1 mutants [Figs. 4.7(c) and 4.9(b)], 
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suggesting that the Pab1p C-terminal domain may be involved in a step distinct from 
that involving the other domains. All of the pab1 mutant extracts show full sensitivity to 
cap analog when programmed with poly(A)- miniUAA1 mRNA [Fig. 4.7(e)], but 
recombinant Pab1p could not complement the phenotypes of these extracts, further 
suggesting dominant-negative effects of the mutated proteins (data not shown). 
The differences in cap analog sensitivity of the different pab1 extracts are 
consistent with the loss of interactions characteristic of specific Pab1p domains 
(Mangus et al. 2003) being involved in closed loop mRNP formation and stabilization. 
Accordingly, we analyzed miniUAA1 mRNA toeprints in extracts from strains harboring 
mutations in genes encoding different Pab1p-interacting proteins. Extracts of eIF4G1-
ΔN300 cells (Otero et al. 1999), in which there is no eIF4G2 and Pab1p:eIF4G1 
interaction is disrupted, show strong sensitivity to cap analog and correlate well with the 
cap analog sensitivity phenotype of pab1-184 extracts (Figs. 4.7(c) and 4.8). Likewise, 
extracts harboring mutated eRF3 (sup35-R419G) (Salas-Marco and Bedwell 2004) or 
eRF1 (sup45-2) (Stansfield et al. 1997) termination factors show both sensitivity to cap 
analog (but not to GTP [Fig. 4.7(d)]) and toeprint patterns that are strikingly similar to 
those obtained with the pab1-ΔC-term extract (Fig. 4.9), with the exception that they 
also yield two extra bands 5’ of the AUG toeprint (asterisks) that are suggestive of 
initiation anomalies. Control reactions demonstrated that the termination mutant extracts 
were fully sensitive to cap analog when programmed with poly(A)- miniUAA1 mRNA 
(Fig. 4.10) and that the addition of extra Mg2+ to the different translation reactions (to 
compensate for a possible titration by cap analog) had no affect on their toeprint 
phenotypes (Fig. 4.11). These results, and the observation that toeprinting of miniUAA1 
93
mRNA after translation in extracts defective in eIF3 and eIF4E also exhibited more 
sensitivity to cap analog than did wild-type extracts (Fig. 4.12), imply that cap analog 
resistance results from formation of a stable closed loop structure. 
 
Cap analog resistance is independent of translation termination  
Further insights into closed loop formation followed from experiments using 
extracts supplemented with mutant transcripts or different competitive inhibitors, or 
independent analytical methods. First, we evaluated whether the role of 
eIF4G:PABP:eRF3 interactions in closed loop formation, and possibly ribosome 
recycling (Uchida et al. 2002), was also dependent on translation termination (Uchida et 
al. 2002). We prepared a mini mRNA with no stop codon and analyzed its response to 
cap analog in extracts derived from wild-type or termination-defective cells. Translation 
of nonstopminiUAA1 in wild-type extracts showed strong cap analog resistance (Fig. 
4.13, lanes 1 and 2), suggesting that conventional termination steps are not required for 
a stable closed loop mRNP. In contrast, sup35-R419G and sup45-2 extracts 
programmed with nonstopminiUAA1 RNA exhibit strong sensitivity to cap analog (Fig. 
4.13, lanes 3-6), indicating that, while termination per se is not required, de novo 
formation of a stable closed loop structure in yeast is dependent on the principal 
termination factors.  
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Cap analog resistance or sensitivity of miniUAA1 mRNA appears at the onset of 
translation  
Second, since there was no requirement for termination, we considered the 
possibility that closed loop formation precedes the first round of mRNA translation and 
thus analyzed the toeprinting of miniUAA1 mRNA after two-minute time courses of 
translation in wild-type or Pab1p-mutant extracts. In wild-type extracts, cap analog-
resistant AUG toeprints were obtained within 30 sec of incubation with miniUAA1 
mRNA. Similarly, in pab1-184 and pab1-∆RRM1 extracts, sensitivity to cap analog was 
observed at the same time point (Fig. 4.14).  
 
Polysome profiling of ribosome:mRNA association in wild-type and mutant 
extracts  
Third, to monitor mRNA:ribosome association by an independent method, we 
fractionated translation reactions by velocity sedimentation in sucrose gradients and 
utilized northern blotting to analyze the gradient fractions for their respective content of 
different mRNAs. Fig. 4.15 shows the A254 profile of a representative gradient. For 
simplicity, all fractions from the top of the gradient up to the size of 80S ribosomes were 
designed “non-polysomal” and the remaining part of the gradient, including mRNAs 
associated with one or more ribosomes, was designated “polysomal”. Application of this 
methodology to translation reactions incubated for 4 min in the absence of cap analog, 
followed by 3 min of incubation with CHX, demonstrated that 60-70% of the miniUAA1 
mRNA was distributed across the polysomal fractions in all extracts tested (Fig. 4.16(a), 
left panel). However, when the same reactions were supplemented with cap analog, the 
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mutant extracts (pab1-ΔRRM1, sup35-R419G, and sup45-2) displayed 2- to 4-fold less 
mRNA in the polysomal fractions while the distribution of mRNA in the wild-type extract 
showed essentially the same distribution as in the absence of the drug (Fig. 4.16(a), 
right panel). These data provide important additional evidence that the translation of 
capped and polyadenylated miniUAA1 mRNA is resistant to cap analog in wild-type 
extracts, but sensitive to the drug in extracts derived from pab1 cells or those of 
termination mutants. Additional experiments, in which GMP-PNP, the non-hydrolyzable 
GTP analog that blocks 48S to 80S conversion in vitro,  was added at the beginning of a 
5 min translation reaction showed that all extracts tested had similar distributions of the 
miniUAA1 mRNA in the absence of cap analog (Fig. 4.16(b), left panel). The 
distributions differed from those observed in CHX-treated extracts (i.e., the relative 
percentage of non-polysomal mRNA was considerably higher; compare Fig. 4.16(a) and 
Fig. 4.16(b), left panels), but this result was expected since GMP-PNP blocks the joining 
of the 60S subunit to form an 80S complex (Dmitriev et al. 2003). Further, the addition 
of cap analog to the GMP-PNP-treated extracts had no significant effects on the mRNA 
distributions in wild-type and termination mutant extracts whereas the pab1-ΔRRM1 
mutant extract manifested a substantial shift of the miniUAA1 mRNA to the free 
fractions (Fig. 4.16(b), right panel). These data suggest that, in the presence of cap 
analog, 48S complex formation proceeds in both the wild-type and termination mutant 
extracts, but not in the pab1-ΔRRM1 extract.  
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Two states of the closed loop structure of mRNA can be distinguished  
The previous observations are consistent with the notion that interactions 
between the mRNP 5’ and 3’ ends are established early in the translation process (Figs. 
4.13 and 4.14). Hence, we sought to identify the step of translation initiation associated 
with closed loop formation. The toeprinting assays described above utilized CHX to 
stabilize the 80S ribosome on the initiator AUG (Dmitriev et al. 2003) and thus 
monitored a late step in initiation. To determine whether closed loop mRNP formation 
occurred earlier, we analyzed mRNA toeprints in extracts supplemented with GMP-PNP 
(Dmitriev et al. 2003). In both wild-type and pbp1Δ extracts, translation of miniUAA1 
mRNA in the presence of GMP-PNP gave the same results observed with CHX, 
namely, full resistance to 2.7mM cap analog (Fig. 4.17(a), lanes 1, 2 and 5, 6). This 
result implies that steps essential to establishing the closed loop phenotype occur prior 
to or during formation of the 48S complex.  
 As observed with CHX toeprinting, cap analog sensitivity of miniUAA1 mRNA in 
the presence of GMP-PNP was dependent on a poly(A) tail (data not shown) and the 
availability of functional Pab1p and eIF4G (Figs. 4.17(a), lanes 3, 4, 7-16; and 4.17(b), 
lanes 5-8). However, alterations in termination factor activity yielded different toeprint 
phenotypes. Extracts of termination factor mutants supplemented with GMP-PNP either 
at the beginning of the reaction (data not shown), or after 4 min of translation, were fully 
resistant to cap analog and lacked the upstream toeprints detected with CHX [Fig. 
4.17(c)]. Consistent with these results, sucrose gradient analyses of mRNA:ribosome 
association in extracts supplemented with GMP-PNP at the onset of the reaction 
showed no differences between the wild-type and the termination mutant extracts in the 
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presence or absence of cap analog while the pab1-ΔRRM1 extract manifested a 
phenotype characteristic of cap analog inhibition of translation initiation [Fig. 4.16(b)]. 
Thus, while eRF1 and eRF3 do not appear to affect the rate of translation initiation as 
assayed by one-minute time courses of AUG toeprinting (in the presence of CHX) with 
the miniUAA1 mRNA. (Fig. 4.18) or the formation of the closed loop mRNP that includes 
only the 48S complex, they are required upon 80S formation to generate a second state 
of the closed loop structure.  
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Fig. 4.1 : Yeast cell extracts recapitulate the synergy between the cap structure and 
the poly(A) tail in vitro. The presence of both the cap structure and the poly(A) tail 
stimulate translation of LUC mRNA in wild-type extracts.
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Fig. 4.2 : General schematic of the miniUAA1, UAA, and AAA mRNAs. Sizes (in nt) 
listed under each construct respectively refer to the length of the 5’ UTR, the coding 
region, the 3’ UTR, and the poly(A) tail.
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(10 ng) and non-capped non-polyadenylated AAA mRNA [-AAA-] (40 ng) with primer 
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Fig. 4.5 : Cap analog sensitivity in the presence of CHX in wild-type extracts is 
mRNA size dependent. (a) Toeprinting analyses of miniADE2 mRNA (485nt) and 
full-length ADE2 mRNA (2070nt) in the presence or absence of cap analog. (b) Sensitivity 
to 2.7 mM cap analog for mRNAs of  increasing length. The values on the graph are the 
average of two independent experiments. (c) Cap analog resistance depends on the size 
of the mRNA and the presence of a poly(A) tail. mRNAs of different sizes, monitored by 
northern blotting, are equally stable during translation in vitro.
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Fig. 4.6 : Cap analog resistance of the miniUAA1 mRNA is cap and poly(A) 
dependent in wild-type extracts and suggests formation of a stable closed loop 
structure. (a) AUG toeprint analyses of uncapped mRNA. (b)  AUG toeprint analyses of 
poly(A)-deficient mRNAs. (c) Northern blot of miniUAA1 mRNAs containing either a cap 
structure or poly(A) tail, or both, after translation in vitro. (d) AUG toeprint analyses of 
miniUAA1 mRNAs with poly(A) tails of differing sizes. (e) Northern blot of miniUAA1 
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Fig. 4.7 : Formation of a stable closed-loop structure on a capped and 
polyadenylated mRNA in the presence of an 80S complex requires Pab1p 
interactions with eIF4G, mRNA, and Sup35p. (a) Toeprinting analyses of miniUAA1 
mRNA in Pab1p-defective, wild–type, or pbp1Δ extracts. (b) Toeprinting analyses of 
miniUAA1 mRNA after the addition of recombinant Pab1p to pab1Δpbp1Δ extracts. (c) 
Toeprinting analyses of cap analog sensitivities of miniUAA1 mRNA in Pab1p-defective 
extracts. (d) Toeprinting analyses of miniUAA1 mRNA in the presence of excess GTP.  
(e) Toeprinting analyses of poly(A)- miniUAA1 mRNA translated in wild-type or pab1 
extracts.
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Fig. 4.8 : Formation of a stable closed-loop structure on a capped and polyadenylated 
mRNA in the presence of an 80S complex requires Pab1p interactions with eIF4G. (a) 
Toeprinting analyes of miniUAA1 mRNA in the eIF4G1∆-300 mutant incapable of Pab1p 
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incapable of Pab1p interaction. 
106
bA U G
0 .5 1 2 3 5
sup35 -R419G
0 0 .5 1 2 3 5
sup45 -2
0
%  se n s itiv ity : 0 9 20 8 5
*
*
ca p  a n a lo g : 
(m M ) 
pab1 -∆C -te rm
0 .5 1 2 3 50
0 8 6
- + - +
W
ild
-ty
pe
su
p4
5-
2
AU G *
*
2 .7m M  cap  an a lo g : - +
W
ild
-t
yp
e
- +
su
p3
5-
R
41
9G
1 2 3 4 5 6 7 8
Fig. 4.9 : Formation of a stable closed-loop structure on a capped and 
polyadenylated mRNA in the presence of an 80S complex requires Sup35p. (a) 
Toeprinting analyses of sup35-R419G and sup45-2 mutants show sensitivity to cap 
analog and additional toeprint bands upstream of the initiator AUG. (b)Toeprinting 
analyses of with differening concentrations of cap analog in sup35-R419G and sup45-2 
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initiator AUG.
a
107
- + - - ++2 .7 m M  c a p  a n a lo g :
W
ild
-ty
pe
su
p3
5-
R
41
9G
su
p4
5-
2
AU G
Fig. 4.10 : Cap analog resistance depends on the presence of a poly(A) tail. 
Toeprinting analyses of poly(A)- miniUAA1 mRNA translated in termination-defective 
extracts.
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Fig. 4.15 : Typical polysome profile of an extract after micrococcal nuclease 
treatment and translation of the miniUAA1 mRNA. Numbers on the X-axis represent 
fractions collected in decreasing order of density, such that “bottom” corresponds to the 
heaviest and “top” to the lightest fractions.
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Fig. 4.16 : Translation of the miniUAA1 mRNA as assayed by sucrose density 
centrifugation and northern blot analysis. Sucrose gradient fractionation of miniUAA1 
mRNA translated in wild-type and mutant extracts in the absence and presence of cap 
analog, and in the presence of CHX (a) or GMP-PNP (b). The values above the horizontal 
line depict fraction numbers and those below the line denote the respective percentages 
of mRNA associated with polysomal or non-polysomal fractions.
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Fig. 4.17 : Stabilization of the closed-loop structure on a capped and 
polyadenylated mRNA in the presence of a 48S complex requires Pab1p 
interactions with eIF4G and miniUAA1 mRNA. (a) Toeprinting analyses of extracts 
from Pab1p- and eIF4G1-deficient strains in the presence of GMP-PNP. (b) Toeprinting 
analyses of resistance to cap analog in pab1Δpbp1Δ extracts in the presence of 
GMP-PNP after addition of recombinant Pab1p. (c) Toeprinting analyses of 
sup35-R419G and sup45-2 termination mutant extracts in the presence of GMP-PNP. 
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 Chapter V - Discussion 
 
Elaborating the “closed loop” model 
The 5' cap and 3’ poly(A) tail act synergistically to promote the stability and 
translatability of an mRNP (Mangus et al. 2003). Here we show that both elements are 
required for optimum translation of a synthetic mRNA in our cell-free translation system 
(Fig. 4.1), supporting the idea that the 5' cap and 3’ poly(A) tail of an mRNA may exert 
this effect by forming a closed loop structure (Jacobson 1996), evidence for which has 
also been provided by electron microscopy (Wells et al. 1998; Kopeina et al. 2008). 
Most evidence for the presence of a circularized mRNP structure comes from 
evaluations of reporter RNAs lacking certain cis elements to be expressed in translation 
systems under different conditions (Munroe and Jacobson 1990; Gallie 1991). These 
data, although informative, are the end result of polypeptide synthesis and release and 
are indirect measures of structural aspects of events leading up to the expression of the 
reporter RNAs. In order to more easily monitor and characterize the formation of a 
circularized mRNA and early events in the translation cycle, we developed a toeprinting 
assay that allowed us to visualize 80S ribosomes that initiate translation on a synthetic 
reporter mRNA in vitro (Figs. 4.3-4.5). Translation of a long mRNA demonstrated 
sensitivity to cap analog as expected, suggesting that the drug is able to effectively 
compete for binding of the eIF4E cap-binding protein to the 5’ cap of the mRNA, 
resulting in disruption of the closed loop, and reduced translation initiation (leading to 
the loss of the AUG toeprint). On the other hand, a short mRNA was resistant to the 
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loss of the AUG toeprint at a similar cap analog concentration (Fig. 4.3-4.5), suggesting 
that decreasing the length of an mRNA may allow a tighter interaction of eIF4E to the 
capped mRNA and possibly the formation of a stronger closed loop, an idea supported 
by testing mRNAs of varying lengths for cap analog sensitivity (Fig. 4.5). Polysome 
profiling experiments showed that this cap analog resistance correlated well with the 
ability of the mRNA to be translated (Fig. 4.16). The idea of a closed loop being formed 
was supported by the observations that cap analog resistance was dependent on the 
mRNA containing a poly(A) tail (Fig. 4.6 and 4.10), the presence of Pab1p capable of 
interacting with eIF4G (Fig. 4.7), eIF4G capable of interacting with Pab1p (Fig. 4.8), 
eIF3 (Fig. 4.12), and eIF4E (Fig.4.12), all of which support earlier observations (Munroe 
and Jacobson 1990; Jacobson 1996; Tarun and Sachs 1996; Wells et al. 1998; Sachs 
2000), except that we were able to more clearly define the requirement for at least two 
molecules of Pab1p to be associated with the mRNA [Fig. 4.6(d)]. Surprisingly, we 
observed a requirement for the eRF1 and eRF3 translation termination factors in 
maintaining this 80S-dependent cap analog-resistance phenotype even though a 
termination event per se did not appear to be required (Fig. 4.13). Accordingly, a pab1 
mutant deleted for its eRF3 binding domain was also susceptible to the effects of cap 
analog (Fig. 4.7) suggesting that eRF association with the “closed loop complex” may 
be mediated through Pab1p interaction. Further inquiry into what stages of translation 
initiation were dependent on the presence of the eRFs demonstrated that two forms of 
the stable closed loop structure can be distinguished during initiation on short mRNAs in 
vitro. The integrity of both forms requires the mRNA cap and poly(A) tail, as well as 
eIF4E, eIF4G, Pab1p, and eIF3, and is dependent on the length of both the mRNA and 
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the poly(A) tail. The first requires the preinitiation 48S complex but not eRF1 and eRF3 
(Figs. 4.16 and 4.17), whereas the second is formed after 60S joining and requires the 
two eRFs as well as all the other components of the first structure. An intriguing 
possibility is whether the Pab1p-eRF1-eRF3 complex present as part of the closed loop 
structure maintains a local pool of termination factors in the vicinity of the normal 
termination codon thus enabling the rapid and highly efficient termination events thought 
to occur at normal terminators. The requirement for at least two molecules of Pab1p for 
cap analog resistance of the small mRNAs suggests that Pab1p interaction with both 
eIF4G and eRF3 simultaneously contributes to maintaining the strength of the closed 
loop. This hypothesis predicts that Pab1p-eRF3 interaction may confer protection of the 
poly(A) tail from deadenylation and disruption of the loop. Indeed, overexpression of a 
Pab1p-interacting N-terminal fragment of eRF3 decreases the rates of deadenylation of 
a reporter mRNA in yeast and mammalian cells (Hosoda et al. 2003; Funakoshi et al. 
2007). Further analyses demonstrated that eRF3 mediated deadenylation through the 
Pan2p-Pan3p and Caf1p-Ccr4p deadenylases in yeast and human cells and that eRF3 
binding to PABPC1 was in competition with hPan2-hPan3 in a manner that was 
translation-dependent (Funakoshi et al. 2007). These findings are consistent with a 
model wherein eRF1 and eRF3 are present as part of a stable closed loop complex and 
also act to antagonize deadenylase activity through their interaction with Pab1p. 
Moreover, the efficiency with which ribosomes at the normal termination codon undergo 
termination events, including subunit dissociation and possibly subunit recycling to the 
5’ end, may be enhanced by the proximity and ready availability of the closed loop-
associated eRFs (Fig. 5.1). 
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 One can also imagine that usage of such localized eRFs in translation 
termination may allow their dissociation from Pab1p (and the closed loop complex), 
leading to a change in mRNP structure that would allow deadenylases to access the 
poly(A) tail through an interaction with Pab1p. This event may be further regulated by 
other 3’-UTR-associated factors or recruitment of additional molecules of eRF1 and 
eRF3 to maintain closed loop stability and continued translation termination efficiency. 
Thus, deadenylation mediated by eRF cycling would require active translation and 
termination to allow dissociation of the eRFs, and the ability of the cytoplasmic 
deadenylases to interact with Pab1p would be in direct competition with factors (such as 
eRF3) that prevent that association. 
 
Normal and premature termination are biochemically distinct events 
In light of the closed loop model, it is not inconceivable that distal sequences and 
factors bound to them can influence events occurring at more upstream locations on an 
mRNA. As suggested by the faux 3’-UTR model (Jacobson and Peltz 2000; Maderazo 
et al. 2003), proper termination of translation and normal rates of mRNA decay are likely 
to require interactions between a terminating ribosome and a specific RNP structure or 
set of factors (including Pab1p and Sup35p) localized 3’ to the stop codon. Some of the 
evidence for this model is based on studies examining the effects of PTC positioning 
with respect to the normal terminator, and by observing decay phenotypes of mRNAs 
that eliminate sequences between a PTC and the 3’-UTR (Losson and Lacroute 1979; 
Peltz et al. 1993; Hagan et al. 1995; Yun and Sherman 1995; Zhang et al. 1995). In our 
studies, we utilized a tethering approach to show that localizing Pab1p in the vicinity of 
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an otherwise NMD-sensitive PTC stabilized the nonsense-containing mRNA (Fig. 2.11). 
Since the tethered Pab1p coimmunoprecipitated with eRF3 (Fig. 2.12), it was possible 
that part of Pab1p’s role might be to stabilize eRF3 on the terminating ribosome to effect 
efficient termination (Hoshino et al. 1999; Cosson et al. 2002). Indeed, tethering eRF3, 
but not eRF1, was able to stabilize the nonsense reporter mRNA, although not to the 
extent that tethering Pab1p did (Fig. 2.13). Thus, decreasing the physical distance 
between an NMD-sensitive stop codon and 3’-bound Pab1p leads to the nonsense 
codon being regarded as normal. It has now been demonstrated that this phenomenon 
is not limited to yeast and can occur in a wide variety of organisms (Behm-Ansmant et 
al. 2007; Eberle et al. 2008; Silva et al. 2008; Singh et al. 2008). 
Given that differential mRNA stability effects arise when a stop codon is located 
at a “normal” vs. “premature” position, we speculated that there might be differential 
effects on translation termination at each of those positions. Our results indicated that 
not all termination events are equivalent, a notion that is further strengthened by the 
recent discovery of a small molecule drug (ataluren) that is specifically able to elicit 
readthrough of premature, but not normal, nonsense codons both in vitro and in vivo 
(Welch et al. 2007). Utilizing our in vitro translation/toeprinting system, we found that 
termination at a PTC was aberrant, occurring more inefficiently, and could be toeprinted 
(Fig. 2.2), whereas no toeprints could be observed for termination codons located at 
their “normal” positions in an mRNA (Fig. 2.2). The latter could be toeprinted if eRF1 
(sup45p) was defective (Fig. 2.10), reflecting the ability of wild-type terminating 
ribosomes to dissociate rapidly at a normal stop codon. The addition of CHX to the 
translation reactions resulted in an interesting phenomenon – the repositioning of the 
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ribosome at nearby AUGs (Figs. 2.3 and 2.7). Since the newly positioned ribosomes 
appeared to arise from ribosomes that had previously been positioned at the PTC [Fig. 
2.3(c)] this phenomenon was indicative of post-termination reinitiation (Fig. 2.5). Based 
on reinitiation models for the GCN4 mRNA (Hinnebusch 2005), it is likely that upon 
termination at a PTC, dissociation of the 60S subunit takes place, leaving the 40S 
subunit to scan for a nearby start codon. The observed retro-reinitiation as well as 
normal reinitiation phenotypes suggest that the ribosomal subunit is able to oscillate 
back and forth for varying distances until it encounters an AUG codon from which to 
reinitiate (Figs. 2.5-2.7). This aberrant post-termination event is somehow related to 
NMD, since ribosomes could not reinitiate in the absence of Upf1p (Figs. 2.3 and 2.5). 
The latter event must only be a symptom of aberrant termination, not a cause of NMD, 
because elimination of reinitiation site AUGs does not alter the decay rate of nonsense-
containing mRNAs (data not shown). However, the failure to effectively release a 
terminating ribosome may be a stimulus for NMD, promoted, perhaps, by the ribosome's 
failure to recycle in cis (Uchida et al. 2002) and/or by the recruitment of Upf1p to the 
aberrant termination event or to a bound negative regulatory factor. At a minimum, the 
absence of aberrant termination toeprints in extracts prepared from upf1Δ cells links 
aberrant termination to NMD, and suggests that inactivation of this factor may preclude 
or perturb events that regulate ribosome stability and movement at a premature stop 
codon. The in vivo implications of the in vitro retro-reinitiation phenotype are still 
unclear. Whether or not such backward movements of ribosomes occur in a 
physiological context remains to be tested, but one can envision that retro-reinitiation 
coupled to subsequent in-frame premature termination could serve to amplify an NMD-
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triggering signal for a given mRNA. A caveat to this hypothesis is the presence of 80S 
ribosomes upstream of the post-termination scanning 40S subunit. However, evidence 
suggesting that nonsense substrates may be translationally repressed in vivo (Muhlrad 
and Parker 1999) may preclude this obstacle. 
In light of these observations, a slightly revised faux 3’-UTR model suggests that 
at a PTC, the absence of proximal Pab1p leads to inefficient termination and stable 
binding of the Upf proteins, which are prerequisites for decapping and subsequent 
Xrn1p-mediated degradation. In yeast, the mechanism of Upfp recruitment at PTC is still 
unclear. Of the several models that have been put forth, one posits that Upf2p/Nmd2p 
and Upf3p associate with nonsense substrates only after Upf1p-mediated localization to 
P bodies (Sheth and Parker 2006).  
Finally, it is unlikely that the mechanism of NMD is fundamentally different in 
yeast and metazoans. The demonstration of a role for PTC-proximal PABPC in 
antagonizing NMD suggests a common underlying mechanism for nonsense recognition 
in eukaryotes (Behm-Ansmant et al. 2007; Eberle et al. 2008; Silva et al. 2008; Singh et 
al. 2008). Metazoans have probably evolved a more extensive regulatory mechanism to 
take into account additional steps of gene expression, such as splicing, to ensure that 
only correctly processed transcripts get expressed (Kawashima et al. 2009).  If aberrant 
termination is also the trigger for NMD in higher organisms, Upf1p associated with the 
SURF complex may be stably associated with the termination complex in the absence 
of proximal PABPC (Kashima et al. 2006). The exon-junction complexes (EJC) 
deposited during splicing of mammalian pre-mRNAs may not reflect a specialized 
mRNA decay apparatus poised for activation in an early round of translation (Le Hir et 
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al. 2000; Kim et al. 2001; Gatfield et al. 2003; Gehring et al. 2003; LeBlanc and Beemon 
2004). Rather, the EJC factors may function like the proteins associated with a normal 
3’-UTR in yeast and render an mRNA competent for proper translation when present in 
an appropriate context and may serve to mediate NMD by enhancing translation of the 
substrate mRNAs (Nott et al. 2004). Alternatively, the EJC may act as a mark to 
enhance NMD (Stalder and Muhlemann 2008) through the associated Upf2p and Upf3p. 
In support of this model, it has been shown that that certain mRNAs undergo EJC-
independent NMD that is dependent on the distance between the termination codon and 
the poly(A) tail (Buhler et al. 2006). Additionally, even though Upf2p and Upf3p are 
associated with the EJC and are known to promote phosphorylation of Upf1p, a 
necessary step for Upf1p function in metazoans, there exist examples of NMD occurring 
in a Upf2p- or Upf3p-independent manner (Gehring et al. 2005; Chan et al. 2007). 
 
A role for Upf1p in translation 
Results from both yeast and mammalian cells have implicated possible roles for 
Upf1p, Upf2p/Nmd2p, and Upf3p in the regulation of translational termination, 
repression, and reinitiation (Czaplinski et al. 1998; Muhlrad and Parker 1999; Maderazo 
et al. 2000; Wang et al. 2001; Isken et al. 2008; Ivanov et al. 2008). To consider the 
possible general translational involvement of these factors in yeast, we sought to 
examine whether the in vitro results supporting a Upfp role in translational reinitiation in 
Chapter II could be recapitulated in vivo. Using a series of PGK1/LUC reporter 
constructs, we defined a cell-based assay in which approximately 2.5% of the 
ribosomes that prematurely terminate the PGK1 ORF subsequently reinitiate and 
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translate the LUC ORF. Relative to wild-type cells, strains that lacked the function of 
any one of the three UPF genes manifested markedly reduced reinitiation activity in this 
assay [Fig. 3.1(d)], but reinitiation per se played no role in activating NMD (Fig. 3.3). 
These observations not only served to confirm and elaborate the earlier results we had 
obtained in cell-free extracts (Chapter II), but led us to investigate in greater detail the 
mechanism by which the Upf proteins influence translational activity.  
Prior studies indicated that Upf1p regulation of translation might not be limited to 
nonsense-containing mRNAs. For example, yeast cells expressing WT-like (“normal”) 
CUP1 reporters showed reduced Cup1p levels when UPF1 was deleted (Muhlrad and 
Parker 1999). Further, in vitro translation of synthetic CAN1/LUC (WT) mRNA in yeast 
extracts was found to require Upf1p (Chapter II), and mammalian cell-free extracts 
containing hyperphosphorylated Upf1p showed reduced translation of synthetic Renilla 
LUC mRNA (Isken et al. 2008). Consistent with these observations, we not only 
confirmed that optimal translation of the CAN1/LUC mRNA is Upf1p-dependent, but that 
Upf2p/Nmd2p and Upf3p are also required (Fig. 3.4 and data not shown). Moreover, 
using a novel assay for ribosome reutilization, we found that elimination of any one of 
the Upf proteins led to reduced translation initiation on CAN1/LUC mRNA (Fig. 3.4(d) 
and data not shown). The significance of these results was underscored by the 
observation that the translational defect(s) of upf1Δ extracts could be overcome by the 
addition of purified recombinant Upf1p (Figs. 3.5 and 3.8). Collectively, these 
experiments suggested that Upf1p plays a direct role in regulating the initiation 
efficiency of ribosomes that enter a new cycle of translation. 
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A further understanding of the apparent initiation defect was obtained by 
attempting to identify the stage of initiation that was impaired. Toeprinting analyses of 
the CAN1/LUC initiator AUG codon indicated that although upf1Δ extracts had fewer 
80S ribosomes at the AUG than did WT extracts, the two extracts exhibited similar 40S 
recruitment, suggesting that a loss of Upf1p affects subunit joining (Fig. 3.6). Indeed, 
the addition of purified WT 40S or 60S ribosomal subunits to upf1Δ extracts stimulated 
translation in these extracts, but not in WT extracts [Fig. 3.9(a)]. Further analyses 
showed that Upf1p was preferentially associated with 40S subunits suggesting that 
enhanced translation observed upon 40S addition may in part be due to the bound 
Upf1p [Fig. 3.9(b)]. In combination with the toeprinting results, these data implied that: i) 
the increase in luciferase activity detected upon addition of 40S subunits to upf1Δ 
extracts was most likely Upf1p-mediated and ii) the stimulation of translation occurring 
in upf1Δ extracts upon addition of 60S subunits was probably attributable to the 
accumulation of inactive 60S subunits in those extracts.   
It is becoming increasingly apparent that factors involved in regulating translation 
may have multiple functions and that this multitasking may link the initiation pathway to 
those for termination and/or NMD (Amrani et al. 2008; Saini et al. 2009). Moreover, it 
has been shown that: i) eIF3, eIF1, and eIF1A, as well as the eIF3j subunit, not only 
play a role in initiation, but also stimulate the in vitro dissociation of post-termination 80S 
complexes (Pisarev et al. 2007); ii) at elevated temperatures, yeast strains harboring 
the temperature-sensitive prt1-1 mutation (in eIF3) lose their abilities to both initiate 
translation and promote NMD (Welch and Jacobson 1999); iii) yeast cells with mutations 
in both SUI1 (encoding eIF1) and UPF1 manifest synthetic lethality (Harger and Dinman 
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2004); and iv) phosphorylated mammalian Upf1p can interact with eIF3 and this 
interaction appears to inhibit cap-dependent in vitro translation (Isken et al. 2008). 
Consistent with these observations, we find that yeast upf1Δ extracts are unable to 
recycle ribosomes efficiently from a nonsense-containing mRNA (Figs. 3.7 and 3.8), a 
result suggesting that events at termination can influence the subsequent activity of 
ribosomal subunits. Since our in vitro translation system does not support NMD (e.g., 
see Fig. 3.8(b) and Chapter II), we hypothesize that Upf1p’s role in promoting ribosome 
dissociation and/or recycling from nonsense-containing mRNAs represents an 
independent function that occurs concurrently or prior to its role in promoting decapping 
(Fig. 5.2). How these events may be linked remains to be elucidated. Since premature 
termination in yeast is considerably less efficient than normal termination (Chapter II), 
one possibility is that the post-peptide hydrolysis recruitment of eIF3, and perhaps other 
initiation factors, to a prematurely terminating ribosome is Upf1p-dependent and that 
inclusion of Upf1p allows termination complex remodeling and efficient 80S dissociation, 
yielding a 40S subunit capable of reinitiating translation and a 60S subunit capable of 
being primed for subsequent translation cycles. It remains to be seen whether Upf1p 
that copurifies with 40S subunits reflects a cause or consequence of ribosome 
dissociation, whether other NMD factors show a similar association with ribosomal 
subunits, and what other factors may be present in a Upfp-dependent manner. Upf1p 
has intrinsic ATPase and helicase activities (Czaplinski et al. 1995) and it will be of 
interest to test whether these activities are required for ribosome remodeling at a 
premature termination codon or for the stimulation of decay. An additional question that 
has remained unanswered is the fate of the released polypeptide upon premature 
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termination. Recent work in yeast has revealed that Upf1p-dependent, proteasome-
mediated degradation of polypeptides arising from PTC-containing mRNAs takes place 
(Kuroha et al. 2009), and it has been suggested that Upf1p may serve as an E3 
ubiquitin ligase to couple peptides arising from the translation of PTC substrates to the 
proteasome-mediated peptide degradation machinery (Takahashi et al. 2008). Thus, 
Upf1p (and perhaps the other NMD factors) appears to play a multifaceted role in 
dealing with all aspects of premature termination and its consequences in yeast. 
 
 
Future directions 
Despite gaining some understanding of the interplay between translation and mRNA 
decay factors, a more mechanistic understanding of the events underlying the roles 
played by NMD factors at premature termination will involve: 
1.) characterizing the ribosome-binding domains of Upf1p, 
2.) characterizing the phenotypes in vitro of other NMD factors in termination events 
at a PTC and subsequent initiation events, 
3.) identifying what other factors are required to mediate premature termination 
events, 
4.) determining whether Upf1p is recruited to terminating ribosomes in an eRF-
dependent manner at a PTC,  
5.) identifying the domains of Upf1p required to observe the in vitro phenotypes 
associated with premature termination events, 
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6.) characterizing the order of assembly of factors required to mediate termination at 
a PTC, and 
7.) determining how events at a PTC trigger downstream decapping and decay of 
substrate mRNAs? 
 
Further insight into closed loop dynamics and function will require us to: 
1.) directly visualize interactions between the components of the Pab1p-eIF4G-
eIF4E complex, 
2.) identify which domains of eRFs 1 and 3 contribute to closed loop formation, 
3.) determine the localization of the termination factors in the closed loop structure 
(proximal or distal on the 3’-UTR to the termination codon), 
4.) determine whether the closed loop regulates post-termination ribosome 
recycling, and 
5.) characterize the roles of the termination factors in closed loop function. 
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Fig. 5.1 : Two states model of 
the closed loop. mRNA closed 
loop formation takes place in two 
disctinct steps: (1) 5’ cap-bound 
eIF4E interacts with eIF4G, which 
in turn associates with Pab1p to 
mediate 48S initiation complex 
formation on the mRNA, followed 
by (2) association of the 
translation termination factors, 
eRF1 and eRF3, to stabilize the 
closed loop complex (CLC) to 
allow the formation of a stable 80S 
translation complex on the mRNA. 
In addition to their roles in allowing 
formation of a stable 80S 
ribosomal complex at the initiator 
AUG, presence of the eRFs as 
part of the closed loop complex 
may enhance normal termination 
events and ribosome recycling. 
4E, eIF4E; 4G, eIF4G; 3, eIF3; 4A, 
eIF4A; R1, eRF1; R3, eRF3; red 
ovals, Pab1p; yellow ovals, 40S 
and 60S ribosomal subunits.  
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Fig. 5.2 : Upf1p enhances ribosome reutilization post-termination from a PTC. (1)Termination at a PTC is inefficient and 
allows some (gray arrows) 40S subunits to remain associated with the nonsense mRNA, where they scan for nearby AUGs (both 
upstream and downstream of the PTC) to  reinitiate translation on the same mRNA in a UPF-dependent manner. (2) Ribosomes 
terminating at a PTC require the activity of Upf1p to allow events resulting in proper 60S dissociation in a manner that allows the 
dissociated 60S subunit to join a 48S initiation complex and form an 80S ribosomal complex. Dark yellow ovals, normal 40S and 
60S ribosomal subunits; light yellow oval (60S*), 60S subunit defective in 80S formation; R1, eRF1; R3, eRF3; 1, Upf1p; 2, 
Upf2p/Nmd2p; 3, Upf3p; PTC, premature termination codon; NTC, normal termination codon; horizontal arrows, directions of 
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Appendix A – Methods used in Chapter II 
 
Synthetic mRNAs 
Synthetic, capped poly(A)-containing RNA was synthesized in vitro from chimeric 
genes cloned in a pSP65A vector that included ~65 dT residues for transcription of a 
poly(A) tail (Promega). The construct utilized for synthesis of UAA RNA contained a 5' 
fragment of the S. cerevisiae can1-100 allele upstream of the firefly LUC open reading 
frame. The can1-100 DNA fragment used for this construct contained EcoR I and Sal I 
sites, respectively 114 bp 5' and 147 bp 3' of the initiator ATG. This DNA fragment was 
generated in a one-step PCR amplification, using oligonucleotides #13 (5'-CCGGAA 
TTCCGGATCCAGTTTTTAATCTGTCG-3') and #12 (5'-CGTCGACTTAACTTTTCT 
CATCTTTC-3') and cloned into the EcoR I and Sal I restriction sites of the pSP65A 
vector. The remainder of the construct was derived by insertion of a Sal I LUC/PGK1-3' 
fragment into the Sal I restriction site of the same plasmid, generating pSP65A-can1-
100/LUC. All other constructs used in this study were derived from pSP65A-can1-
100/LUC by site-directed mutagenesis (Stratagene). The mini-DNA constructs were 
generated by deletion of the LUC ORF from a Pst I restriction site (created by site-
directed mutagenesis) 10-15 nt downstream of the premature stop codon and a Pst I 
site immediately 3’ to the normal stop codon. All plasmid constructions were confirmed 
by DNA sequencing. Capped and polyadenylated RNAs were synthesized with the SP6 
mMessage mMachine kit (Ambion), according to the manufacturer's protocol, from Hind 
III-linearized plasmids. RNA yields were quantified by spectrophotometry and their 
integrities were assessed by agarose gel electrophoresis. 
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 Extracts and translation reactions 
Saccharomyces cerevisiae strains MBS (MATa ade2-1 his3-11,15  leu2-3,112  
trp1-1 ura3-1 can1-100 [rho+] L-o, M-o)(Iizuka and Sarnow 1997), NA101 (MATa ade2-
1 his3-11,15  leu2-3,112  trp1-1 ura3-1 can1-100 upf1::HIS3 [rho+] L-o, M-o), and 
MT552/8a (MATα sup45-2 ade2-1 ura3-1)(Stansfield et al. 1997) were used to make 
extracts for in vitro translation by techniques described previously (Sachs et al. 2002). 
Translation assays were essentially the same as those described before (Sachs et al. 
2002), except that 120 μg of extract was used in each assay, and the treatment with 
micrococcal nuclease (Pharmacia) was done at 25oC for 5 min. Unless indicated 
otherwise, translation reactions were incubated for 4 min, with 120 ng of each RNA 
substrate, and terminated by incubation with CHX (0.6 mg/ml) for 3 min. Samples from 
the translation reactions were used for reverse transcription reactions with the 
oligoprimer #3029, complementary to the LUC sequence 
CGCCCTGGTTCCTGGAACAATTGC. In the CHX chase experiment [Fig. 2.3(c)], the 
drug was added after 4 min of translation and the reactions were incubated for 0 to 5 
minutes. Translation reactions programmed with mini RNAs were incubated with 12 ng 
of the miniUAA, miniUAA-M, miniUAA-M-W, or miniUGA RNAs and toeprinting analyses 
of aliquots from each reaction utilized oligoprimer #55 complementary to the PGK1 3'-
UTR sequence CCGAAAAGAAATAAATTGAATTG. Both primers #3029 and #55 
hybridize to their respective RNAs at comparable positions. Translation reactions 
programmed with the Inf constructs (Fig. 2.5) were incubated with 120 ng of RNA for 45 
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min and luciferase activity was assayed as described previously (Tarun and Sachs 
1995). All data reported are representative of at least three independent experiments. 
 
Analysis of mRNAs with MS2 binding sites 
PCR-amplified 188 nt MS2 coat protein binding sites (Coller et al. 1998) were 
inserted 73 nt 3’ of PTCs in the CAN1 UAA and UGA genes (see above) and 37 (PGK1-
MS2) or 164 (PGK1-3’-MS2) nt 3’ of the UAG of mini-PGK1 (Peltz et al. 1993).  These 
constructs were cloned in pYX142 (CAN1) or pRS316 (PGK1) and introduced into cells 
harboring YCplac111-MS2-PAB1 or pA-MP2 (Coller et al. 1998), YCplac111-MS2-dimer 
or pD-MS2(Coller et al. 1998), pMS2-Sxl (Coller et al. 1998), YCplac111-MS2-SUP35, 
YCplac111-MS2-SUP45 (with MS2 fusions under the control of the TPI1 promoter), or 
no plasmid. RNA was isolated and analyzed by northern blotting as described 
previously (Peltz et al. 1993). Hybridization probes were prepared by random priming of 
double-stranded DNA. PGK1-MS2 and PGK1-3’-MS2 mRNAs were detected with a 0.5-
kb Bgl II fragment of the MS2-binding domain; detection of the CYH2, TCM1, and SCR1 
RNAs utilized gene-specific PCR fragments; and detection of CAN1-MS2-LUC mRNAs 
utilized a fragment of the LUC ORF.   
 
Immunoprecipitation (IP) 
Yeast cells, grown at 30°C in minimal media to OD600=1, were harvested, 
washed, and resuspended in IP buffer (10 mM Tris-HCl at pH 7.5, 30 mM MgCl2, 100 
mM NaCl, 2 mM PMSF, 2X Protease Inhibitor cocktail (Sigma), 0.01% TritonX-100, 50 
µg/ml CHX, 0.1 mM DTT). Glass beads (425-600 µm) were added and cells were 
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broken by vortexing 15 seconds eight times, with intermittent cooling on ice. Lysates 
were clarified twice by centrifugation (7,700Xg, 4°C). Protein A Sepharose beads 
(Pierce) were preincubated for 3h at 4°C in IP buffer with rabbit polyclonal α-MS2 coat 
protein antibodies or normal rabbit serum (Pierce), pre-coated overnight at 4°C with 1 
mg of MBS cell extract in 400 µl of IP buffer, washed 3 times with 1ml of IP buffer, 
mixed with 400 µg aliquots of clarified cell extract, and incubated at 4°C for 3h, under 
agitation. Beads were separated from unbound proteins (sup) by a 10 sec centrifugation 
and washed 4 times with IP buffer at 4°C. The bound fraction was eluted by boiling for 5 
min in SDS gel sample buffer. Wash samples were precipitated by TCA and 
resuspended in sample buffer. Samples were fractionated by SDS-PAGE and 
characterized by western blotting. Input, sup, and wash represented 1/20, 1/10, and 1/3 
of the loading of the IP samples, respectively. RNA recovery from IPs was performed as 
above with two changes: RNasin (80U/ml) was added to the IP buffer and the beads 
were washed with 250µl aliquots of this solution. RNA was recovered from the beads 
and IP fractions by phenol/chloroform extraction (Peltz et al. 1993).  
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Appendix B – Methods used in Chapter III 
 
Yeast strains, vectors, and transformations 
The yeast strains used in this chapter, and their genotypes, are listed in Table 
B1. Strain YRG467 was constructed by transforming HFY467 with plasmid pRS315-
NMD2(C-Sal) (He et al. 1996). For in vivo studies, strains were grown in selective media 
(Amberg et al. 2005) at 30oC, or at 24oC for temperature-sensitive strains. Yeast 
transformations were performed by the rapid protocol (Soni et al. 1993) and yeast 
vectors utilized included pRIP1 (Parker and Jacobson 1990), pRS314 (Sikorski and 
Hieter 1989), YEplac22 (Gietz and Sugino 1988), and pRS316 (Sikorski and Hieter 
1989). For in vitro translation experiments, MBS and strains derived from it (NA101, 
NA102, and NA103) were grown in YEPD at 25oC for extract preparation (Amrani et al. 
2004).  
 
Plasmid-borne expression constructs 
Constructs used for in vivo expression analyses are described in Table B2. 
Oligonucleotides used in this study are listed in Table B3. Construct 1, a chimeric 
PGK1/LUC gene (Fig. 1A), consists of the PGK1 5’-untranslated region (UTR), the first 
5% of the PGK1 open reading frame (ORF) followed by a UAG stop codon (contextually 
a premature termination codon), an 82 nt PGK1 sequence element (derived from a 106 
nt segment previously designated as a DSE [(Peltz et al. 1993)] – see Table B2) that 
contains two AUG codons (out of frame with the upstream PGK1 ORF) fused in frame 
to the LUC ORF lacking its normal start codon, and the 3’-UTR of PGK1. All constructs 
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for in vivo luciferase expression experiments contain a 5’BamHI site and a 3’HindIII site 
and were subcloned into vectors by excising with BamHI/HindIII. PCR fragments 1 and 
2 were generated using the mini-PGK1 allele as a template. This allele contains a 58-nt 
tag in its 3’-UTR to allow later detection of its mRNA on a northern blot (Peltz et al. 
1993). Fragment 1 was generated using the M13/pUC Reverse Amplification primer 
(BRL) and primer 3-106-82 and digested with BamHI and PstI restriction enzymes. 
Fragment 2 was generated using primer 5-PPGKH and the M13/pUC Forward 
Amplification primer (BRL) and digested with PstI and HindIII. Fragment 3 was 
generated by PCR using pXP1 as a template (a kind gift from Dr. Paul Dobner), and 
primers 5-PSLUCP and 3-PLUCSP, and digested with PstI. Fragments 1 and 2 were 
ligated into pGEM-3Z(f)+ (Promega) and cut with BamHI/HindIII. The resulting construct 
was cut with PstI, incubated with calf intestinal alkaline phosphatase (CIAP), and ligated 
with fragment 3 to generate construct 3. Construct 1 was generated by digesting 
construct 3 with SalI to remove a 10bp fragment and religating to close. BamHI/HindIII 
fragments containing construct 3 and construct 1 were then subcloned into the 
centromeric yeast vectors pRIP1 (cut with BamHI/HindIII) and pRS314 (cut with SmaI), 
and the high-copy plasmid, YEplac112 (cut with BamHI/HindIII). The resulting 
constructs were transformed into strains HFY114, YRG467, HFY115, HFY861, 
HFY467, HFY872, and HFY874. 
Construct 2 was generated with the Chameleon site-directed mutagenesis kit 
(Stratagene) using the following strategy: plasmid pRIP1 containing construct 1 was 
digested with BamHI/SalI to yield an 800bp fragment containing the 5’-end of construct 
1 from the PGK1 start to the junction of the 82 nt PGK1 sequence element and LUC 
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and an 8kb fragment containing the remainder of the construct and pRIP1. The smaller 
fragment was subcloned into pGEM-3Z(f)+ to yield pGEM-3Z(f)+/PGKBS. The resulting 
plasmid was mutagenized with primers PGKDATG and pGEM-SEL. A BamHI/SalI 
fragment containing the mutagenized construct was then ligated with the 8kb fragment 
described above to yield construct 2. Construct 5 was generated similarly, with primers 
PGKΔTAG and pGEM-SEL, followed by mutagenic primer FUSION. These constructs 
were also placed into pRS314 and YCplac22. Construct 4 was generated using primers 
PGKDELINIT and PGKΔTAG. Construct 6 was generated as follows: an approximately 
560bp fragment was made by PCR using pGEM-3Z(f)+/PGKBS as a template and 
primers M13 reverse and PGKUAGSAL2, and cut with BamHI/SalI. This fragment was 
ligated into the 8kb fragment described above to yield construct 6. All of the above 
constructs were transformed into HFY114, YRG467, HFY115, HFY861, HFY467, 
HFY872, and HFY874.  
To generate construct 7, construct 1 was subcloned into pGEM-3Z(f)+ and cut 
with NheI. Linkers NHELINKERA and NHELINKERB were annealed together and 
ligated into the NheI site. These constructs were sequenced for orientation such that 
NHELINKERA reads 5’?3’. The resulting construct [pGEM-(Sal)lucNHE] was digested 
with StuI to cut within the NHE linker and treated with CIAP. Oligonucleotide primers 
HPR1A and HPR2A were annealed together and HPL1A and HPL2A were annealed 
together. The resulting short double-stranded fragments (designated HairpinR and 
HairpinL, respectively) were isolated on a 15% acrylamide gel and purified by the crush 
and soak method (Maxam and Gilbert 1977). Ligations were performed such that 
HairpinR and HairpinL were ligated together for 0 and 5 minutes before addition of the 
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StuI-cut pGEM-(Sal)lucNHE. Colonies from the above ligations were screened by 
colony PCR for 162bp inserts containing HairpinR and HairpinL (as opposed to double 
HairpinR or double HairpinL inserts) and sequenced for orientation such that HairpinL 
was 5’ of HairpinR. The resulting BamHI/HindIII fragment-containing construct 7 was 
subcloned into YCplac22. This construct was transformed into HFY114, YRG467, 
HFY115, HFY861, HFY467, HFY872, and HFY874. Construct 8 was made by deleting 
the UAG stop codon of construct 7 using the Quick-Change site-directed mutagenesis 
kit (Stratagene). Mutagenic primers were DSTOP1 and DSTOP2. This construct was 
transformed into yeast strains HFY114, YRG467, HFY115, HFY861, HFY467, HFY872, 
and HFY874.  
The CAN1/LUC (“Fusion”) construct used as a template for the preparation of 
synthetic mRNA for in vitro translation experiments has been described elsewhere 
(Amrani et al. 2004). pRS316pA-CAN1 and pRS316pA-can1-100 templates were 
derived by ligating an EcoRI/HindIII fragment of plasmid CFE86 (containing the 
complete CAN1 gene; a kind gift from Chunfang Li) or plasmid CFE87 (which contains 
the complete can1-100 gene; a kind gift from Chunfang Li) into pRS316pA linearized by 
cleavage with EcoRI and HindIII. To generate pRS316pA, oligonucleotide primers Xho-
pA-Asp (5’-[phos]TCGAG(A)75G-3’) and Asp-pT-Xho (5’-[phos]GTACC(T)75C-3’) were 
annealed, alkaline phosphatase-treated (Roche), and ligated into XhoI/Asp718-
linearized pRS316.      
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Measurement of luciferase activity in cells, Bradford assays, and northern 
analyses 
Yeast cultures (30ml) were grown in selective medium overnight at 24oC to an 
OD600 of 0.7-1.2. Fourml of each culture were removed and the cells pelleted and frozen 
at -70oC for later RNA extraction. An additional 20ml of each culture was pelleted and 
washed twice with 1X PBS (0.01M NaH2PO4, 0.15M NaCl). The cells were resuspended 
in 2ml 1X PBS and split between 2 microcentrifuge tubes. These were then pelleted and 
stored at -70oC to await glass bead extraction. The frozen cell pellets were resuspended 
in 200 μL luciferase extraction buffer (LEB) (0.1M KPO4, pH 7.8, 1mM DTT, 1mM 
PMSF). Acid-washed glass beads (200 mg; Sigma 425-600 μm) were added and the 
tubes were then vortexed for 30 sec and placed on ice for 30 sec, alternately, for 5 min. 
The tubes were then spun in a microcentifuge at 14,000 rpm for 5 min at 4oC and the 
supernatant (extract) placed into a fresh tube on ice. The following components were 
then added to a luminometer cuvette: 100 μL LEB, 20 μL extract, and 350 μL Luciferase 
assay buffer (LAB), pH 7.8 (25 mM glycylglycine, pH 7.8, 15 mM KPO4, pH 7.8, 15 mM 
MgSO4, 4 mM EGTA, 2 mM ATP, 1 mM DTT). Assays were performed in a Monolight 
2010 luminometer by injecting 100 μL of 200 μM D-luciferin, potassium salt (Analytical 
Luminescence Labs) in 25 mM glycylglycine, pH 7.8 and measuring light output for 10 
sec. Extracts were stored at -70oC following luciferase assays until Bradford assays 
were performed. Bradford assays were performed on a Beckman DU7400 
Spectrophotometer with the Biorad Protein Assay Kit according to the microassay 
protocol using 10 μL extract per assay. RNA was prepared from frozen cell pellets as 
described previously (Herrick et al. 1990) and quantitated on a Beckman DU7400 
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Spectrophotometer. Aliquots (10 μg) of total RNA were loaded onto a 1% 
agarose/formaldehyde/MOPS gel and electrophoresed, blotted, and hybridized as 
described previously (Herrick et al. 1990). Transcripts derived from the different 
constructs were detected with an oligonucleotide (Peltz et al. 1993) which hybridizes to 
the 3’-UTR of the respective construct mRNAs, but which does not hybridize to the 
endogenous PGK1 mRNA. mRNA signals were quantitated using a Betascope 
(Betagen) blot analyzer. mRNA levels were normalized for loading by stripping the blots 
and rehybridizing with a random-primed probe targeted to the CYH2 mRNA. Final 
luciferase activity was expressed as relative light units (RLU) of 20 μL extract, per μg 
protein in 20 μL extract, per unit of construct mRNA in 10 μg total RNA, normalized for 
loading differences with the CYH2 mRNA signal. Each set of assays performed on a 
given day included three cultures of construct 1 in strain HFY114 on a YCp plasmid, 
and each northern blot from each set of assays contained the RNAs from these three 
cultures. The average luciferase activity (expressed in RLU/μg protein/unit mRNA) of 
these three cultures was assigned a value of 100% to which all other luciferase 
activities in a set of assays were compared. 
 
Extract preparation, synthetic mRNA, in vitro translation, and toeprinting assays 
S.cerevisiae strains MBS, NA101, NA102, and NA103 were used to make 
extracts for in vitro translations as described (Iizuka and Sarnow 1997; Wu et al. 2007; 
He et al. 2008). Capped and polyadenylated CAN1/LUC mRNA was synthesized with 
the SP6 mMessage mMachine kit (Ambion) as per the manufacturer’s protocol, from 
HindIII-linearized plasmids. Capped and polyadenylated CAN1 and can1-100 mRNAs 
 
 
143
were synthesized in vitro from KpnI-linearized pRS316pA-CAN1 and pRS316pA-can1-
100 plasmids using the T7 mMessage mMachine kit (Ambion) as per the manufacturer’s 
protocol. Translation assays were as described (Amrani et al. 2004; Wu et al. 2007), 
except that each assay was performed at 18oC without prior treatment of the extract 
with micrococcal nuclease (MN), unless otherwise specified, and used 100 μg of extract 
and 100ng of the CAN1/LUC mRNA unless specified otherwise. When used, MN pre-
treatment of extracts was performed at 25°C for 5 min (Amrani et al. 2004). Protein 
concentrations of translation extracts were measured using the BCA Protein Assay Kit 
(Pierce). Translation reactions were incubated as specified in the figure legends and 
frozen in a dry ice/ethanol bath until luciferase assays were to be performed. The latter 
were done with a TD20/20 luminometer (Promega), as described previously (Amrani et 
al. 2004). For translation reactions involving FLAG-Upf1p (a kind gift from Dr. Stephanie 
Kervestin), 270-360ng of FLAG-Upf1p or BSA was preincubated with extracts on ice for 
10 min prior to adding the rest of the components of the translation reactions. For add-
back of purified 40S and 60S ribosomal subunits, 5μg of purified 40S subunits, 10μg of 
purified 60S subunits, or BSA was added to the reaction without prior incubation with 
extracts. For toeprinting reactions, translations were terminated by incubation for 3 min 
with 2 mM cycloheximide or GMP-PNP (Sigma), aliquotted, frozen in a dry ice/ethanol 
bath, and stored at -70oC until reverse transcription reactions were to be performed 
(Amrani et al. 2008) with oligomer #105 (5’-CGTCTGTGGTCTGTTTGTGAAGCC-3’). All 
in vitro translation experiments, except add-back experiments with ribosomal subunits, 
were performed at least three times with independently prepared extracts. Add-back 
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experiments with ribosomal subunits were done at least twice with independently 
prepared extracts. 
 
Sucrose gradient analyses 
For mRNA:ribosome association assays, the equivalent of six translation 
reactions were incubated for 30 min at 18oC, stopped by the addition of 2mM CHX, and 
fractionated on an 11ml 7-47% sucrose gradient. The gradients were scanned at A254 , 
and the resulting absorbance profiles were used to determine the position of the 
polysomal and non-polysomal fractions (Mangus and Jacobson 1999; Amrani et al. 
2008). RNA was extracted from each fraction and analysed by northern blotting as 
described previously (Mangus and Jacobson 1999), using random-primed  probes 
directed against the LUC ORF or the 3’ half of the can1-100 ORF (Amrani et al. 2008). 
All experiments were done at least twice with independently prepared extracts. 
 
Ribosome subunit preparation and western blot analysis 
We utilized a procedure for purification of 40S and 60S ribosomal subunits that 
had been described previously (Algire et al. 2002), except that we used 9L of strain 
MBS grown in YPD at 25oC to an OD600 of 1.0. Fractions enriched for 40S and 60S 
subunits were concentrated in Amicon Ultra-15 100K NMWL filter devices (Miilipore). 
Protein concentrations were measured using the BCA Protein Assay Kit (Pierce). The 
40S fraction contained 18S rRNA, but no detectable 25S rRNA, and the 60S fraction 
contained 25S rRNA, but no detectable 18S rRNA, as visualized on a 1% 
formaldehyde-agarose gel stained with ethidium bromide. Upf1 association with 40S 
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and 60S ribosomal subunits was assessed by western blot analysis using methods and 
anti-Upf1p antibody described previously (Mangus and Jacobson 1999).  
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Table B1. Yeast strains used in this study 
 
Strain                            Genotype                                                   Reference            
 
HFY114 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,   (He et al. 2003) 
                     ura3-1, can1-100 
 
HFY115 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (He et al. 2003) 
           ura3-1, can1-100, nmd2::HIS3 
 
HFY467 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (He and Jacobson 1995) 
           ura3-1, can1-100, nmd2::HIS3, upf1::URA3 
 
HFY861 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (He et al. 1997) 
           ura3-1, can1-100, upf3::HIS3 
 
HFY872 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (He et al. 1997) 
           ura3-1, can1-100, upf1::URA3, upf3::HIS3 
 
HFY874 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (He et al. 1997) 
           ura3-1, can1-100, upf3::HIS3, nmd2::URA3 
 
YRG467 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,     This study 
                      ura3-1,  can1-100, nmd2::HIS3, upf1::URA3 + 
                      [ pRS315-NMD2(C-Sal)] 
 
RY262  MATα, his4-519, ura3-52, rpb1-1     (Herrick et al. 1990) 
 
SWP154(-)    MATα,upf1-Δ1::URA3,ura3-52,rpb1-1,leu2-1,    (Peltz et al. 1993) 
          his4-38 
 
MBS              MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,    (Iizuka and Sarnow 1997)                       
                      ura3-1, can1-100, [rho+], L-o, M-o 
 
NA101    MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,     (Amrani et al. 2004) 
             ura3-1, can1-100, [rho+], L-o, M-o, upf1::HIS3 
 
NA102 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,     (Amrani et al. 2004) 
           ura3-1, can1-100, [rho+], L-o, M-o, nmd2::HIS3 
 
NA103 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1,       This study 
           ura3-1, can1-100, [rho+], L-o, M-o, upf3::HIS3 
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Table B2. Pertinent features of constructs used in this study 
 
Construct            Description 
 
Mini-PGK1   Contains the 5’-UTR and first 5% of the PGK1 ORF followed by a 
premature termination codon, a 106 nt PGK1 sequence element 
required for NMD-sensitivity that contains two AUG codons, and the 
3’-UTR of PGK1 (Peltz et al. 1993). There is an NheI restriction site 
at the UAG stop codon that terminates the PGK1 ORF prematurely. 
This PGK1 construct and all other related constructs were 
subcloned into various vectors with a 5’ BamHI site and a 3’ HindIII 
site. 
 
Construct 1 Similar to the mini-PGK1 allele (above), except that the 106 
nt sequence element was truncated to 82 nt (retaining the two AUG 
codons) and the LUC coding region (minus its endogenous AUG 
start codon) was inserted immediately 3’ to it. The LUC coding 
region is in frame with the two AUG codons of the 82 nt sequence 
element, generating a 1716 bp ORF in the +1 reading frame 
relative to the PGK1 ORF. A SalI site joins the 82 nt sequence 
element and the 5’ end of the LUC coding region; a PstI site joins 
the 3’ end of the LUC coding region and the PGK1 3’-UTR. As in 
mini-PGK1, an NheI site lies at the UAG codon. 
 
Construct 2 Identical to construct 1, except that each of the two AUGs of the 82 
nt PGK1 sequence element were deleted. The first ORF following 
the PGK1 premature termination codon begins at an AUG codon 82 
nt into the LUC coding region. 
 
Construct 3 Similar to construct 1, except that the LUC coding region is in the 
+2 reading frame, relative to the PGK1 ORF, and out of frame with 
the two AUGs of the 82 nt PGK1 sequence element. There is a 
10bp linker between the 82 nt PGK1 sequence element and the 
LUC coding region containing the sites 5’-SalI-PstI-SalI-3’. 
Digestion with SalI and religation to close yielded construct 1. 
 
Construct 4 Identical to construct 1, except that the premature UAG codon 
between the PGK1 ORF and the 82 nt PGK1 sequence element 
was deleted.  
 
 
Construct 5 Identical to construct 1, except that the premature UAG codon of 
PGK1 plus the first nt of the 82 nt PGK1 sequence element were 
deleted, generating an ORF that begins at the PGK1 AUG initiation 
codon and ends at the LUC termination codon. 
 
 
 
148
Construct 6 The PGK1 ORF and the 82 nt PGK1 sequence element of 
construct 1 were deleted between the PGK1 AUG initiation codon 
and the beginning of the LUC coding region. A SalI site lies at the 
junction of the PGK1 5’-UTR and the LUC coding region. 
 
Construct 7 A stem-loop cassette consisting of a strong stem-loop preceded by 
a 30nt leader was inserted into construct 1 between the premature 
UAG codon of PGK1 and the 82 nt PGK1 sequence element. NheI 
sites are present at the UAG codon and between the stem-loop and 
the 82 nt PGK1 sequence element. A SalI site lies between the 82 
nt PGK1 sequence element and the LUC coding region. A PstI site 
is at the LUC UAA termination codon. 
 
Construct 8 Identical to construct 8, except that the UAG termination codon of 
PGK1 was deleted, generating an ORF starting at the PGK1 
initiation codon and ending at the LUC termination codon. 
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Table B3. Oligonucleotide primers used in this study 
 
Oligonucleotide        Sequence 
 
3-106-82   5’-AAAACTGCAGTCGACGCCAGCCAGCTGGAATACCT 
T-3’ 
 
5-PPGKH 5’-AAAACTGCAGGATCTCCCATGTCTCTACTGGT-3’ 
 
5-PSLUCP 5’-AAAACTGCAGTCGACGCCAAAAACATAAAGAAAG-3’ 
 
3-PLUCSP AAAACTGCAGTTACAATTTGGACTTTCCGCC-3’ 
 
PGKDATG 5’-AGTCCTAGCTAGCTAGGACTTCATCATTGCTGCTTT 
CTCTGCTGCCAACACCAAGACTGTCACTGACAA-3’ 
 
pGEM-SEL 5’-CTATAGGGCGATATCGAGCTCG-3’ 
 
PGKΔTAG 5’-AGAGTTCTAGCTAGCGACTTCATCATTGCT-3’ 
 
FUSION 5’-ATTCCAGCTGGCTGGGTCGACCTGCAGGCA-3’ 
 
PGKDELINIT 5’-ACAAATATAAAAACATCTTTATCTTCAAAG-3’ 
 
106DEL83 5’-TTCCAGCTGGCTGGCTCGACGCCAAAAACA-3’ 
 
106DEL1 5’-GTTCTAGCTAGCTAGACTTCATCATTGCTG-3’ 
 
PGKUAGSAL2 5’-GTCGACCCTAGCTAGCTAGAACTCTGAT-3’ 
 
NHELINKERA 5’-CTAGCTAGAGCGCTGATATCAGGCCTCTAG-3’ 
 
NHELINKERB 5’-CTAGCTAGAGGCCTGATATCAGCGCTCTAG-3’ 
 
SALLINKERA 5’-TCGACAGCGCTGATATCAGGCCTG-3’ 
 
SALLINKERB 5’-TCGACAGGCCTGATATCAGCGCTG-3’ 
 
HPR1A 5’-TGGGCAGAAGCCTTGACAGCGGCTTC-3’ 
 
HPR2A 5’-GAAGCCGCTGTCAAGGCTTCTGCCCAAT-3’ 
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HPL1A 5’-GTCGGTCCAGAAGTTGAAGCCGCTGTCAAGGCTTCT 
GCCCAAT-3’ 
 
HPL2A 5’-TGGGCAGAAGCCTTGACAGCGGCTTCAACTTCTGGA 
CCGAC-3’ 
 
HAIRPINL1 5’-GTCGGTCCAGAAGTTGAAGCCGCTGTCAAGGCTTCT 
GCTTAAT-3’ 
 
HAIRPINL2 5’-TAAGCAGAAGCCTTGACAGCGGCTTCAACTTCTGGA 
CCGAC-3’  
 
HAIRPINR1 5’-TAAGCAGAAGCCTTGACAGCGGCTTC-3’ 
 
HAIRPINR2 5’-GAAGCCGCTGTCAAGGCTTCTGCTTAAT-3’ 
 
DSTOP1 5’-CATCAGAGTTCTAGCTAGCAGCGCTGATATCAGGGT 
CG-3’ 
 
DSTOP2  5’-CGACCCTGATATCAGCGCTGCTAGCTAGAACTCTGA 
TG -3’ 
 
SAL-PST  5’-TCGATGCA-3’ 
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 Appendix C – Methods used in Chapter IV 
 
 
 
Synthetic mRNAs  
Synthetic, capped poly(A)-containing miniUAA1, UAA and AAA mRNAs were 
transcribed in vitro from chimeric genes cloned in a pSP65A vector that included ~65 dT 
residues for transcription of a poly(A) tail (Amrani et al. 2004). mRNAs of intermediate 
lengths originated from truncated DNA constructs derived from pSP65A-CAN1/LUC 
(Amrani et al. 2004) by deletion of the LUC ORF from Pst I restriction sites (created by 
site-directed mutagenesis; Stratagene). mRNAs differing in poly(A) tail length were 
synthesized from miniUAA1 DNA cloned in pSP65A vectors that contain the 
corresponding lengths of dT residues (Munroe and Jacobson 1990). The construct 
utilized for synthesis of long ADE2 mRNA was generated in a one-step PCR 
amplification, using EcoR I site-containing oligonucleotide #165 (which also contains 
mutations of two upstream AUGs) (5'-
CGGAATTCATTATAGAGCATTTCATATATAAATTGGTGCGTAAAATCGTTGGATCTC
TC-3') and BamH I site-containing oligonucleotide #164 (5'-
GAGGATCCAAATTCTTAAAAAAGGACACCTGTAAGCGTTG -3') and cloned into the 
EcoR I and BamH I restriction sites of the pSP65A vector. The miniADE2 DNA construct 
was generated by deletion of the 1575nt fragment from a Pst I restriction site 260-265 nt 
downstream of the start of the construct and a Pst I site immediately 5’ to the normal 
stop codon (both sites were created by site-directed mutagenesis). All plasmid 
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constructions were confirmed by DNA sequencing. Capped and polyadenylated RNAs 
were synthesized with the SP6 mMessage mMachine kit (Ambion), according to the 
manufacturer's protocol, from Hind III-linearized plasmids for poly(A)-containing mRNA 
or from Cla I linearized plasmids for mRNA lacking the poly(A) tail. At least 80% of in 
vitro transcribed mRNAs were capped, as determined by immunoprecipitation using 
anti-2,2,7-trimethylguanosine agarose conjugate (Calbiochem). Uncapped mRNA was 
synthesized using the MEGAscript kit (Ambion). RNA yields were quantified by 
spectrophotometry and their integrities were assessed by agarose gel electrophoresis. 
 
Extracts and translation reactions  
Saccharomyces cerevisiae strains (Table C1) were used to make extracts for in 
vitro translation by techniques described previously (Wu et al. 2007). Wild-type strains 
from different genetic backgrounds gave similar results. Translation and toeprinting 
assays were essentially the same as those described before (Amrani et al. 2004). 
Unless indicated otherwise, translation reactions were incubated for 4 min with 
0.06 pmol of each RNA substrate, and terminated by incubation for 3 min with 2mM 
cycloheximide or GMP-PNP. Where indicated, translation initiation was subjected to 
competitive inhibition by 2.7 mM cap analog (m7GpppG), a concentration that readily 
distinguishes initiation complexes that are, respectively, sensitive or resistant to this 
compound. Toeprinting utilized two different primers that were complementary to their 
respective targets at comparable distances from the AUG of interest.  Primer #3029 was 
used for mRNAs spanning 600nt (miniUAA2) to 2135nt (AAA) and primer #55 was used 
with miniUAA1 mRNA. Samples from translation reactions programmed with ADE2 and 
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miniADE2 mRNAs were toeprinted with primer #172, complementary to the sequence 
CACTAAAGAATCTTCAAGTAAAACATCCC, and primer #3238, complementary to the 
sequence GGACTTCATACATAGAAATCAACG, respectively. For mRNA:ribosome 
association assays, the equivalent of four translation reactions were fractionated in an 
11ml sucrose gradient (7-47%). The gradients were fractionated and scanned at 254 
nm, and the resulting absorbance profiles were used to determine the position of the 
polysomal and non-polysomal fractions (Mangus and Jacobson 1999). RNA was 
extracted from each fraction and analyzed by northern blotting as described previously 
(Mangus and Jacobson 1999). 
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Table C1. Yeast strains used in this study 
Strain Genotype 
MBS (Iizuka and 
Sarnow 1997) 
MATa ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 can1-
100 [rho+] L-o, M-o
yDM206 (Mangus 
et al. 1998) 
MATa ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 can1-
100 pab1::HIS3 pbp1::LEU2
yDM146 (Mangus 
et al. 1998) 
MATa ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 can1-
100 pbp1::LEU2
yJP62 MATα ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 pab1::HIS3 [pYCplac111PAB1 LEU2 CEN4] 
yJP103 MATα ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 pab1::HIS3 [pYCplac111pab1-134 LEU2 CEN4]  
yJP104 MATα ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 pab1::HIS3 [pYCplac111pab1-184 LEU2 CEN4]  
yJP78 MATα ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 pab1::HIS3 [pYCplac11pab1-ΔRRM1 LEU2 CEN4]  
yJP68 
MATα ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 
pab1::HIS3 [pYCplac111pab1-ΔC-term (deletion of aa 
406-577) LEU2 CEN4] 
yAS2069 (Tarun 
et al. 1997) 
MATa ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 
pep4::HIS3 tif4631::LEU2 tif4632::ura3 [pTIF4631 TRP1 
CEN] 
yAS2071 (Tarun 
et al. 1997) 
MATa ade2-1 his3-11,15  leu2-3,112  trp1-1 ura3-1 
pep4::HIS3 tif4631::LEU2 tif4632::ura3 [pTIF4631-ΔN300 
TRP1 CEN] 
NA200 MATα  ade2-1 ura3-1
NA207 MATα  ade2-1 ura3-1 sup35::ADE2 [pRS316, sup35-R419G, URA3,CEN]
MT552/8a 
(Stansfield et al. 
1997) 
MATα sup45-2 ade2-1 ura3-1 
TP11B-4-1 
(Barnes et al. 
1993) 
MATa ade1 leu2-3,112 ura3-52 prt1-1 
21R (Barnes et 
al. 1993) MATa ade1 leu2-3,112 ura3-52 
H3016 (Nielsen 
et al. 2004) 
MATα ade8 leu1  trp1 ura3 cdc33 [p3351 CDC33 URA3 
2μ] 
H3015 (Nielsen 
et al. 2004) MATα ade8 leu1  trp1 ura3 cdc33 [p1992 URA3 2μ] 
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Appendix D – Toeprinting overview  
 
 
We have used the toeprinting technique to study ribosomal positioning on 
synthetic mRNAs. This assay is based on primer extension inhibition by reverse 
transcriptase (RT) encountering a physical block, such as a ribosome on an mRNA 
molecule. In our assays, translation reactions containing synthetic RNAs are terminated 
by the addition of a drug that blocks ribosomal movement. The elongation inhibitor 
cycloheximide (CHX) is used to visualize 80S ribosomes positioned at AUG codons 
(Fig. D1). Use of the non-hydrolyzable GTP analog, GMP-PNP, allows visualization of 
40S ribosomal subunits at an AUG codon (Fig. D2). Alternatively, these drugs can be 
omitted to visualize ribosomes whose movement/dissociation is markedly slower, thus 
allowing inhibition of RT activity. Translation reaction termination is followed by the 
addition of a radiolabeled oligonucleotide complementary to a sequence on the mRNA 
downstream of a region of interest. Addition of the RT allows extension of this 
oligonucleotide until the enzyme encounters the stalled ribosome or ribosomal subunit 
on the mRNA. The cDNA products are resolved on a sequencing gel and the leading 
edge of the ribosome is inferred by comparison of the position of the cDNA product to 
the sequence of the same region of the exogenously added RNA. The position of the 
cDNA band is usually 16/17 nucleotides downstream of the codon situated in the 
ribosomal P site (designated +16/17 toeprint) and 12-14 nucleotides downstream of the 
codon situated in the A site (designated +12 or +14 toeprint). Bonafide toeprint bands 
are distinguished from background bands by performing the analysis in parallel 
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reactions supplemented with the translation initiation inhibitor, cap analog, which results 
in a cDNA product with a highly diminished signal at positions which are occupied by 
ribosomes in reactions lacking the cap analog. 
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product. The yellow highlighted lanes on the gel show toeprint bands in the absence or 
presence of cap analog.
a b
Fig. D1 : Toeprinting 80S ribosomes. (a) Schematic outlining formation of the cDNA products visualized as toeprint bands. In the presence 
of CHX, 80S ribosomes (yellow circles) are stalled with an AUG codon in their P sites. A radiolabeled oligonucleotide (red bar) is annealed to a 
complementary sequence on the mRNA. Reverse transcriptase (RT; purple oval) extends the oligonucleotide until it is blocked by the stalled 
ribosome. The cDNA product (blue bar) can then be visualized on a polyacrylamide sequencing gel. Addition of cap analog reduces formation 
of 80S complexes on the mRNA and leads to dimished 80S-dependent cDNA products. (b) Polyacrylamide sequencing gel showing the 
presence of CHX-dependent +16/17 toeprint bands (yellow box) in the absence and presence of cap analog. A sequencing reaction of plasmid 
template DNA corresponding to the mRNA of interest is shown on the left with the position of the AUG codon highlighted (yellow stars).   
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product. The yellow highlighted lanes on the gel show toeprint bands in the absence or 
presence of cap analog.
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Fig. D2 : Toeprinting 40S ribosomal subunits. (a) Schematic outlining formation of the cDNA products visualized as toeprint bands. In the 
presence of GMP-PNP, 40S ribosomes (yellow circles) are stalled with an AUG codon in their P sites. A radiolabeled oligonucleotide (red bar) is 
added which anneals to a complementary sequence on the mRNA. Reverse transcriptase (RT; purple oval) extends the oligonucleotide until it is 
blocked by the stalled ribosomal subunit. The cDNA product (blue bar) can then be visualized on a polyacrylamide sequencing gel. Addition of 
cap analog reduces formation of 40S complexes on the mRNA and leads to dimished 40S-dependent cDNA products. (b) Polyacrylamide 
sequencing gel showing the presence of GMP-PNP-dependent +16/17 toeprint bands (yellow box) in the absence and presence of cap analog. 
A sequencing reaction of plasmid template DNA corresponding to the mRNA of interest is shown on the left with the position of the AUG codon 159
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